10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________________________________________

FORM 10-Q/A

(Amendment No. 1)

_______________________________________________________

(Mark One)
☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 27, 2021

OR
o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________ to ________

Commission File Number: 001-38115

___________________________________________________________________________________________________________

The Simply Good Foods Company

(Exact name of registrant as specified in its charter)

___________________________________________________________________________________________________________

Delaware	82-1038121
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

1225 17th Street, Suite 1000

Denver, CO 80202

(Address of principal executive offices and zip code)

(303) 633-2840

(Registrant’s telephone number, including area code)

___________________________________________________________________________________________________________

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading symbol	Name of each exchange on which registered
Common Stock, par value $0.01 per share	SMPL	Nasdaq

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Date File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of April 5, 2021, there were 95,762,832 shares of common stock, par value $0.01 per share, issued and outstanding.

EXPLANATORY NOTE

    This Amendment No. 1 to Form 10-Q (this “Amendment” or “Form 10-Q/A”) amends The Simply Good Foods Company’s Quarterly Report on Form 10-Q for the thirteen and twenty-six weeks ended February 27, 2021, which was originally filed with the SEC on April 8, 2021 (the “Original Filing”). See Note 2, Restatement of Previously Issued Financial Statements, in Part I, Item 1, Financial Statements, for additional information.

    On April 12, 2021, the SEC issued a statement (the “SEC Statement”) on the accounting and reporting considerations for warrants issued by special purpose acquisition companies (“SPACs”). The SEC Statement discussed certain features of warrants issued in SPAC transactions that may be common across many entities. Specifically, the SEC Statement focused in part on provisions in warrant agreements that provide for potential changes to the settlement amounts dependent upon the characteristics of the warrant holder. The SEC Statement indicated that, because the holder of a warrant is not an input into the pricing of a fixed-for-fixed option on equity shares, such provisions would preclude the warrant from being classified in equity and thus the warrant should be classified as a liability. Following consideration of the guidance in the SEC Statement, The Simply Good Foods Company (the “Company”) concluded that its private warrants (“Private Warrants”) should be classified as a liability and measured at fair value, with changes in fair value each period reported in earnings in accordance with Accounting Standards Codification 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity.

    On May 13, 2021, the Audit Committee of the Company’s Board of Directors, in consultation with management, concluded that the Company’s previously issued consolidated financial statements for the fiscal years ended August 29, 2020, August 31, 2019, and August 25, 2018, and for each of the Company’s previously issued unaudited interim quarterly financial statements for fiscal years 2020, 2019 and 2021 (the “Non-Reliance Period”), should no longer be relied upon. As such, the Company resolved to restate the consolidated financial statements for the Non-Reliance Period. See Note 2, Restatement of Previously Issued Financial Statements, in Part 1, Item 1, Financial Statements for additional information.

    The Company is filing this Amendment to amend and restate the previously issued financial statements for the Company’s second fiscal quarter of 2021 to correct the misapplication of the accounting for the Private Warrants. This Amendment also amends and restates the Company’s Management’s Discussion and Analysis of Financial Condition and Results of Operations and other disclosures made in the Original Filing as appropriate to reflect the restatement of the relevant periods (the “Restatement”).

Effect of Restatement

    As a result of the Restatement, the Private Warrants are now reflected as a liability measured at fair value on the Company’s Condensed Consolidated Balance Sheets, and the change in the fair value of this liability in each period is recognized as a gain or loss in the Company’s Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

    The effect of these adjustments on net income for the thirteen and twenty-six weeks ended February 27, 2021 was a loss of $45.3 million and a loss of $24.9 million, respectively. The adjustments increased total liabilities at February 27, 2021 by $118.5 million, with a corresponding decrease to total stockholders’ equity.

    The restatement of the financial statements had no effect on the Company’s liquidity, cash, or cash equivalents, or cash flows from operating, investing and financing activities. See Note 2 to the Condensed Consolidated Financial Statements included in Part I, Item 1, Financial Statements, of this Amendment for additional information on the restatement and the related financial statement effects.

Internal Control Considerations

    As previously disclosed in our Annual Report on Form 10-K/A for the year ended August 29, 2020, we identified a material weakness in our internal controls over financial reporting related to inaccurate accounting for warrants issued in connection with our initial public offerings and private placement. As a result of the material weakness, the Company’s disclosure controls and procedures were not effective as of August 29, 2020. Management plans to implement changes to strengthen internal controls and to remediate the material weakness. For additional information, see Part I, Item 4, Controls and Procedures, of this Form 10-Q/A.

Items Amended in this Form 10-Q/A

The following sections in the Original Filing are amended and restated in the entirety in this Form 10-Q/A to reflect the restatement:

•Part I - Item 1 - Financial Statements (Unaudited)

•Part I - Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations

•Part I - Item 4 - Controls and Procedures

•Part II - Item 6 - Exhibits

    Our principal executive officer and principal financial officer have also provided new certifications as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 dated as of the filing date of this Form 10-Q/A. The certifications are included in this Form-10Q/A as Exhibits 31.1, 31.2, and 32.1.

    This Form 10-Q/A sets forth only those items from the Original Filing that have been modified and superseded to reflect the Restatement. Except as provided above, this Amendment does not reflect events occurring after the filing of the Original Filing. Accordingly, this Form 10-Q/A should be read in conjunction with the Original Filing and filings with the SEC subsequent to the date on which the Company filed the Original Filing with the SEC.

THE SIMPLY GOOD FOODS COMPANY AND SUBSIDIARIES

FORM 10-Q

FOR THE QUARTER ENDED FEBRUARY 27, 2021

INDEX

		Page
PART I. Financial Information
Item 1.	Financial Statements (Unaudited)	6
	Condensed Consolidated Balance Sheets (As Restated)	6
	Condensed Consolidated Statements of Operations and Comprehensive Income (As Restated)	7
	Condensed Consolidated Statements of Cash Flows (As Restated)	8
	Condensed Consolidated Statements of Stockholders’ Equity (As Restated)	10
	Notes to Unaudited Condensed Consolidated Financial Statements	11
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	27
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	37
Item 4.	Controls and Procedures	37
PART II. Other Information
Item 1A.	Risk Factors	39
Item 6.	Exhibits	40
	Signatures	41

4

PART I. Financial Information

Item 1. Financial Statements (Unaudited)

The Simply Good Foods Company and Subsidiaries

Condensed Consolidated Balance Sheets

(Unaudited, dollars in thousands, except share and per share data)

	February 27, 2021		August 29, 2020
	(As Restated, see Note 2)
Assets
Current assets:
Cash and cash equivalents	$	91,307	$	95,847
Accounts receivable, net	97,329		89,740
Inventories	82,771		59,085
Prepaid expenses	4,894		3,644
Other current assets	12,833		11,947
Total current assets	289,134		260,263
Long-term assets:
Property and equipment, net	11,092		11,850
Intangible assets, net	1,146,039		1,158,768
Goodwill	543,134		544,774
Other long-term assets	32,119		32,790
Total assets	$	2,021,518	$	2,008,445
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$	43,585	$	32,240
Accrued interest	384		960
Accrued expenses and other current liabilities	36,313		38,007
Current maturities of long-term debt	278		271
Total current liabilities	80,560		71,478
Long-term liabilities:
Long-term debt, less current maturities	548,884		596,879
Deferred income taxes	92,536		84,352
Warrant liability	118,519		93,638
Other long-term liabilities	20,880		22,765
Total liabilities	861,379		869,112
See commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $0.01 par value, 100,000,000 shares authorized, none issued	—		—
Common stock, $0.01 par value, 600,000,000 shares authorized, 95,856,715 and 95,751,845 shares issued at February 27, 2021 and August 29, 2020, respectively	959		958
Treasury stock, 98,234 and 98,234 shares at cost at February 27, 2021 and August 29, 2020, respectively	(2,145)		(2,145)
Additional paid-in-capital	1,080,340		1,076,472
Retained earnings	81,666		64,927
Accumulated other comprehensive loss	(681)		(879)
Total stockholders’ equity	1,160,139		1,139,333
Total liabilities and stockholders’ equity	$	2,021,518	$	2,008,445

See accompanying notes to the unaudited condensed consolidated financial statements.

5

Table of Contents

The Simply Good Foods Company and Subsidiaries

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

(Unaudited, dollars in thousands, except share and per share data)

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
	February 27, 2021		February 29, 2020		February 27, 2021		February 29, 2020
	(As Restated, see Note 2)				(As Restated, see Note 2)
Net sales	$	230,607	$	227,101	$	461,759	$	379,254
Cost of goods sold	140,342		141,707		277,453		231,654
Gross profit	90,265		85,394		184,306		147,600
Operating expenses:
Selling and marketing	26,150		27,041		51,345		45,475
General and administrative	26,562		28,103		51,977		46,248
Depreciation and amortization	4,212		4,287		8,456		6,740
Business transaction costs	—		694		—		26,853
Total operating expenses	56,924		60,125		111,778		125,316
Income from operations	33,341		25,269		72,528		22,284
Other income (expense):
Interest income	—		85		3		1,464
Interest expense	(7,995)		(10,589)		(16,367)		(15,558)
(Loss) gain in fair value change of warrant liability	(45,334)		37,644		(24,881)		50,952
Gain (loss) on foreign currency transactions	975		(194)		984		(178)
Other income	112		8		159		45
Total other (expense) income	(52,242)		26,954		(40,102)		36,725
(Loss) income before income taxes	(18,901)		52,223		32,426		59,009
Income tax expense	7,313		3,922		15,687		2,193
Net (loss) income	$	(26,214)	$	48,301	$	16,739	$	56,816
Other comprehensive income:
Foreign currency translation adjustments	243		(141)		198		(141)
Comprehensive (loss) income	$	(25,971)	$	48,160	$	16,937	$	56,675
(Loss) earnings per share from net (loss) income:
Basic	$	(0.27)	$	0.51	$	0.17	$	0.61
Diluted	$	(0.27)	$	0.11	$	0.17	$	0.06
Weighted average shares outstanding:
Basic	95,734,591		95,339,489		95,712,057		92,524,061
Diluted	95,734,591		100,336,571		96,997,012		97,597,614

See accompanying notes to the unaudited condensed consolidated financial statements.

6

Table of Contents

The Simply Good Foods Company and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited, dollars in thousands)

	Twenty-Six Weeks Ended
	February 27, 2021		February 29, 2020
	(As Restated, see Note 2)
Operating activities
Net income	$	16,739	$	56,816
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	9,021		7,119
Amortization of deferred financing costs and debt discount	2,108		1,569
Stock compensation expense	3,594		3,795
Loss (gain) in fair value change of warrant liability	24,881		(50,952)
Unrealized loss (gain) on foreign currency transactions	(985)		178
Deferred income taxes	8,119		2,485
Amortization of operating lease right-of-use asset	2,253		1,652
Loss on operating lease right-of-use asset impairment	681		—
Gain on lease termination	(154)		—
Other	216		789
Changes in operating assets and liabilities, net of acquisition:
Accounts receivable, net	(7,015)		(19,062)
Inventories	(24,502)		768
Prepaid expenses	(1,191)		(873)
Other current assets	(674)		(5,808)
Accounts payable	10,275		(2,953)
Accrued interest	(577)		175
Accrued expenses and other current liabilities	(1,881)		(8,760)
Other assets and liabilities	(1,144)		(1,824)
Net cash provided by (used in) operating activities	39,764		(14,886)
Investing activities
Purchases of property and equipment	(449)		(481)
Issuance of note receivable	—		(1,250)
Acquisition of business, net of cash acquired	—		(984,201)
Proceeds from sale of business	5,800		—
Investments in intangible assets	(114)		—
Net cash provided by (used in) investing activities	5,237		(985,932)
Financing activities
Proceeds from option exercises	527		931
Tax payments related to issuance of restricted stock units	(252)		(80)
Payments on finance lease obligations	(168)		(157)
Principal payments of long-term debt	(50,000)		(21,000)
Proceeds from issuance of common stock	—		352,542
Equity issuance costs	—		(3,323)
Proceeds from issuance of long-term debt	—		460,000
Deferred financing costs	—		(8,208)
Net cash (used in) provided by financing activities	(49,893)		780,705
Cash and cash equivalents
Net decrease in cash	(4,892)		(220,113)
Effect of exchange rate on cash	352		(113)
Cash at beginning of period	95,847		266,341
Cash and cash equivalents at end of period	$	91,307	$	46,115

7

Table of Contents

	Twenty-Six Weeks Ended
	February 27, 2021		February 29, 2020
	(As Restated, see Note 2)
Supplemental disclosures of cash flow information
Cash paid for interest	$	14,835	$	13,814
Cash paid for taxes	$	10,023	$	4,345
Non-cash investing and financing transactions
Non-cash proceeds from sale of business	$	3,000	$	—
Operating lease right-of-use assets recognized at ASU No 2016-02 transition	$	—	$	5,102
Finance lease right-of-use assets recognized at ASU No 2016-02 transition	$	—	$	1,185
Operating lease right-of-use assets recognized after ASU No 2016-02 transition	$	316	$	2,733

See accompanying notes to the unaudited condensed consolidated financial statements.

8

Table of Contents

The Simply Good Foods Company and Subsidiaries

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited, dollars in thousands, except share data)

							(As Restated, see Note 2)		(As Restated, see Note 2)				(As Restated, see Note 2)
	Common Stock			Treasury Stock			Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Total
	Shares	Amount		Shares	Amount
Balance at August 29, 2020	95,751,845	$	958	98,234	$	(2,145)	$	1,076,472	$	64,927	$	(879)	$	1,139,333
Net income	—	—		—	—		—		42,953		—		42,953
Stock-based compensation	—	—		—	—		1,110		—		—		1,110
Foreign currency translation adjustments	—	—		—	—		—		—		(45)		(45)
Shares issued upon vesting of restricted stock units	53,908	—		—	—		(201)		—		—		(201)
Exercise of options to purchase common stock	13,118	—		—	—		157		—		—		157
Balance at November 28, 2020	95,818,871	$	958	98,234	$	(2,145)	$	1,077,538	$	107,880	$	(924)	$	1,183,307
Net income	—	—		—	—		—		(26,214)		—		(26,214)
Stock-based compensation	—	—		—	—		2,484		—		—		2,484
Foreign currency translation adjustments	—	—		—	—		—		—		243		243
Shares issued upon vesting of restricted stock units	7,034	—		—	—		(51)		—		—		(51)
Exercise of options to purchase common stock	30,810	1		—	—		369		—		—		370
Balance at February 27, 2021	95,856,715	$	959	98,234	$	(2,145)	$	1,080,340	$	81,666	$	(681)	$	1,160,139

	Common Stock			Treasury Stock			Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Total
	Shares	Amount		Shares	Amount
Balance at August 31, 2019	81,973,284	$	820	98,234	$	(2,145)	$	715,740	$	(711)	$	(836)	$	712,868
Net loss	—	—		—	—		—		8,515		—		8,515
Stock-based compensation	—	—		—	—		1,673		—		—		1,673
Public equity offering	13,379,205	134		—	—		349,085		—		—		349,219
Shares issued upon vesting of restricted stock units	46,911	—		—	—		(70)		—		—		(70)
Exercise of options to purchase common stock	17,372	—		—	—		208		—		—		208
Balance at November 30, 2019	95,416,772	$	954	98,234	$	(2,145)	$	1,066,636	$	7,804	$	(836)	$	1,072,413
Net income	—	—		—	—		—		48,301		—		48,301
Stock-based compensation	—	—		—	—		2,122		—		—		2,122
Foreign currency translation adjustments	—	—		—	—		—		—		(141)		(141)
Shares issued upon vesting of restricted stock units	771	—		—	—		(10)		—		—		(10)
Exercise of options to purchase common stock	58,994	1		—	—		723		—		—		724
Balance at February 29, 2020	95,476,537	$	955	98,234	$	(2,145)	$	1,069,471	$	56,105	$	(977)	$	1,123,409

See accompanying notes to the unaudited condensed consolidated financial statements.

9

Table of Contents

Notes to Unaudited Condensed Consolidated Financial Statements

(Unaudited, dollars in thousands, except for share and per share data)

1. Nature of Operations and Principles of Consolidation

Description of Business

    The Simply Good Foods Company (“Simply Good Foods” or the “Company”) is a consumer-packaged food and beverage company that aims to lead the nutritious snacking movement with trusted brands that offer a variety of convenient, innovative, great-tasting, better-for-you snacks and meal replacements. The Company’s nutritious snacking platform consists of the following core brands that specialize in providing products for consumers that follow certain nutritional philosophies, dietary approaches and/or health-and-wellness trends: Atkins® for those following a low-carb lifestyle; and Quest® for consumers seeking to partner with a brand that makes the foods they crave work for them, not against them, through a variety of protein-rich foods and beverages that also limit sugars and simple carbs. The Company distributes its products in major retail channels, primarily in North America, including grocery, club and mass merchandise, as well as through e-commerce, convenience, specialty and other channels. The Company’s portfolio of nutritious snacking brands gives it a strong platform with which to introduce new products, expand distribution, and attract new consumers to its products. The Company’s platform also positions it to continue to selectively pursue acquisition opportunities of brands in the nutritious snacking category.

    The common stock of Simply Good Foods is listed on the Nasdaq Capital Market under the symbol “SMPL.”

Unaudited Interim Condensed Consolidated Financial Statements

    The unaudited interim condensed consolidated financial statements include the accounts of Simply Good Foods and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated. Unless the context otherwise requires, “we,” “us,” “our” and the “Company” refer to Simply Good Foods and its subsidiaries.

    The Company maintains its accounting records on a 52/53-week fiscal year, ending on the last Saturday in August of each year.

    The interim condensed consolidated financial statements and related notes of the Company and its subsidiaries are unaudited. The unaudited interim condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”). The unaudited interim condensed consolidated financial statements reflect all adjustments and disclosures which are, in the Company's opinion, necessary for a fair presentation of the results of operations, financial position and cash flows for the indicated periods. All such adjustments were of a normal and recurring nature unless otherwise disclosed. The year-end balance sheet data was derived from the audited financial statements and, in accordance with the instructions to Form 10-Q, certain information and footnote disclosures required by GAAP have been condensed or omitted. The results reported in these unaudited interim condensed consolidated financial statements are not necessarily indicative of the results that may be reported for the entire fiscal year and should be read in conjunction with the Company’s consolidated financial statements for the fiscal year ended August 29, 2020, included in Amendment No. 1 to Form 10-K (“Form 10-K/A”) filed with the SEC on June 30, 2021. As discussed in Note 2, Restatement of Previously Issued Financial Statements, the consolidated financial statements have been restated to reflect certain warrants as liabilities rather than equity.

    The Company remains uncertain of the ultimate effect COVID-19 could have on its business notwithstanding the distribution of several U.S. government approved vaccines and various federal, state and local governments having begun to ease the movement restrictions and public health initiatives while continuing to adhere to enhanced safety measures, such as physical distancing and face mask protocols. This uncertainty as to the duration and severity of economic effects from the COVID-19 pandemic stems from the potential for, among other things, (i) continued rates of reported cases of COVID-19 and the potential for mutations of COVID-19 to result in increased rates of reported cases for which currently approved vaccines are not effective, (ii) unexpected supply chain disruptions, (iii) changes to customer operations, (iv) continued or additional changes in consumer purchasing and consumption behavior beyond those evidenced to date, and (v) the closure of customer establishments.

2. Restatement of Previously Issued Financial Statements

    On April 12, 2021, the SEC issued a statement (the “SEC Statement”) on the accounting and reporting considerations for warrants issued by special purpose acquisition companies (“SPAC”). The SEC Statement discussed certain features of warrants issued in SPAC transactions that may be common across many entities. Specifically, the SEC Statement focused in part on provisions in warrant agreements that provide for potential changes to the settlement amounts dependent upon the characteristics of the warrant holder. The SEC Statement indicated that, because the holder of a warrant is not an input into the pricing of a fixed-for-fixed option on equity shares, such provisions would preclude the warrant from being classified in equity and thus the warrant should be classified as a liability. Following consideration of the guidance in the SEC Statement, the Company concluded that its private warrants should be classified as a liability and measured at fair value at each reporting period, rather than as equity awards. Management concluded the effect of this error on the

10

Table of Contents

Company’s previously reported condensed consolidated financial statements is material and, as such, the accompanying condensed consolidated financial statements as of February 27, 2021, and the thirteen and twenty-six weeks ended February 27, 2021, and accompanying notes thereto have been restated from the amounts previously reported to give effect to the correction of this error (the “Restatement”). Effects of the Restatement on the Consolidated Balance Sheets as of August 29, 2020, and the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the thirteen and twenty-six weeks ended February 29, 2020, are presented in the Company’s Amendment No. 1 to Form 10-K (“Form 10-K/A”) for the fiscal year ended August 29, 2020 filed with the SEC on June 30, 2021. Additionally, see Note 13, Earnings (Loss) Per Share, for restated earnings (loss) per share amounts.

    As a result of the Restatement, the Company’s private warrants (the “Private Warrants”) are now reflected as a liability measured at fair value on the Company’s Condensed Consolidated Balance Sheets, and the change in the fair value of this liability in each period is recognized as a gain or loss in the Company’s Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). The effect of the Restatement on the Condensed Consolidated Balance Sheets as of February 27, 2021, and Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) and Condensed Consolidated Statements of Cash Flows for the thirteen and twenty-six weeks ended February 27, 2021, are presented below. Regarding the Condensed Consolidated Statements of Cash Flows, the adjustments below to net income were offset by adjustments to non-cash operating activities within cash flow provided by operations. The Restatement had no effect on total net cash flows from operating, investing or financing activities. The effect of the Restatement on the February 27, 2021 stockholders’ equity balances is presented in the Condensed Consolidated Statements of Stockholders’ Equity below.

Condensed Consolidated Balance Sheet	February 27, 2021
(In thousands)	As Previously Reported		Restatement Adjustment	As Restated
Warrant liability	$	—	118,519	$	118,519
Total liabilities	742,860		118,519	861,379
Additional paid-in-capital	1,098,375		(18,035)	1,080,340
Retained earnings	182,150		(100,484)	81,666
Total stockholders’ equity	1,278,658		(118,519)	1,160,139

Condensed Consolidated Statement of Operations and Comprehensive Income (Loss)	Thirteen Weeks Ended
	February 27, 2021
(In thousands)	As Previously Reported		Restatement Adjustment		As Restated
Loss in fair value change of warrant liability	—		(45,334)		(45,334)
Total other expense	(6,908)		(45,334)		(52,242)
Income (loss) before income taxes	26,433		(45,334)		(18,901)
Net income (loss)	19,120		(45,334)		(26,214)
Comprehensive income (loss)	$	19,363	$	(45,334)	$	(25,971)

As a result of the Restatement adjustments, basic earnings per share decreased $0.47, from earnings of $0.20 per share to a loss of $0.27 per share, and diluted earnings per share decreased $0.46, from earnings of $0.19 per share to a loss of $0.27 per share.

Condensed Consolidated Statement of Operations and Comprehensive Income (Loss)	Twenty-Six Weeks Ended
	February 27, 2021
(In thousands)	As Previously Reported		Restatement Adjustment		As Restated
Loss in fair value change of warrant liability	—		(24,881)		(24,881)
Total other expense	(15,221)		(24,881)		(40,102)
Income before income taxes	57,307		(24,881)		32,426
Net income	41,620		(24,881)		16,739
Comprehensive income	$	41,818	$	(24,881)	$	16,937

As a result of the Restatement adjustments, basic earnings per share decreased $0.26, from earnings of $0.43 per share to $0.17 per share, and diluted earnings per share decreased $0.24, from earnings of $0.41 per share to $0.17 per share.

11

Table of Contents

	Twenty-Six Weeks Ended
Condensed Consolidated Statement of Cash Flows	February 27, 2021
(In thousands)	As Previously Reported		Restatement Adjustment		As Restated
Operating activities
Net income	$	41,620	$	(24,881)	$	16,739
Adjustments to reconcile net income to net cash provided by operating activities:
Loss in fair value change of warrant liability	—		24,881		24,881
Net cash provided by operating activities	$	39,764	$	—	$	39,764

Condensed Consolidated Statement of Stockholders’ Equity	February 27, 2021
(In thousands)	As Previously Reported		Restatement Adjustment		As Restated
Additional paid-in-capital	$	1,098,375	$	(18,035)	$	1,080,340
Net income	41,620		(24,881)		16,739
Retained earnings	182,150		(100,484)		81,666
Total stockholders’ equity	$	1,278,658	$	(118,519)	$	1,160,139

3. Summary of Significant Accounting Policies

    Refer to Note 4, Summary of Significant Accounting Policies, to the consolidated financial statements included in the Company’s Form 10-K/A for a description of significant accounting policies.

Recently Issued and Adopted Accounting Pronouncements

Recently Issued Accounting Pronouncements Not Yet Adopted

    In December 2019, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which amends the existing guidance relating to the accounting for income taxes. This ASU is intended to simplify the accounting for income taxes by removing certain exceptions to the general principles of accounting for income taxes and to improve the consistent application of U.S. GAAP for other areas of accounting for income taxes by clarifying and amending existing guidance. This ASU is effective for fiscal years beginning after December 15, 2021, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements and does not expect that the adoption of this ASU will be material to its consolidated financial statements.

    In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance for a limited period of time to ease the potential burden in accounting for reference rate reform on financial reporting. The amendments in this ASU are effective for all entities and can be applied to contract modifications due to rate reform and eligible existing and new hedging relationships entered into between March 12, 2020 through December 31, 2022. The amendments of this ASU should be applied on a prospective basis. The Company will continue to monitor the effects of rate reform, if any, on its contracts and the effects of adoption of this ASU through December 31, 2022. The Company does not anticipate the amendments in this ASU to be material to its consolidated financial statements.

    In October 2020, the FASB issued ASU No. 2020-10, Codification Improvements, which provides updates for technical corrections, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements across various areas of accounting within U.S. GAAP. This ASU is effective for all entities for fiscal years beginning after December 15, 2020, with early adoption permitted. The amendments of this ASU should be applied retrospectively. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements and does not anticipate the adoption of this ASU will be material to its consolidated financial statements.

12

Table of Contents

Recently Adopted Accounting Pronouncements

    In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326), which modified the measurement of expected credit losses of certain financial instruments. The Company adopted this ASU as of the first day of fiscal 2021. As a result of adopting this ASU, the Company changed its method of estimating its allowance for doubtful accounts for trade receivables to be based upon the Company’s historical credit loss experience adjusted for asset-specific risk characteristics, current economic conditions, and reasonable forecasts. The change in estimating the allowance for doubtful accounts did not have a material effect on the Company’s consolidated financial statements.

    In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820), which modified disclosure requirements on fair value measurements of Accounting Standards Codification (“ASC”) 820. The Company adopted this ASU as of the first day of fiscal 2021. The adoption of this ASU did not have a material effect on the consolidated financial statements or the related disclosures.

4. Business Combination

    On August 21, 2019, the Company’s wholly-owned subsidiary Simply Good Foods USA, Inc., formerly known as Atkins Nutritionals, Inc., (“Simply Good USA”) entered into a Stock and Unit Purchase Agreement (the “Purchase Agreement”) to acquire Quest Nutrition, LLC (“Quest”), a healthy lifestyle food company (the “Acquisition of Quest”). On November 7, 2019, Simply Good USA completed the Acquisition of Quest, via Simply Good USA’s direct or indirect acquisition of 100% of the equity interests of Voyage Holdings, LLC and VMG Quest Blocker, Inc. (the “Target Companies”) for a cash purchase price at closing of $988.9 million subject to customary post-closing adjustments for the Target Companies’ levels of cash, indebtedness, net working capital and transaction expenses as of the closing date.

    Simply Good USA acquired Quest as a part of the Company’s vision to lead the nutritious snacking movement with trusted brands that offer a variety of convenient, innovative, great-tasting, better-for-you snacks and meal replacements. Quest is a healthy lifestyle food company offering a variety of bars, cookies, chips, ready-to-drink shakes and pizzas that compete in many of the attractive, fast growing sub-segments within the nutritional snacking category.

    The Acquisition of Quest was funded by the Company through a combination of cash, equity and debt financing. Total consideration paid on the closing date was $988.9 million. Cash sources of funding included $195.3 million of cash on hand, net proceeds of approximately $350.0 million from an underwritten public offering of common stock, and $443.6 million in new term loan debt. In the third fiscal quarter of 2020, the Company received a post-closing release from escrow of approximately $2.1 million related to net working capital adjustments, resulting in a total net consideration paid of $986.8 million as of February 27, 2021.

    For the twenty-six weeks ended February 29, 2020, Business transaction costs within the Consolidated Statements of Operations and Comprehensive Income were $26.9 million, which included $14.5 million of transaction advisory fees related to the Acquisition of Quest, $3.2 million of banker commitment fees, $6.1 million of non-deferrable debt issuance costs related to the incremental term loan, and $3.1 million of other costs, including legal, due diligence, and accounting fees. Included in the transaction advisory fees was $12.0 million paid to Centerview Partners LLC, an investment banking firm that served as the lead financial advisor to the Company for this transaction. Three members of the Company’s Board of Directors, Messrs. Kilts, West, and Ratzan, have business relationships with certain partners of Centerview Partners LLC (including relating to Centerview Capital Consumer, a private equity firm and affiliate of Conyers Park Sponsor LLC), but they are not themselves partners, executives or employees of Centerview Partners LLC, and Centerview Partners LLC is not a related party of the Company pursuant to applicable rules and policies. The advisory fee paid to Centerview Partners LLC represented approximately 1.2% of the total cash purchase price paid by the Company on the closing date of the Acquisition of Quest. All transaction advisory fees relating to the Acquisition of Quest were approved by the Company’s Audit Committee.

13

Table of Contents

    The following table sets forth the final purchase price allocation of the Acquisition of Quest to the estimated fair value of the net assets acquired at the date of acquisition, in thousands:

Assets acquired:
Cash and cash equivalents	$	4,745
Accounts receivable, net	25,359
Inventories	44,032
Prepaid assets	1,214
Other current assets	3,812
Property and equipment, net(1)	9,843
Intangible assets, net(2)	868,375
Other long-term assets	20,997
Liabilities assumed:
Accounts payable	25,200
Other current liabilities	11,237
Deferred income taxes(3)	10,754
Other long-term liabilities	18,891
Total identifiable net assets	912,295
Goodwill(4)	74,525
Total assets acquired and liabilities assumed	$	986,820

(1)    Property and equipment, net primarily consisted of leasehold improvements for the Quest headquarters of $6.9 million, furniture and fixtures of $2.2 million, and equipment of $0.7 million. The Quest headquarters lease ends in April 2029. The useful lives of the leasehold improvements, furniture and fixtures, and equipment are consistent with the Company’s accounting policies.

(2)    Intangible assets were recorded at fair value consistent with ASC 820 as a result of the Acquisition of Quest. Intangible assets consisted of $750.0 million of indefinite brands and trademarks, $115.0 million of amortizable customer relationships, and $3.4 million of internally developed software. The useful lives of the intangible assets are disclosed in Note 6 of the consolidated financial statements. The fair value measurement of the assets and liabilities was based on significant inputs not observable in the market and thus represent Level 3 measurements within the fair value measurement hierarchy. Level 3 fair market values were determined using a variety of information, including estimated future cash flows and market comparable data and companies. The fair values of the intangible assets were estimated using inputs primarily from the income approach and the with/without method, which estimates the value using the cash flow impact in a hypothetical scenario where the customer relationships are not in place. The significant assumptions used in estimating the fair value of the intangible assets include the estimated life the asset will contribute to cash flows, profitability, and the estimated discount rate.

(3)    Primarily as a result of the fair value attributable to the identifiable intangible assets, the deferred income tax liability was $10.8 million.

(4)    Goodwill was recorded at fair value consistent with ASC 820 as a result of the Acquisition of Quest. Amounts recorded for goodwill created in an acquisition structured as a stock purchase for tax are generally not expected to be deductible for tax purposes. Amounts recorded for goodwill resulting in a tax basis step-up are generally expected to be deductible for tax purposes. Tax deductible Goodwill was estimated to be $67.7 million. Goodwill represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized.

    The Company completed its final assessment of purchase price allocation for the Acquisition of Quest to the estimated fair value of the net assets acquired at the date of acquisition during the first quarter of fiscal 2021. Since the initial preliminary estimates reported in the first fiscal quarter of 2020, the Company updated certain amounts reflected in the final purchase price allocation, as summarized in the fair values of assets acquired and liabilities assumed as set forth above. Specifically, the carrying amount of the intangible assets, net were increased by $20.0 million as a result of valuation adjustments related to the Company’s finalization of tax attributes, which also resulted in a decrease to deferred income taxes of $3.2 million. Additionally, accounts receivable, net decreased $4.3 million and inventories increased $0.9 million due to fair value measurement period adjustments, and the carrying amount of property and equipment, net decreased by $0.5 million to reflect its estimated fair value. As a result of these adjustments and the change in total net consideration paid of approximately $2.1 million related to net working capital adjustments discussed above, goodwill decreased $21.5 million. Measurement period adjustments were recognized in the reporting period in which the adjustments were determined and calculated as if the accounting had been completed at the acquisition date.

14

Table of Contents

    The results of Quest’s operations have been included in the Company’s Consolidated Financial Statements since November 7, 2019, the date of acquisition. The following table provides net sales from the acquired Quest business included in the Company’s results:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(in thousands)	February 27, 2021		February 29, 2020		February 27, 2021		February 29, 2020
Net sales(1)	$	105,025	$	88,305	$	200,794	$	105,387

(1)    Net sales for the thirteen and twenty-six weeks ended February 27, 2021 excludes immaterial international net sales.

Unaudited Pro Forma Financial Information

    Pro forma financial information is not intended to represent or be indicative of the actual results of operations of the combined business that would have been reported had the Acquisition of Quest been completed at the beginning of the fiscal year 2019, nor is it representative of future operating results of the Company. The pro forma combined financial information includes the fair value adjustments of the liability-classified Private Warrants.

The following unaudited pro forma financial information presents the combined results of the Company and Quest as if the Acquisition of Quest has occurred at the beginning of fiscal 2019:

	Thirteen Weeks Ended		Twenty-Six Weeks Ended
(in thousands)	February 29, 2020		February 29, 2020
Revenue	$	227,101	$	447,657
Gross profit	$	90,479	$	178,667
Net income	$	52,693	$	81,649

5. Revenue Recognition

    Revenues from transactions with external customers for each of the Company’s products would be impracticable to disclose and management does not view its business by product line. The following is a summary of revenue disaggregated by geographic area and core brands:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(In thousands)	February 27, 2021		February 29, 2020		February 27, 2021		February 29, 2020
North America
Atkins	$	114,155	$	131,435	$	236,916	$	259,247
Quest (2)	105,025		88,305		200,794		105,387
Total North America (1)	219,180		219,740		437,710		364,634
International	11,427		7,361		24,049		14,620
Total net sales	$	230,607	$	227,101	$	461,759	$	379,254

(1)    The North America geographic area consists of net sales substantially related to the United States and there is no individual foreign country to which more than 10% of Company’s net sales are attributed or that is otherwise deemed individually material. The North America geographic area includes the divested SimplyProtein brand.

(2)    Quest net sales are primarily in North America.

    Charges related to credit loss on accounts receivables from transactions with external customers were nominal for each of the thirteen and twenty-six weeks ended February 27, 2021 and were approximately $0.1 million for each of the thirteen and twenty-six weeks ended February 29, 2020. As of February 27, 2021 and August 29, 2020, the allowance for doubtful accounts related to these accounts receivable was $0.6 million and $0.5 million, respectively.

15

Table of Contents

6. Goodwill and Intangibles

    Changes to Goodwill during the thirteen week period ended February 27, 2021 were as follows:

(in thousands)	Goodwill
Balance as of August 29, 2020	$	544,774
Acquisition of business, measurement period adjustment	1,178
Sale of business	(2,818)
Balance as of February 27, 2021	$	543,134

    The change in Goodwill attributed to the acquisition of a business during the twenty-six weeks ended February 27, 2021 was the result of measurement period adjustments made to finalize the acquisition method of accounting for the Acquisition of Quest as described in Note 4. Additionally, effective September 24, 2020, the Company sold the assets exclusively related to its SimplyProtein® brand of products for approximately $8.8 million of consideration, including cash of $5.8 million and a note receivable for $3.0 million, to a newly formed entity led by the Company’s former Canadian-based management team who had been responsible for this brand prior to the sale transaction (the “SimplyProtein Sale”). In addition to purchasing these assets, the buyer assumed certain liabilities related to the SimplyProtein brand’s business. There was no gain or loss recognized as a result of the SimplyProtein Sale. In conjunction with the SimplyProtein Sale, the Company disposed of $2.8 million of goodwill associated with the SimplyProtein business.

    There were no impairment charges related to goodwill during the thirteen and twenty-six weeks ended February 27, 2021 or since the inception of the Company.

    Intangible assets, net in the Consolidated Balance Sheets consist of the following:

				February 27, 2021
(In thousands)	Useful life			Gross carrying amount		Accumulated amortization		Net carrying amount
Intangible assets with indefinite life:
Brands and trademarks	Indefinite life			$	974,000	$	—	$	974,000
Intangible assets with finite lives:
Customer relationships	15 years			174,000		24,303		149,697
Proprietary recipes and formulas	7 years			7,000		3,631		3,369
Licensing agreements	14 years			22,000		5,706		16,294
Software and website development costs	3	-	5 years	5,302		2,678		2,624
Intangible assets in progress	3	-	5 years	55		—		55
				$	1,182,357	$	36,318	$	1,146,039

				August 29, 2020
(In thousands)	Useful life			Gross carrying amount		Accumulated amortization		Net carrying amount
Intangible assets with indefinite life:
Brands and trademarks	Indefinite life			$	979,000	$	—	$	979,000
Intangible assets with finite lives:
Customer relationships	15 years			174,000		18,503		155,497
Proprietary recipes and formulas	7 years			7,000		3,131		3,869
Licensing agreements	14 years			22,000		4,920		17,080
Software and website development costs	3	-	5 years	5,967		2,645		3,322
				$	1,187,967	$	29,199	$	1,158,768

    Changes in Intangible assets, net during the twenty-six weeks ended February 27, 2021 were primarily related to the SimplyProtein Sale and recurring amortization expense. In conjunction with the SimplyProtein Sale, the Company sold its SimplyProtein brand intangible asset, which had a carrying value of approximately $5.0 million as of the date of the sale. Amortization expense related to intangible assets during each of the thirteen weeks ended February 27, 2021 and February 29, 2020 was $3.9 million, respectively. Amortization expense related to intangible assets during the twenty-six weeks ended February 27, 2021 and February 29, 2020 was $7.7 million and $6.2 million, respectively. There were no impairment charges related to intangible assets during the thirteen and twenty-six weeks ended February 27, 2021 and February 29, 2020.

16

Table of Contents

    Estimated future amortization for each of the next five fiscal years and thereafter is as follows:

(In thousands)	Amortization
Remainder of 2021	$	7,674
2022	15,224
2023	14,938
2024	14,257
2025	13,171
2026 and thereafter	106,720
Total	$	171,984

7. Long-Term Debt and Line of Credit

    On July 7, 2017, the Company entered into a credit agreement with Barclays Bank PLC and other parties (as amended to date, the “Credit Agreement”). The Credit Agreement provides for (i) a term facility of $200.0 million (“Term Facility”) with a seven year maturity and (ii) a revolving credit facility of up to $75.0 million (the “Revolving Credit Facility”) with a five year maturity. Substantially concurrent with the consummation of the Acquisition of Atkins, the full $200.0 million of the Term Facility (the “Term Loan”) was drawn. The interest rate per annum is based on either (i) a base rate equaling the higher of (a) the “prime rate”, (b) the federal funds effective rate plus 0.50% and (c) the Euro-currency rate applicable for an interest period of one month plus 1.00% plus (x) 3.00% margin for the Term Loan or (y) 2.00% margin for the Revolving Credit Facility, or (ii) London Interbank Offered Rate (“LIBOR”) adjusted for statutory reserve requirements, plus (x) 4.00% margin for the Term Loan subject to a floor of 1.00% or (y) 3.00% margin for the Revolving Credit Facility. As security for the payment or performance of its debt, the Company has pledged certain equity interests in its subsidiaries.

    On March 16, 2018 (the “Amendment Date”), the Company entered into an amendment (the “Repricing Amendment”) to the Credit Agreement. As a result of the Repricing Amendment, the interest rate on the Term Loan was reduced and, as of the Amendment Date, such loans had an interest rate equal to, at the Company’s option, either LIBOR plus an applicable margin of 3.50% or a base rate plus an applicable margin of 2.50%. The Repricing Amendment did not change the interest rate on the Revolving Credit Facility. The Revolving Credit Facility continued to bear interest based upon the Company’s consolidated net leverage ratio as of the last financial statements delivered to the administrative agent. No additional debt was incurred, or any proceeds received, by the Company in connection with the Repricing Amendment. The incremental fees paid to the administrative agent are reflected as additional debt discount and are amortized over the terms of the long-term financing agreements using the effective-interest method.

    On November 7, 2019, the Company entered into an amendment (the “Incremental Facility Amendment”) to the Credit Agreement to increase the principal borrowed on the Term Facility by $460.0 million. The Term Facility together with the incremental borrowing make up the Initial Term Loans (as defined in the Incremental Facility Amendment) and as of the Amendment No. 2 Effective Date (as defined in the Incremental Facility Amendment), the Initial Term Loans bear interest at a rate equal to, at the Company’s option, either LIBOR plus an applicable margin of 3.75% or a base rate plus an applicable margin of 2.75%. The Incremental Facility Amendment was executed to partially finance the Acquisition of Quest. No amounts under the Term Facility were repaid as a result of the execution of the Incremental Facility Amendment.

    The Credit Agreement contains certain financial and other covenants that limit the Company’s ability to, among other things, incur and/or undertake asset sales and other dispositions, liens, indebtedness, certain acquisitions and investments, consolidations, mergers, reorganizations and other fundamental changes, payment of dividends and other distributions to equity and warrant holders, and prepayments of material subordinated debt, in each case, subject to customary exceptions materially consistent with credit facilities of such type and size. The Revolving Credit Facility has a maximum total net leverage ratio equal to or less than 6.25:1.00 (with a reduction to 6.00:1.00 on and after the third anniversary of the closing date of the Credit Agreement) contingent on credit extensions in excess of 30% of the total amount of commitments available under the Revolving Credit Facility. Any failure to comply with the restrictions of the credit facilities may result in an event of default. The Company was in compliance with all financial covenants as of February 27, 2021 and August 29, 2020, respectively.

17

Table of Contents

    Long-term debt consists of the following:

(In thousands)	February 27, 2021		August 29, 2020
Term Facility (effective rate of 4.8% at February 27, 2021)	$	556,500	$	606,500
Finance lease liabilities (effective rate of 5.6% at February 27, 2021)	826		922
Less: Deferred financing fees	8,164		10,272
Total debt	549,162		597,150
Less: Current finance lease liabilities	278		271
Long-term debt, net of deferred financing fees	$	548,884	$	596,879

    The Company is not required to make principal payments on the Term Facility over the twelve months following the period ended February 27, 2021. The outstanding balance of the Term Facility is due upon its maturity in July 2024. Additionally, as of February 27, 2021 and August 29, 2020, there were no amounts drawn against the Revolving Credit Facility.

    As of February 27, 2021, the Company had letters of credit in the amount of $4.2 million outstanding. These letters of credit offset against the availability of the Revolving Credit Facility and exist to support three of the Company’s leased buildings and insurance programs relating to workers’ compensation. No amounts were drawn against these letters of credit at February 27, 2021.

    The Company utilizes market approaches to estimate the fair value of certain outstanding borrowings by discounting anticipated future cash flows derived from the contractual terms of the obligations and observable market interest and foreign exchange rates. The Company carries debt at historical cost and discloses fair value. As of February 27, 2021 and August 29, 2020, the book value of the Company’s debt approximated fair value. The estimated fair value of the Term Loan is valued based on observable inputs and classified as Level 2 in the fair value hierarchy.

8. Fair Value of Financial Instruments

    Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measurements, a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies, is as follows:

Level 1 – Valuations based on quoted prices for identical assets and liabilities in active markets.

Level 2 – Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.

Level 3 – Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.

    The carrying amounts of cash and cash equivalents, accounts receivable and accounts payable approximated fair value as of February 27, 2021 and August 29, 2020 due to the relatively short maturity of these instruments.

Level 3 Measurements

    The Company has outstanding liability-classified Private Warrants that allow holders to purchase 6,700,000 shares of the Company’s common stock. Such Private Warrants are held by Conyers Park Sponsor, LLC, a related party. The Company utilizes the Black-Scholes valuation model to estimate the fair value of the Private Warrants at each reporting date. The application of the Black-Scholes model utilizes significant assumptions, including volatility. Significant judgment is required in determining the expected volatility (the key assumption) of the Private Warrants. In order to determine the most accurate measure of this volatility, the Company measured expected volatility based on several inputs, including considering a peer group of publicly traded companies, the Company’s implied volatility based on traded options, the implied volatility of comparable SPAC warrants, and the implied volatility of any outstanding Public Warrants during the periods they were outstanding. As a result of the unobservable inputs that were used to determine the expected volatility of the Private Warrants, the fair value measurement of these warrants reflects a Level 3 measurement within the fair value measurement hierarchy.

18

Table of Contents

There were 6,700,000 Private Warrants outstanding as of November 28, 2020 and November 30, 2019. The table below summarizes the inputs used to calculate the fair value of the warrant liability at each of the dates indicated below:

	February 27, 2021			February 29, 2020
Exercise Price	$	11.50		$	11.50
Stock Price	$	29.17		$	22.06
Dividend Yield	—		%	—		%
Expected Term (in Years)	1.35			2.35
Risk-Free Interest Rate	0.10		%	0.85		%
Expected Volatility	28.00		%	29.10		%
Per Share Value of Warrants	$	17.69		$	10.99

    The periodic remeasurement of the warrant liability is reflected in (Loss) gain in fair value change of warrant liability within the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). The adjustments for the thirteen and twenty-six weeks ended February 27, 2021 were a loss of $45.3 million and $24.9 million, respectively. The adjustments for the thirteen and twenty-six weeks ended February 29, 2020 were a gain of $37.6 million and $51.0 million, respectively. The adjustments resulted in a total warrant liability at February 27, 2021 and February 29, 2020 of $118.5 million and $73.6 million, respectively.

9. Income Taxes

    The tax expense and the effective tax rate resulting from operations were as follows:

	Twenty-Six Weeks Ended
(In thousands)	February 27, 2021			February 29, 2020
(Loss) income before income taxes	$	32,426		$	59,009
Income tax expense	$	15,687		$	2,193
Effective tax rate	48.4		%	3.7		%

    The effective tax rate for the twenty-six weeks ended February 27, 2021 was 44.7% greater than the effective tax rate for the twenty-six weeks ended February 29, 2020, which was primarily driven by the non-cash change in the fair value of the warrant liability and other permanent differences.

10. Leases

    The components of lease expense were as follows:

		Thirteen Weeks Ended				Twenty-Six Weeks Ended
(In thousands)	Statement of Operations Caption	February 27, 2021		February 29, 2020		February 27, 2021		February 29, 2020
Operating lease cost:
Lease cost	Cost of goods sold and General and administrative	$	1,496	$	1,441	$	2,994	$	2,247
Variable lease cost (1)	Cost of goods sold and General and administrative	378		426		776		736
Operating lease cost		1,874		1,867		3,770		2,983
Short term lease cost	General and administrative	—		18		—		24
Finance lease cost:
Amortization of right-of-use assets	Cost of goods sold	68		66		136		136
Interest on lease liabilities	Interest expense	12		16		25		32
Total finance lease cost		80		82		161		168
Total lease cost		$	1,954	$	1,967	$	3,931	$	3,175

19

Table of Contents

(1)    Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs.

    In conjunction with the Company’s restructuring activities as discussed in Note 14, the Company incurred impairment charges of $0.3 million and $0.7 million in the thirteen and twenty-six weeks ended February 27, 2021, respectively, related to its operating lease right-of-use assets for leases in Toronto, Ontario and the Netherlands. Additionally, the Company terminated the lease in Toronto, Ontario, which resulted in a gain on lease termination of $0.2 million in the thirteen and twenty-six weeks ended February 27, 2021. The effect of these restructuring activities has been included within General and administrative on the Consolidated Statements of Operations and Comprehensive Income. Refer to Note 14, Restructuring and Related Charges, for additional information regarding restructuring activities.

    The gross amounts of assets and liabilities related to both operating and finance leases are as follows:

(In thousands)	Balance Sheet Caption	February 27, 2021		August 29, 2020
Assets
Operating lease right-of-use assets	Other long-term assets	$	23,089	$	25,703
Finance lease right-of-use assets	Property and equipment, net	776		912
Total lease assets		$	23,865	$	26,615
Liabilities
Current:
Operating lease liabilities	Accrued expenses and other current liabilities	$	4,235	$	4,329
Finance lease liabilities	Current maturities of long-term debt	278		271
Long-term:
Operating lease liabilities	Other long-term liabilities	20,880		22,764
Finance lease liabilities	Long-term debt, less current maturities	548		651
Total lease liabilities		$	25,941	$	28,015

    Future maturities of lease liabilities as of February 27, 2021 were as follows:

(In thousands)	Operating Leases		Finance Leases
Fiscal year ending:
Remainder of 2021	$	2,935	$	157
2022	4,607		313
2023	4,071		278
2024	4,232		145
2025	3,838		—
Thereafter	11,050		—
Total lease payments	30,733		893
Less: Interest	(5,618)		(67)
Present value of lease liabilities	$	25,115	$	826

    As of February 27, 2021, the Company had entered into a lease with estimated total minimum future lease payments of $32.2 million over a 10.0-year minimum lease term that had not yet commenced, and as a result it is not recorded on the Consolidated Balance Sheets. The Company expects the lease to commence in fiscal year 2021, and the Company has the option to renew the lease for an additional 5.0 years or 10.0 years after the minimum lease term.

    The weighted-average remaining lease term and weighted-average discount rate for operating and finance leases were as follows:

	February 27, 2021		August 29, 2020
Weighted-average remaining lease term (in years)
Operating leases	6.76		6.97
Finance leases	2.92		3.41
Weighted-average discount rate
Operating leases	5.8	%	5.7	%
Finance leases	5.6	%	5.6	%

20

Table of Contents

    Supplemental and other information related to leases was as follows:

	Twenty-Six Weeks Ended
(In thousands)	February 27, 2021		February 29, 2020
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	3,689	$	2,817
Operating cash flows from finance leases	12		9
Financing cash flows from finance leases	$	157	$	157

11. Commitments and Contingencies

Litigation

    The Company is a party to certain litigation and claims that are considered normal to the operations of the business. From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of business. The Company is not presently a party to any litigation that it believes to be material, and the Company is not aware of any pending or threatened litigation against it that its management believes could have a material adverse effect on its business, operating result, financial condition or cash flows.

    During the fiscal year ended August 31, 2019, the Company reserved $3.5 million for the potential settlement of class action litigation concerning certain product label claims. During the twenty-six weeks ended February 29, 2020, the Company reserved an additional $0.3 million. The reserve was included within General and administrative in the Consolidated Statements of Operations and Comprehensive Income, and the reserve was fully paid into escrow and settled during the fiscal year ended August 29, 2020.

    As of February 27, 2021 and August 29, 2020, the Company had $0.7 million and $1.3 million reserved for potential settlements, respectively.

Other

    The Company has entered into endorsement contracts with certain celebrity figures and social media influencers to promote and endorse the Atkins and Quest brands and product lines. These contracts contain endorsement fees, which are expensed ratably over the life of the contract, and performance fees, that are recognized at the time of achievement. Based on the terms of the contracts in place and achievement of performance conditions as of February 27, 2021, the Company will be required to make payments of $2.8 million over the next year.

12. Stockholders’ Equity

Public Equity Offering

    On October 9, 2019, the Company completed an underwritten public offering of 13,379,205 shares of common stock at a price to the public of $26.35 per share. The Company paid underwriting discounts and commissions of $0.19 per share resulting in net proceeds to the Company of $26.16 per share, or approximately $350.0 million (the “Offering”). The Company paid $0.8 million for legal, accounting and registrations fees related to the Offering. The net proceeds were used to pay a portion of the purchase price and related fees and expenses for the Acquisition of Quest.

Warrants to Purchase Common Stock

Prior to the Acquisition of Atkins, Conyers Park issued 13,416,667 public warrants and 6,700,000 Private Warrants. The Company assumed the Conyers Park warrants to purchase common stock in connection with the Acquisition of Atkins. As a result of the Acquisition of Atkins, the warrants issued by Conyers Park were no longer exercisable for shares of Conyers Park common stock, but were instead exercisable for common stock of the Company. All other features of the warrants were unchanged.

Each whole warrant entitles the holder to purchase one share of the Company’s common stock at a price of $11.50 per share. The warrants became exercisable 30 days after the completion of the Acquisition of Atkins in 2017 and expire five years after that date, or earlier upon redemption or liquidation, as applicable.

    From August 26, 2018 through October 5, 2018, public warrants to purchase an aggregate of 9,866,451 shares of the Company’s common stock were exercised for cash at an exercise price of $11.50 per share, resulting in aggregate gross proceeds to the Company of $113.5 million.

21

Table of Contents

    On October 4, 2018, the Company delivered a notice for the redemption (the “Redemption Notice”) of all of its public warrants that remained unexercised immediately after November 5, 2018. Exercises of public warrants following the Redemption Notice were required to be done on a cashless basis. Accordingly, holders were no longer permitted to exercise public warrants in exchange for payment in cash of $11.50 per share. Instead, a holder exercising a public warrant was deemed to have paid the $11.50 per share exercise price by the surrender of 0.61885 of a share of common stock that the holder would have been entitled to receive upon a cash exercise of each public warrant. Exercising holders received 0.38115 of a share of the Company’s common stock for each public warrant surrendered for exercise. Following the Redemption Notice, 3,499,639 public warrants were exercised on a cashless basis. An aggregate of 1,333,848 shares of the Company’s common stock were issued in connection with these exercises of the public warrants. All remaining public warrants were redeemed as of November 5, 2018 for an immaterial amount.

    As of February 27, 2021, the Private Warrants to purchase 6,700,000 shares of the Company’s common stock remain outstanding, have not been transferred by Conyers Park Sponsor, LLC, a related party, and remain liability-classified. As discussed in Note 8, the liability-classified warrants are remeasured on a recurring basis, primarily based on observable market data while the related theoretical private warrant volatility assumption within the Black-Scholes model represents a Level 3 measurement within the fair value measurement hierarchy. The periodic remeasurement of the warrant liability is reflected in (Loss) gain in fair value change of warrant liability within the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

Stock Repurchase Program

    On November 13, 2018, the Company announced that its Board of Directors had adopted a $50.0 million stock repurchase program. Under the stock repurchase program, the Company may repurchase shares from time to time in the open market or in privately negotiated transactions. The stock repurchase program does not obligate the Company to acquire any specific number of shares or acquire shares over any specific period of time. The stock repurchase program may be suspended or discontinued at any time by the Company and does not have an expiration date.

    During the twenty-six weeks ended February 27, 2021 and February 29, 2020, the Company did not repurchase any shares of common stock. As of February 27, 2021, approximately $47.9 million remained available under the stock repurchase program.

13. Earnings (Loss) Per Share

    Basic earnings or loss per share is based on the weighted average number of common shares issued and outstanding. In computing diluted earnings per share, basic earnings per share is adjusted for the assumed issuance of all potentially dilutive securities. In periods in which the Company has a net loss, diluted earnings per share is based on the weighted average number of common shares issued and outstanding as the effect of including common stock equivalents outstanding would be antidilutive.

    The Company has outstanding liability-classified Private Warrants to purchase 6,700,000 shares of the Company’s common stock. During periods when the effect is dilutive, the Company assumes share settlement of the instruments as of the beginning of the reporting period and adjusts the numerator to remove the change in fair value of the warrant liability and adjusts the denominator to include the dilutive shares, calculated using the treasury stock method. During periods when the impact is antidilutive, the share settlement is excluded.

22

Table of Contents

    The following table reconciles the numerators and denominators used in the computations of both basic and diluted earnings per share:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(In thousands, except per share data)	February 27, 2021		February 29, 2020		February 27, 2021		February 29, 2020
Basic earnings per share computation:
Numerator:
Net (loss) income available to common stock stockholders	$	(26,214)	$	48,301	$	16,739	$	56,816
Denominator:
Weighted average common shares - basic	95,734,591		95,339,489		95,712,057		92,524,061
Basic (loss) earnings per share from net (loss) income	$	(0.27)	$	0.51	$	0.17	$	0.61
Diluted earnings per share computation:
Numerator:
Net (loss) income available to common stock stockholders	$	(26,214)	$	48,301	$	16,739	$	56,816
Gain in fair value change of warrant liability	—		(37,644)		—		(50,952)
Numerator for diluted earnings per share	$	(26,214)	$	10,657	$	16,739	$	5,864
Denominator:
Weighted average common shares outstanding - basic	95,734,591		95,339,489		95,712,057		92,524,061
Private Warrants	—		3,706,986		—		3,766,141
Employee stock options	—		1,173,631		1,056,707		1,194,968
Non-vested shares	—		116,465		228,248		112,444
Weighted average common shares - diluted	95,734,591		100,336,571		96,997,012		97,597,614
Diluted (loss) earnings per share from net income	$	(0.27)	$	0.11	$	0.17	$	0.06

    Diluted earnings per share calculations for the thirteen weeks ended February 27, 2021 and February 29, 2020 excluded 1.4 million and 0.4 million shares underlying stock options issuable upon exercise, respectively, that would have been anti-dilutive. Diluted earnings per share calculations for the thirteen weeks ended February 27, 2021 excluded 0.3 million number of non-vested shares and 3.9 million of Private Warrants that would have been anti-dilutive

    Diluted earnings per share calculations for the twenty-six weeks ended February 27, 2021 and February 29, 2020 excluded 0.6 million and 0.3 million shares underlying stock options issuable upon exercise, respectively, that would have been anti-dilutive. Diluted earnings per share for the twenty-six weeks ended February 27, 2021 excluded an immaterial number of non-vested shares and 3.6 million of Private Warrants that would have been anti-dilutive.

14. Omnibus Incentive Plan

    Stock-based compensation includes stock options, restricted stock units, performance stock unit awards and stock appreciation rights, which are awarded to employees, directors, and consultants of the Company. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period of the award based on their grant date fair value. Stock-based compensation expense is included within General and administrative expense, which is the same financial statement caption where the recipient’s other compensation is reported.

    The Company recorded stock-based compensation expense of $2.5 million and $2.1 million in the thirteen weeks ended February 27, 2021 and February 29, 2020, respectively, and $3.6 million and $3.8 million in the twenty-six weeks ended February 27, 2021 and February 29, 2020, respectively.

23

Table of Contents

Stock Options

    The following table summarizes stock option activity for the twenty-six weeks ended February 27, 2021:

	Shares Underlying Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)
Outstanding as of August 29, 2020	2,615,899	$	14.33
Granted	289,555	20.47
Exercised	(43,928)	12.00
Forfeited	(39,575)	23.08
Outstanding as of February 27, 2021	2,821,951	$	14.88	7.11
Vested and expected to vest as of February 27, 2021	2,821,951	$	14.88	7.11
Exercisable as of February 27, 2021	2,197,655	$	13.24	6.61

    As of February 27, 2021, the Company had $3.5 million of total unrecognized compensation cost related to stock option plans that will be recognized over a weighted average period of 1.9 years. During the twenty-six weeks ended February 27, 2021 and February 29, 2020, the Company received $0.5 million and $0.9 million in cash from stock option exercises, respectively.

Restricted Stock Units

    The following table summarizes restricted stock unit activity for the twenty-six weeks ended February 27, 2021:

	Restricted Stock Units	Weighted average grant-date fair value
Non-vested as of August 29, 2020	208,023	$	22.82
Granted	311,873	21.57
Vested	(72,568)	25.89
Forfeited	(15,706)	22.99
Non-vested as of February 27, 2021	431,622	$	21.39

    As of February 27, 2021, the Company had $7.6 million of total unrecognized compensation cost related to restricted stock units that will be recognized over a weighted average period of 2.2 years.

Performance Stock Units

    During the twenty-six weeks ended February 27, 2021, the Board of Directors granted performance stock units under the Company’s equity compensation plan. Performance stock units vest in a range between 0% and 200% based upon certain performance criteria in a three-year period. Performance stock units were valued using a Monte-Carlo simulation.

    The following table summarizes performance stock unit activity for the twenty-six weeks ended February 27, 2021:

	Performance Stock Units	Weighted average grant-date fair value
Non-vested as of August 29, 2020	295,256	$	17.93
Granted	116,309	23.59
Vested	—	—
Forfeited	(26,400)	22.06
Non-vested as of February 27, 2021	385,165	$	19.35

    As of February 27, 2021, the Company had $4.4 million of total unrecognized compensation cost related to performance stock units that will be recognized over a weighted average period of 1.6 years.

24

Table of Contents

Stock Appreciation Rights

    Stock appreciation rights (“SARs”) permit the holder to participate in the appreciation of the Company’s common stock price. The Company’s SARs settle in shares of its common stock once the applicable vesting criteria has been met. SARs cliff vest 3 years from the date of grant and must be exercised within 10 years.

    The following table summarizes SARs activity for the twenty-six weeks ended February 27, 2021:

	Shares Underlying SARs	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)
Outstanding as of August 29, 2020	150,000	$	24.20
Granted	—	—
Exercised	—	—
Forfeited	—	—
Outstanding as of February 27, 2021	150,000	$	24.20	8.68
Vested and expected to vest as of February 27, 2021	150,000	$	24.20	8.68
Exercisable as of February 27, 2021	—	$	—	0.00

    As of February 27, 2021, the Company had $0.2 million of total unrecognized compensation cost related to its SARs that will be recognized over a weighted average period of 1.7 years.

14. Restructuring and Related Charges

    In May 2020, the Company announced certain restructuring activities in conjunction with the implementation of the Company’s future-state organization design, which created a fully integrated organization with its completed Acquisition of Quest. The new organization design became effective on August 31, 2020. These restructuring plans primarily include workforce reductions, changes in management structure, and the relocation of business activities from one location to another.

    The one-time termination benefits and employee severance costs to be incurred in relation to these restructuring activities are accounted for in accordance with ASC Topic 420, Exit or Disposal Cost Obligations, and ASC Topic 712, Compensation-Nonretirement Postemployment Benefits, respectively. The Company recognizes a liability and the related expense for these restructuring costs when the liability is incurred and can be measured. Restructuring accruals are based upon management estimates at the time and can change depending upon changes in facts and circumstances subsequent to the date the original liability was recorded.

    Changes to the restructuring liability during the twenty-six weeks ended February 27, 2021 were as follows:

(in thousands)	Termination benefits and severance		Other		Restructuring Liability
Balance as of August 29, 2020	$	4,139	$	—	$	4,139
Charges	3,118		144		3,262
Cash payments	(6,146)		(144)		(6,290)
Non-cash settlements or adjustments	—		—		—
Balance as of February 27, 2021	$	1,111	$	—	$	1,111

    In addition to the restructuring costs shown above, the Company incurred impairment charges of $0.3 million and $0.7 million in the thirteen and twenty-six weeks ended February 27, 2021, respectively, related to its operating lease right-of-use assets for leases in Toronto, Ontario and the Netherlands. Additionally, the Company terminated the lease in Toronto, Ontario, which resulted in a gain on lease termination of $0.2 million in the thirteen and twenty-six weeks ended February 27, 2021. As a result, for the thirteen and twenty-six weeks ended February 27, 2021, the Company incurred a total of $1.3 million and $3.8 million in restructuring and restructuring related costs, respectively, which have been included within General and administrative on the Consolidated Statements of Operations and Comprehensive Income.

    As of February 27, 2021, the Company has incurred aggregate restructuring and restructuring-related costs of $9.3 million since May 2020. Overall, the Company expects to incur a total of approximately $10.0 million in restructuring and restructuring related costs, which are to be paid throughout fiscal 2021 and the first quarter of fiscal 2022.

25

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    This Quarterly Report on Form 10-Q/A (this “Amendment”) contains forward-looking statements. When used anywhere in this Amendment, the words “expect,” “believe,” “anticipate,” “estimate,” “intend,” “plan” and similar expressions are intended to identify forward-looking statements. These statements relate to future events or our future financial or operational performance and involve known and unknown risks, uncertainties and other factors that could cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. These statements include, but are not limited to, the effect of the COVID-19 pandemic on our business, financial condition and results of operations. We disclaim any undertaking to publicly update or revise any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. These statements reflect our current views with respect to future events and are based on assumptions subject to risks and uncertainties. Such risks and uncertainties include those related to our ability to sell our products.

    The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes included in our Annual Report on Form 10-K/A for the fiscal year ended August 29, 2020 and our unaudited condensed consolidated financial statements and the related notes appearing elsewhere in this Amendment. In addition to historical information, the following discussion contains forward-looking statements, including but not limited to, statements regarding the Company’s expectation for future performance, liquidity and capital resources that involve risks, uncertainties and assumptions that could cause actual results to differ materially from the Company’s expectations. The Company’s actual results may differ materially from those contained in or implied by any forward-looking statements. Factors that could cause such differences include those identified in Item 1A. “Risk Factors” of our Annual Report on Form 10-K/A. The Company assumes no obligation to update any of these forward-looking statements.

    Unless the context requires otherwise in this Amendment, the terms “we,” “us,” “our,” the “Company” and “Simply Good Foods” refer to The Simply Good Foods Company and its subsidiaries.

Overview

    The Simply Good Foods Company is a consumer-packaged food and beverage company that aims to lead the nutritious snacking movement with trusted brands that offer a variety of convenient, innovative, great-tasting, better-for-you snacks and meal replacements. Our nutritious snacking platform consists of the following core brands that specialize in providing products for consumers that follow certain nutritional philosophies, dietary approaches and/or health-and-wellness trends: Atkins® for those following a low-carb lifestyle; and Quest® for consumers seeking to partner with a brand that makes the foods they crave work for them, not against them, through a variety of protein-rich foods and beverages that also limit sugars and simple carbs. We distribute our products in major retail channels, primarily in North America, including grocery, club and mass merchandise, as well as through e-commerce, convenience, specialty and other channels. Our portfolio of nutritious snacking brands gives us a strong platform with which to introduce new products, expand distribution, and attract new consumers to our products. Our platform also positions us to continue to selectively pursue acquisition opportunities of brands in the nutritious snacking category.

    To that end, in November 2019, we completed the acquisition of Quest Nutrition, LLC (“Quest”), a healthy lifestyle food company, for a cash purchase price of approximately $1.0 billion (subject to customary adjustments) (the “Acquisition of Quest”). For more information, please see “Liquidity and Capital Resources - Acquisition of Quest.”

Effects of COVID-19

    In December 2019, a novel coronavirus disease, or COVID-19, was reported and in January 2020, the World Health Organization, or WHO, declared it a Public Health Emergency of International Concern. On February 28, 2020, the WHO raised its assessment of the COVID-19 threat from high to very high at a global level due to the continued increase in the number of cases and affected countries, and on March 11, 2020, the WHO characterized COVID-19 as a pandemic. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was signed into law. The CARES Act provided a substantial stimulus and assistance package intended to address the effect of the COVID-19 pandemic, including tax relief and government loans, grants and investments. Additionally, various federal, state and local government-imposed movement restrictions and initiatives have been implemented to reduce the global transmission of COVID-19, including reduced or eliminated food services, the closure of retailing establishments, the promotion of social distancing and the adoption of remote working policies.

    Beginning in the third quarter of 2020, we actively engaged with the various elements of our value chain, including our customers, contract manufacturers, and logistics and transportation providers, to meet demand for our products and to remain informed of any challenges within our value chain. Given the unpredictable nature of the COVID-19 pandemic and the initial surge in consumption, we increased finished goods inventory of some of our key products. In the fourth quarter of 2020 and continuing into the second quarter of 2021, consumer consumption habits became more steady and inventory levels normalized. Based on information available to us as of the date of this Amendment, we believe we will be able to deliver our products to meet customer orders on a timely basis, and therefore, we expect our products will continue to be available for purchase to meet consumer meal replacement and snacking needs for the foreseeable

26

future. We continue to monitor customer and consumer demand, and intend to adapt our plans as needed to continue to drive our business and meet our obligations during the evolving COVID-19 situation.

    We implemented remote work arrangements and restricted business travel in March 2020, and to date, these arrangements have not materially affected our ability to maintain our business operations, including the operation of financial reporting systems, internal control over financial reporting, and disclosure controls and procedures. We believe our lean infrastructure, which allows for significant flexibility, speed-to-market and minimal capital investment, has enabled us to adjust our expenditures to maintain cash flow until the more fulsome reopening of the U.S. economy and the associated return of shopping behavior to more normal patterns occurs. We also believe the return of these shopping patterns along with our brand benefits of active nutrition and weight management will drive more better-for-you snacking and meal replacement usage occasions.

    During the fiscal second quarter of 2021, several vaccines were first authorized for use against COVID-19 in the United States and internationally. As a result of distribution of the vaccines, various federal, state and local government have begun to ease the movement restrictions and initiatives while continuing to adhere to enhanced safety measures, such as physical distancing and face mask protocols. However, the uncertainty continues to exist regarding the severity and duration of the pandemic, the speed and effectiveness of vaccine and treatment developments and deployment, potential mutations of COVID-19, and the effect of actions taken and that will be taken to contain COVID-19 or treat its effect, among others.

    Our consolidated results of operations for the thirteen and twenty-six weeks ended February 27, 2021 continued to be affected by changes in consumer shopping and consumption behavior due to COVID-19. The nutritional snacking category has experienced a marked decrease in shopping trips (particularly in the mass channel) and fewer usage occasions. There is still uncertainty related to the duration of reduced consumer mobility and when shopping trips will return to pre-pandemic levels, particularly in the mass market retail channel. This has affected our portable and convenient on-the-go products, especially the nutrition and protein bar portion of our business for both our Atkins and Quest brands. While our Quest brand has outperformed its portion of the nutritious snaking segment, the performance of our Atkins brand, which is part of the weight management portion of the market, has remained slower due to what we believe is the temporary softer interest in weight management for consumers, fewer on-the-go usage occasions and weakness in the mass channel that has experienced reduced shopper traffic during the pandemic.

    We remain uncertain of the ultimate effect COVID-19 could have on our business notwithstanding the distribution of several U.S. government approved vaccines and various federal, state and local governments having begun to ease the movement restrictions and public health initiatives while continuing to adhere to enhanced safety measures, such as physical distancing and face mask protocols. This uncertainty as to the duration and severity of economic effects from severity of economic effects from the COVID-19 pandemic stems from the potential for, among other things, (i) continued rates of reported cases of COVID-19 and the potential for mutations of COVID-19 to result in increased rates of reported cases for which currently approved vaccines are not effective, (ii) unexpected supply chain disruptions, (iii) changes to customer operations, (iv) continued or additional changes in consumer purchasing and consumption behavior beyond those evidenced to date, and (v) the closure of customer establishments.

Restructuring and Related Charges

    In May 2020, we announced certain restructuring activities in conjunction with the implementation of our future-state organization design, which created a fully integrated organization with our completed Acquisition of Quest. The new organization design became effective on August 31, 2020. These restructuring plans primarily include workforce reductions, changes in management structure, and the relocation of business activities from one location to another.

    For the thirteen and twenty-six weeks ended February 27, 2021, we incurred a total of $1.3 million and $3.8 million in restructuring and restructuring related costs, respectively, which have been included within General and administrative on the Consolidated Statements of Operations and Comprehensive Income. As of February 27, 2021, we have incurred aggregate restructuring and restructuring related costs of $9.3 million since May 2020. Overall, we expect to incur a total of approximately $10.0 million in restructuring and restructuring-related costs, which are to be paid throughout fiscal 2021 and the first quarter of fiscal 2022. Refer to Note 14, Restructuring and Related Charges, of our Notes to Unaudited Condensed Consolidated Financial Statements in this Amendment for additional information regarding restructuring activities.

SimplyProtein Sale

    Effective September 24, 2020, we sold the assets exclusively related to our SimplyProtein® brand of products for approximately $8.8 million of consideration, including cash of $5.8 million and a note receivable for $3.0 million, to a newly formed entity led by the Company’s former Canadian-based management team who had been responsible for this brand prior to the sale transaction (the “SimplyProtein Sale”). In addition to purchasing these assets, the buyer assumed certain liabilities related to the SimplyProtein brand’s business. There was no gain or loss recognized as a result of the SimplyProtein Sale. The transaction enables our management to focus its full time and our resources on our core Atkins® and Quest® branded businesses and other strategic initiatives.

27

Change in Fair Value of Warrant Liability

    During the thirteen and twenty-six weeks ended February 27, 2021 and February 29, 2020, there were fluctuations in the fair value of our liability-classified private warrants (“Private Warrants”). These fluctuations created significant gains and losses on the remeasurement of our Private Warrants which are recognized as a liability measured at fair value on our Condensed Consolidated Balance Sheets. These remeasurements are recognized as (Loss) gain in fair value change of warrant liability on our Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

Key Financial Definitions

    Net sales. Net sales consist primarily of product sales less the cost of promotional activities, slotting fees and other sales credits and adjustments, including product returns.

    Cost of goods sold. Cost of goods sold consists primarily of the costs we pay to our contract manufacturing partners to produce the products sold. These costs include the purchase of raw ingredients, packaging, shipping and handling, warehousing, depreciation of warehouse equipment, and a tolling charge for the contract manufacturer. Cost of goods sold includes products provided at no charge as part of promotions and the non-food materials provided with customer orders.

    Operating expenses. Operating expenses consist primarily of selling and marketing, general and administrative, depreciation and amortization, and business transaction costs. The following is a brief description of the components of operating expenses:

•Selling and marketing. Selling and marketing expenses are comprised of broker commissions, customer marketing, media and other marketing costs.

•General and administrative. General and administrative expenses are comprised of expenses associated with corporate and administrative functions that support our business, including employee salaries, professional services, integration costs, restructuring costs, insurance and other general corporate expenses.

•Depreciation and amortization. Depreciation and amortization costs consist of costs associated with the depreciation of fixed assets and capitalized leasehold improvements and amortization of intangible assets.

•Business transaction costs. Business transaction costs are comprised of legal, due diligence, consulting and accounting firm expenses associated with the process of actively pursuing potential and completed business combinations, including the Acquisition of Quest.

Results of Operations

    In the second quarter of fiscal 2021, we were able to continue to drive net sales and earnings growth in a challenging operating environment. The strong performance of the Quest brand drove the increases in net sales and net income for the thirteen weeks ended February 27, 2021 compared to the thirteen weeks ended February 29, 2020. We are encouraged by our business’s performance in the first half of fiscal year 2021, including the momentum of the Quest brand and the progress made against our strategic initiatives, however there is still uncertainty related to when customer mobility, consumption behavior and shopping trips will return to pre-COVID-19 levels. However, we anticipate there will be overall marketplace trend improvements in the second half of fiscal 2021 as consumer mobility and on-the-go consumption increases.

    In assessing the performance of our business, we consider a number of key performance indicators used by management and typically used by our competitors, including the non-GAAP measure Adjusted EBITDA. Because not all companies use identical calculations, this presentation of Adjusted EBITDA may not be comparable to other similarly titled measures of other companies. See “Reconciliation of Adjusted EBITDA” below for a reconciliation of Adjusted EBITDA to net income for each applicable period.

28

Table of Contents

Comparison of Unaudited Results for the Thirteen Weeks Ended February 27, 2021 and the Thirteen Weeks Ended February 29, 2020

    The following unaudited table presents, for the periods indicated, selected information from our Condensed Consolidated Statements of Operations and Comprehensive Income, including information presented as a percentage of net sales:

	As Restated
	Thirteen Weeks Ended				Thirteen Weeks Ended
(In thousands)	February 27, 2021		% of Sales		February 29, 2020		% of Sales
Net sales	$	230,607	100.0	%	$	227,101	100.0	%
Cost of goods sold	140,342		60.9	%	141,707		62.4	%
Gross profit	90,265		39.1	%	85,394		37.6	%
Operating expenses:
Selling and marketing	26,150		11.3	%	27,041		11.9	%
General and administrative	26,562		11.5	%	28,103		12.4	%
Depreciation and amortization	4,212		1.8	%	4,287		1.9	%
Business transaction costs	—		—	%	694		0.3	%
Total operating expenses	56,924		24.7	%	60,125		26.5	%
Income from operations	33,341		14.5	%	25,269		11.1	%
Other income (expense):
Interest income	—		—	%	85		—	%
Interest expense	(7,995)		(3.5)	%	(10,589)		(4.7)	%
(Loss) gain in fair value change of warrant liability	(45,334)		(19.7)	%	37,644		16.6	%
Gain (loss) on foreign currency transactions	975		0.4	%	(194)		(0.1)	%
Other income	112		—	%	8		—	%
Total other (expense) income	(52,242)		(22.7)	%	26,954		11.9	%
(Loss) income before income taxes	(18,901)		(8.2)	%	52,223		23.0	%
Income tax expense	7,313		3.2	%	3,922		1.7	%
Net (loss) income	$	(26,214)	(11.4)	%	$	48,301	21.3	%
Other financial data:
Adjusted EBITDA(1)	$	42,644	18.5	%	$	41,731	18.4	%

(1)    Adjusted EBITDA is a non-GAAP financial metric. See “Reconciliation of Adjusted EBITDA” below for a reconciliation of Adjusted EBITDA to net income for each applicable period.

    Net sales. Net sales of $230.6 million represented an increase of $3.5 million, or 1.5%, for the thirteen weeks ended February 27, 2021 compared to the thirteen weeks ended February 29, 2020. The net sales increase of 1.5% was primarily driven by Quest brand net sales growth and solid e-commerce growth across both the Atkins brand and Quest brand. The increase was partially offset by a 1.2% decrease in net sales due to the SimplyProtein Sale and the restructuring related business activities in Europe in fiscal year 2021. Additionally, net sales in the thirteen weeks ended February 27, 2021 were negatively affected by the timing of seasonal inventory shipments as well as higher trade promotions.

    Cost of goods sold. Cost of goods sold decreased $1.4 million, or 1.0%, for the thirteen weeks ended February 27, 2021 compared to the thirteen weeks ended February 29, 2020. The cost of goods sold decrease was driven by the effect of the $5.1 million non-cash inventory step-up related to the Acquisition of Quest in fiscal year 2020, partially offset by sales volume growth primarily attributable to the Quest brand as discussed above.

    Gross profit. Gross profit increased $4.9 million, or 5.7%, for the thirteen weeks ended February 27, 2021 compared to the thirteen weeks ended February 29, 2020. Gross profit of $90.3 million, or 39.1% of net sales, for the thirteen weeks ended February 27, 2021 increased 150 basis points from 37.6% of net sales for the thirteen weeks ended February 29, 2020. The increase in gross profit margin was primarily the result of a $5.1 million non-cash inventory purchase accounting step-up adjustment which resulted in a 220 basis point headwind in fiscal year 2020. This increase was partially offset by higher trade promotions in fiscal year 2021.

29

Table of Contents

    Operating expenses. Operating expenses decreased $3.2 million, or 5.3%, for the thirteen weeks ended February 27, 2021 compared to the thirteen weeks ended February 29, 2020 due to the following:

•Selling and marketing. Selling and marketing expenses decreased $0.9 million, or 3.3%, for the thirteen weeks ended February 27, 2021 compared to the thirteen weeks ended February 29, 2020. The decrease was primarily related to the SimplyProtein Sale and the restructuring related business activities in Europe in fiscal year 2021.

•General and administrative. General and administrative expenses decreased $1.5 million, or 5.5%, for the thirteen weeks ended February 27, 2021 compared to the thirteen weeks ended February 29, 2020. The decrease was primarily attributable to a $2.9 million reduction in costs related to the integration of Quest, partially offset by an increase in restructuring charges of $1.3 million in the thirteen weeks ended February 27, 2021.

•Depreciation and amortization. Depreciation and amortization expenses decreased slightly to $4.2 million for the thirteen weeks ended February 27, 2021 compared to $4.3 million for the thirteen weeks ended February 29, 2020.

•Business transaction costs. Business transaction costs were $0.7 million for the thirteen weeks ended February 29, 2020 and was comprised of expenses related to the Acquisition of Quest.

    Interest income. Interest income was nominal for each of the thirteen weeks ended February 27, 2021 and February 29, 2020.

    Interest expense. Interest expense decreased $2.6 million for the thirteen weeks ended February 27, 2021 compared to the thirteen weeks ended February 29, 2020 primarily due to principal payments reducing the outstanding balance of the Term Facility (as defined below) to $556.5 million as of February 27, 2021 from $635.5 million as of February 29, 2020.

    (Loss) gain in fair value change of warrant liability. During the thirteen weeks ended February 27, 2021 and the thirteen weeks ended February 29, 2020, we recorded a $45.3 million loss and a $37.6 million gain, respectively, related to the change in fair value of our liability-classified Private Warrants, primarily driven by movements in our stock price.

    Gain (loss) on foreign currency transactions. A gain of $1.0 million in foreign currency transactions was recorded for the thirteen weeks ended February 27, 2021 compared to a foreign currency loss of $0.2 million for the thirteen weeks ended February 29, 2020. The change relates to changes in foreign currency rates related to international operations.

    Income tax expense. Income tax expense increased $3.4 million, for the thirteen weeks ended February 27, 2021 compared to the thirteen weeks ended February 29, 2020. The increase in our income tax expense is primarily driven by higher income from operations offset by other permanent differences.

    Net (loss) income. Net income was $26.2 million for the thirteen weeks ended February 27, 2021, a decrease of $74.5 million compared to net income of $48.3 million for the thirteen weeks ended February 29, 2020. The change was primarily related to increased gross profit as well as reductions to operating expenses and interest expense as discussed above, and unfavorable fair value movements in the warrant liability.

    Adjusted EBITDA. Adjusted EBITDA increased $0.9 million, or 2.2%, for the thirteen weeks ended February 27, 2021 compared to the thirteen weeks ended February 29, 2020. For a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, see “Reconciliation of Adjusted EBITDA” below.

30

Comparison of Unaudited Results for the Twenty-Six Weeks Ended February 27, 2021 and the Twenty-Six Weeks Ended February 29, 2020

    The following unaudited table presents, for the periods indicated, selected information from our Condensed Consolidated Statements of Operations and Comprehensive Income, including information presented as a percentage of net sales:

	As Restated
	Twenty-Six Weeks Ended				Twenty-Six Weeks Ended
(In thousands)	February 27, 2021		% of Sales		February 29, 2020		% of Sales
Net sales	$	461,759	100.0	%	$	379,254	100.0	%
Cost of goods sold	277,453		60.1	%	231,654		61.1	%
Gross profit	184,306		39.9	%	147,600		38.9	%
Operating expenses:
Selling and marketing	51,345		11.1	%	45,475		12.0	%
General and administrative	51,977		11.3	%	46,248		12.2	%
Depreciation and amortization	8,456		1.8	%	6,740		1.8	%
Business transaction costs	—		—	%	26,853		7.1	%
Total operating expenses	111,778		24.2	%	125,316		33.0	%
Income from operations	72,528		15.7	%	22,284		5.9	%
Other income (expense):
Interest income	3		—	%	1,464		0.4	%
Interest expense	(16,367)		(3.5)	%	(15,558)		(4.1)	%
(Loss) gain in fair value change of warrant liability	(24,881)		(5.4)	%	50,952		13.4	%
Gain (loss) on foreign currency transactions	984		0.2	%	(178)		—	%
Other income	159		—	%	45		—	%
Total other (expense) income	(40,102)		(8.7)	%	36,725		9.7	%
Income before income taxes	32,426		7.0	%	59,009		15.6	%
Income tax expense	15,687		3.4	%	2,193		0.6	%
Net income	$	16,739	3.6	%	$	56,816	15.0	%
Other financial data:
Adjusted EBITDA(1)	$	91,341	19.8	%	$	73,526	19.4	%

(1)    Adjusted EBITDA is a non-GAAP financial metric. See “Reconciliation of Adjusted EBITDA” below for a reconciliation of Adjusted EBITDA to net income for each applicable period.

    Net sales. Net sales of $461.8 million represented an increase of $82.5 million, or 21.8%, for the twenty-six weeks ended February 27, 2021 compared to the twenty-six weeks ended February 29, 2020. The net sales increase of 21.8% was primarily attributable to the Quest brand, which increased net sales by 25.2%, due to Quest’s partial inclusion in our results of operations in fiscal year 2020 as compared to fiscal year 2021 as well as post-acquisition Quest brand sales volume growth. These increases in net sales were partially offset by decreased sales volume of approximately 1.4% related to the SimplyProtein Sale and the restructuring related business activities in Europe in fiscal year 2021. Additionally, the continued effects of COVID-19 related movement restrictions as well as higher trade promotions partially offset the overall increase in net sales.

    Cost of goods sold. Cost of goods sold increased $45.8 million, or 19.8%, for the twenty-six weeks ended February 27, 2021 compared to the twenty-six weeks ended February 29, 2020. The cost of goods sold increase was driven by sales volume growth primarily attributable to the Quest brand as discussed above, which was partially offset by the effect of the $7.5 million non-cash inventory step-up related to the Acquisition of Quest.

31

    Gross profit. Gross profit increased $36.7 million, or 24.9%, for the twenty-six weeks ended February 27, 2021 compared to the twenty-six weeks ended February 29, 2020. Gross profit of $184.3 million, or 39.9% of net sales, for the twenty-six weeks ended February 27, 2021 increased 100 basis points from 38.9% of net sales for the twenty-six weeks ended February 29, 2020. The increase in gross margin was primarily the result of the $7.5 million non-cash inventory step-up related to the Acquisition of Quest in fiscal year 2020 offset by higher trade promotions in fiscal year 2021.

    Operating expenses. Operating expenses decreased $13.5 million, or 10.8%, for the twenty-six weeks ended February 27, 2021 compared to the twenty-six weeks ended February 29, 2020 due to the following:

•Selling and marketing. Selling and marketing expenses increased $5.9 million, or 12.9%, for the twenty-six weeks ended February 27, 2021 compared to the twenty-six weeks ended February 29, 2020. The increase was primarily related to Quest’s partial inclusion in our results of operations in fiscal year 2020 as compared to fiscal year 2021, which was partially offset by decreased selling and marketing expenses related to the SimplyProtein Sale and the restructuring related business activities in Europe.

•General and administrative. General and administrative expenses increased $5.7 million, or 12.4%, for the twenty-six weeks ended February 27, 2021 compared to the twenty-six weeks ended February 29, 2020. The increase was primarily attributable to Quest’s partial inclusion in our results of operations in fiscal year 2020 as compared to fiscal year 2021 as well as restructuring charges of $3.8 million in fiscal year 2021. These increases were partially offset by the reductions in costs related to the integration of Quest and stock-based compensation.

•Depreciation and amortization. Depreciation and amortization expenses increased $1.7 million, or 25.5%, for the twenty-six weeks ended February 27, 2021 compared to the twenty-six weeks ended February 29, 2020. The increase was primarily due to the partial inclusion amortization expense related to intangible assets recognized in the Acquisition of Quest in fiscal year 2020 as compared to fiscal year 2021.

•Business transaction costs. Business transaction costs were $26.9 million for the twenty-six weeks ended February 29, 2020 and was comprised of expenses related to the Acquisition of Quest.

    Interest income. Interest income decreased $1.5 million for the twenty-six weeks ended February 27, 2021 compared to the twenty-six weeks ended February 29, 2020, primarily due to $195.3 million of cash on hand being utilized for the Acquisition of Quest in the first quarter of fiscal year 2020 and lower market rates.

    Interest expense. Interest expense increased $0.8 million for the twenty-six weeks ended February 27, 2021 compared to the twenty-six weeks ended February 29, 2020, primarily due to the funding of the Term Facility in the amount of $460.0 million to partially finance the Acquisition of Quest in the first quarter of fiscal 2020.

    (Loss) gain in fair value change of warrant liability. During the twenty-six weeks ended February 27, 2021 and the twenty-six weeks ended February 29, 2020, we recorded a $24.9 million loss and a $51.0 million gain, respectively, related to the change in fair value of our liability-classified Private Warrants, primarily driven by movements in our stock price.

    Gain (loss) on foreign currency transactions. A gain of $1.0 million in foreign currency transactions was recorded for the twenty-six weeks ended February 27, 2021 compared to a foreign currency loss of $0.2 million for the twenty-six weeks ended February 29, 2020. The change relates to changes in foreign currency rates related to international operations.

    Income tax expense. Income tax expense increased $13.5 million, for the twenty-six weeks ended February 27, 2021 compared to the twenty-six weeks ended February 29, 2020. The increase in our income tax expense is primarily driven by higher income from operations offset by other permanent differences.

    Net income. Net income was $16.7 million for the twenty-six weeks ended February 27, 2021 a decrease of $40.1 million compared to net income of $56.8 million for the twenty-six weeks ended February 29, 2020. The change was primarily related to increased gross profit as discussed above, decreased transaction costs related to the Acquisition of Quest in fiscal year 2020, and unfavorable fair value movements in the warrant liability.

    Adjusted EBITDA. Adjusted EBITDA increased $17.8 million, or 24.2%, for the twenty-six weeks ended February 27, 2021 compared to the twenty-six weeks ended February 29, 2020, driven primarily by the Acquisition of Quest. For a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, see “Reconciliation of Adjusted EBITDA” below.

32

Reconciliation of Adjusted EBITDA

    Adjusted EBITDA. Adjusted EBITDA is a non-GAAP financial measure commonly used in our industry and should not be construed as an alternative to net income as an indicator of operating performance or as an alternative to cash flow provided by operating activities as a measure of liquidity (each as determined in accordance with GAAP). Simply Good Foods defines Adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) as net income before interest income, interest expense, income tax expense, depreciation and amortization with further adjustments to exclude the following items: business transaction costs, stock-based compensation expense, inventory step-up, integration costs, restructuring costs, non-core legal costs, gain or loss in fair value change of warrant liability, and other non-core expenses. The Company believes that the inclusion of these supplementary adjustments in presenting Adjusted EBITDA, when used in conjunction with net income, are useful to provide additional information to investors, and management of the Company uses Adjusted EBITDA to supplement net income because it reflects more accurately operating results of the on-going operations, enhances the overall understanding of past financial performance and future prospects and allows for greater transparency with respect to the key metrics the Company uses in its financial and operational decision making. The Company also believes that Adjusted EBITDA is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in its industry. Adjusted EBITDA may not be comparable to other similarly titled captions of other companies due to differences in the non-GAAP calculation.

    The following unaudited tables below provide a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, which is net income, for the thirteen and twenty-six weeks ended February 27, 2021 and February 29, 2020:

(In thousands)	Thirteen Weeks Ended				Twenty-Six Weeks Ended
	February 27, 2021		February 29, 2020		February 27, 2021		February 29, 2020
	(As Restated)		(As Restated)		(As Restated)		(As Restated)
Net income	$	(26,214)	$	48,301	$	16,739	$	56,816
Interest income	—		(85)		(3)		(1,464)
Interest expense	7,995		10,589		16,367		15,558
Income tax expense	7,313		3,922		15,687		2,193
Depreciation and amortization	4,508		4,594		9,021		7,119
EBITDA	(6,398)		67,321		57,811		80,222
Business transaction costs	—		694		—		26,853
Stock-based compensation expense	2,484		2,122		3,594		3,795
Inventory step-up	—		5,085		—		7,522
Integration of Quest	968		3,903		2,214		5,341
Restructuring	1,267		—		3,786		—
Non-core legal costs	—		76		—		555
Loss (gain) in fair value change of warrant liability	45,334		(37,644)		24,881		(50,952)
Other (1)	(1,011)		174		(945)		190
Adjusted EBITDA	$	42,644	$	41,731	$	91,341	$	73,526

(1)    Other items consist principally of exchange impact of foreign currency transactions and other expenses.

33

Liquidity and Capital Resources

Overview

    We have historically funded our operations with cash flow from operations and, when needed, with borrowings under our credit facilities. Our principal uses of cash have been debt service, working capital and the Acquisition of Quest.

    We had $91.3 million in cash and cash equivalents as of February 27, 2021. We believe our sources of liquidity and capital will be sufficient to finance our continued operations, growth strategy and additional expenses we expect to incur for at least the next twelve months. As circumstances warrant, we may issue debt and/or equity securities from time to time on an opportunistic basis, dependent upon market conditions and available pricing. We make no assurance that we can issue and sell such securities on acceptable terms or at all.

Debt and Credit Facilities

    On July 7, 2017, we entered into a credit agreement with Barclays Bank PLC and other parties (as amended to date, the “Credit Agreement”). The Credit Agreement provides for (i) a term facility of $200.0 million (“Term Facility”) with a seven year maturity and (ii) a revolving credit facility of up to $75.0 million (the “Revolving Credit Facility”) with a five year maturity. Substantially concurrent with the consummation of the Acquisition of Atkins, the full $200.0 million of the Term Facility (the “Term Loan”) was drawn. The interest rate per annum is based on either (i) a base rate equaling the higher of (a) the “prime rate”, (b) the federal funds effective rate plus 0.50% and (c) the Euro-currency rate applicable for an interest period of one month plus 1.00% plus (x) 3.00% margin for the Term Loan or (y) 2.00% margin for the Revolving Credit Facility, or (ii) London Interbank Offered Rate (“LIBOR”) adjusted for statutory reserve requirements, plus (x) 4.00% margin for the Term Loan subject to a floor of 1.00% or (y) 3.00% margin for the Revolving Credit Facility. As security for the payment or performance of its debt, we have pledged certain equity interests in its subsidiaries.

    On March 16, 2018 (the “Amendment Date”), we entered into an amendment (the “Repricing Amendment”) to the Credit Agreement. As a result of the Repricing Amendment, the interest rate on the Term Loan was reduced and, as of the Amendment Date, such loans had an interest rate equal to, at our option, either LIBOR plus an applicable margin of 3.50% or a base rate plus an applicable margin of 2.50%. The Repricing Amendment did not change the interest rate on the Revolving Credit Facility. The Revolving Credit Facility continued to bear interest based upon our consolidated net leverage ratio as of the last financial statements delivered to the administrative agent. No additional debt was incurred, or any proceeds received, by us in connection with the Repricing Amendment. The incremental fees paid to the administrative agent are reflected as additional debt discount and are amortized over the terms of the long-term financing agreements using the effective-interest method.

    On November 7, 2019, we entered into an amendment (the “Incremental Facility Amendment”) to the Credit Agreement to increase the principal borrowed on the Term Facility by $460.0 million. The Term Facility together with the incremental borrowing make up the Initial Term Loans (as defined in the Incremental Facility Amendment) and as of the Amendment No. 2 Effective Date (as defined in the Incremental Facility Amendment), the Initial Term Loans bear interest at a rate equal to, at our option, either LIBOR plus an applicable margin of 3.75% or a base rate plus an applicable margin of 2.75%. The Incremental Facility Amendment was executed to partially finance the Acquisition of Quest. No amounts under the Term Facility were repaid as a result of the execution of the Incremental Facility Amendment.

    The Applicable Rate per annum applicable to the loans under the Credit Agreement Amendment is, with respect to any Initial Term Loan that is an ABR Loan (as defined in the Credit Agreement), 2.75% per annum, and with respect to any Initial Term Loan that is a Eurodollar Loan, 3.75% per annum. The incremental term loans will mature on the maturity date applicable to the Initial Term Loans, which date is July 7, 2024.

    The Credit Agreement contains certain financial and other covenants that limit our ability to, among other things, incur and/or undertake asset sales and other dispositions, liens, indebtedness, certain acquisitions and investments, consolidations, mergers, reorganizations and other fundamental changes, payment of dividends and other distributions to equity and warrant holders, and prepayments of material subordinated debt, in each case, subject to customary exceptions materially consistent with credit facilities of such type and size. The Revolving Credit Facility has a maximum total net leverage ratio equal to or less than 6.25:1.00 (with a reduction to 6.00:1.00 on and after the third anniversary of the closing date of the Credit Agreement) contingent on credit extensions in excess of 30% of the total amount of commitments available under the Revolving Credit Facility. Any failure to comply with the restrictions of the credit facilities may result in an event of default. We were in compliance with all financial covenants as of February 27, 2021 and August 29, 2020, respectively.

    At February 27, 2021, the outstanding balance of the Term Facility was $556.5 million. We are not required to make principal payments on the Term Facility over the twelve months following the period ended February 27, 2021. The outstanding balance of the Term Facility is due upon its maturity in July 2024. As of February 27, 2021, there were no amounts drawn against the Revolving Credit Facility.

34

Public Equity Offering

    On October 9, 2019, we completed an underwritten public offering of 13,379,205 shares of our common stock at a price to the public of $26.35 per share. We paid underwriting discounts and commissions of $0.19 per share resulting in net proceeds to us of $26.16 per share, or approximately $350.0 million (the “Offering”). We paid $0.8 million for legal, accounting and registrations fees related to the Offering. The net proceeds were used to pay a portion of the purchase price and related fees and expenses for the Acquisition of Quest.

Acquisition of Quest

    On August 21, 2019, our wholly-owned subsidiary Simply Good USA entered into the Purchase Agreement with VMG Voyage Holdings, LLC, VMG Tax-Exempt II, L.P., Voyage Employee Holdings, LLC, and other sellers, as defined in the Purchase Agreement, to acquire Quest, a healthy lifestyle food company. On November 7, 2019, pursuant to the Purchase Agreement, Simply Good USA completed the Acquisition of Quest, for a cash purchase price of approximately $1.0 billion, subject to customary post-closing adjustments.

    The Acquisition of Quest was funded through a combination of cash, equity and debt financing. Total consideration paid on the closing date was $988.9 million. Cash sources of funding included $195.3 million of cash on hand, net proceeds of approximately $350.0 million from an underwritten public offering of common stock, and $443.6 million of new term loan debt. In the third fiscal quarter of 2020, we received a post-closing release from escrow of approximately $2.1 million related to net working capital adjustments, resulting in a total net consideration paid of $986.8 million as of February 27, 2021. For the thirteen and twenty-six weeks ended February 29, 2020, we incurred business transaction costs $0.7 million and $26.9 million, respectively.

Private Warrants to Purchase Common Stock

    As of February 27, 2021, our Private Warrants to purchase 6,700,000 shares of common stock remain outstanding, are held by Conyers Park Sponsor, LLC, a related party, and remain liability-classified. If all Private Warrants are exercised at the $11.50 exercise price per warrant, our cash would increase by $77.1 million.

Cash Flows

    The following table sets forth the major sources and uses of cash for each of the periods set forth below (in thousands):

	Twenty-Six Weeks Ended
	February 27, 2021		February 29, 2020
Net cash provided by (used in) operating activities	$	39,764	$	(14,886)
Net cash provided by (used in) investing activities	$	5,237	$	(985,932)
Net cash (used in) provided by financing activities	$	(49,893)	$	780,705

    Operating activities. Our net cash provided by operating activities increased $54.7 million to $39.8 million for the twenty-six weeks ended February 27, 2021 compared to cash used in operating activities of $14.9 million for the twenty-six weeks ended February 29, 2020. The increase in cash provided by operating activities was primarily caused by higher income before taxes, which was driven by (i) the Quest brand sales volume growth, which increased net sales by 25.2%, due to Quest’s partial inclusion in our results of operations in fiscal year 2020 as compared to fiscal year 2021 as well as post-acquisition Quest brand sales volume growth and (ii) significant reductions in cash outlays and changes in working capital related to the first quarter 2020 Acquisition of Quest, including decreases in business transaction costs of $26.9 million and integration costs of $3.1 million. These increases in cash provided by operations were partially offset by $6.3 million of cash payments made for restructuring related costs, predominately composed of termination benefits and severance payments, during the twenty-six weeks ended February 27, 2021. Additionally, cash paid for taxes increased $5.7 million for the twenty-six weeks ended February 27, 2021 compared to the twenty-six weeks ended February 29, 2020.

    Investing activities. Our net cash provided by investing activities was $5.2 million for the twenty-six weeks ended February 27, 2021, which was primarily related to the $5.8 million of cash proceeds received from the SimplyProtein Sale. The net cash used in investing activities of $985.9 million for the twenty-six weeks ended February 29, 2020 was primarily related to the cash paid for the Acquisition of Quest, net of cash acquired, of $984.2 million.

    Financing activities. Our net cash used in financing activities was $49.9 million for the twenty-six weeks ended February 27, 2021 compared to net cash provided by financing activities of $780.7 million for the twenty-six weeks ended February 29, 2020. Net cash used in financing activities for the twenty-six weeks ended February 27, 2021 primarily consisted of a $50.0 million principal payment on the Term Facility. For the twenty-six weeks ended February 29, 2020, net cash provided by financing activities included gross proceeds of $352.5 million from the Offering offset by issuance costs of $3.3 million, proceeds of $460.0 million from the Term Facility borrowing related to the Incremental Facility Amendment offset by issuance costs of $8.2 million, and a $21.0 million principal payment on the Term Facility.

35

Table of Contents

Contractual Obligations

    Our contractual obligations are related to our Credit Agreement and our finance and operating leases. There have been no material changes to our contractual obligations from our Annual Report on Form 10-K/A.

Off-Balance Sheet Arrangements

    As of February 27, 2021, we had no material off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial condition, income or expenses, results of operations, liquidity, capital expenditures or capital resources.

New Accounting Pronouncements

    For a description of critical accounting policies that affect our significant judgments and estimates used in the preparation of our consolidated financial statements, refer to our Annual Report on Form 10-K/A. There have been no significant changes to our critical accounting policies since August 29, 2020. Refer to Note 3 of our unaudited interim consolidated financial statements in this Amendment for further information regarding recently issued accounting standards.

Item 3.    Quantitative and Qualitative Disclosures about Market Risk

    There were no material changes in our market risk exposure during the thirteen week period ended February 27, 2021. While the Company’s input costs are not expected to have a meaningful negative effect on results of operations and financial condition for fiscal year 2021, the Company is seeing some inflationary pressure as it analyzes its fiscal year 2022 input requirements. As a result, the Company is assessing available alternatives to mitigate potential input cost inflation for fiscal year 2022. For a discussion of our market risks, see “Quantitative and Qualitative Disclosures About Market Risk” in Part II, Item 7A of our Annual Report on Form 10-K.

Item 4.    Controls and Procedures

    We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required financial disclosures.

    Management, including the participation of our Chief Executive Officer and our Chief Financial Officer, conducted an evaluation (pursuant to Rule 13a-15(b) under the Exchange Act) of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Amendment. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of February 27, 2021, the Company’s disclosure controls and procedures were not effective due to a material weakness in internal control over financial reporting described below.

As previously disclosed in our Annual Report on Form 10-K/A for the year ended August 29, 2020, we identified a material weakness in our internal controls over financial reporting related to inaccurate accounting for warrants issue in connection with our initial public offering and private placement. Notwithstanding this material weakness, management has concluded that our unaudited condensed consolidated financial statements included in the Quarterly Report on Form 10-Q are fairly stated in all material respects in accordance with GAAP for each of the periods presented therein.

Remediation Plan

    We have expended, and will continue to expend, a substantial amount of effort and resources for the remediation and improvement of our internal control over financial reporting. Our plans at this time include acquiring enhanced access to accounting literature, increased communication among our personnel regarding the application of complex accounting transactions, hiring additional technical resources and enhanced reviews of technical analyses to ensure the proper application of GAAP. Our remediation plan can only be accomplished over time and will be continually reviewed to determine that it is achieving its objectives. We can offer no assurance that these initiatives will ultimately have the intended effects.

Changes in Internal Control over Financial Reporting

    There has been no change in the Company’s internal control over financial reporting that occurred during the quarter ended February 27, 2021 that have materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

36

Table of Contents

Inherent Limitations on Effectiveness of Controls

    Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Additionally, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

37

PART II. Other Information

Item 1A. Risk Factors

    Readers should carefully consider the factors discussed in Part I, Item 1A. “Risk Factors” in our Amendment No. 1 to Form 10-K (“Form 10-K/A”), which could materially affect our business, financial condition, cash flows or future results. There have been no material changes in our risk factors included in our Form 10-K/A. The risks described in our Form 10-K/A are not the only risks facing the Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results.

38

Table of Contents

Item 6. Exhibits

Exhibit No.	Document
31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002.
31.2	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002.
32.1	Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes Oxley Act.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).

39

Table of Contents

SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		By:	THE SIMPLY GOOD FOODS COMPANY /s/ Timothy A. Matthews
Date:	June 30, 2021	Name:	Timothy A. Matthews
		Title:	Vice President, Controller, and Chief Accounting Officer
			(Principal Accounting Officer)

40

EX-31.1

Exhibit 31.1

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

OF THE U.S. SECURITIES EXCHANGE ACT OF 1934

(Section 302 of the Sarbanes-Oxley Act of 2002)

I, Joseph E. Scalzo, certify that:

    1.  I have reviewed this Quarterly Report on Form 10-Q/A of The Simply Good Foods Company (the "registrant");

    2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

    3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

    4.  The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)       designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)      designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)       evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)      disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

    5.  The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)       all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)      any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	June 30, 2021	By:	/s/ Joseph E. Scalzo
		Name:	Joseph E. Scalzo
		Title:	Chief Executive Officer, President and Director
			(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

OF THE U.S. SECURITIES EXCHANGE ACT OF 1934

(Section 302 of the Sarbanes-Oxley Act of 2002)

I, Todd E. Cunfer, certify that:

    1.  I have reviewed this Quarterly Report on Form 10-Q/A of The Simply Good Foods Company (the "registrant");

    2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

    3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

    4.  The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)       designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)      designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)       evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)      disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

    5.  The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)       all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)      any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	June 30, 2021	By:	/s/ Todd E. Cunfer
		Name:	Todd E. Cunfer
		Title:	Chief Financial Officer
			(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

    In connection with the Quarterly Report of The Simply Good Foods Company (the “Company”) on Form 10-Q/A for the fiscal period ended February 27, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to such officer's knowledge:

    1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

    2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company covered by the Report.

    This certificate is being furnished solely for the purposes of 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.

Date:	June 30, 2021	By:	/s/ Joseph E. Scalzo
		Name:	Joseph E. Scalzo
		Title:	Chief Executive Officer, President and Director
			(Principal Executive Officer)
Date:	June 30, 2021	By:	/s/ Todd E. Cunfer
		Name:	Todd E. Cunfer
		Title:	Chief Financial Officer
			(Principal Financial Officer)

XML

Cover - shares	6 Months Ended
	Feb. 27, 2021	Apr. 05, 2021
Document Information [Line Items]
Entity Central Index Key	0001702744
Document Type	10-Q/A
Document Quarterly Report	true
Document Period End Date	Feb. 27, 2021
Entity Registrant Name	The Simply Good Foods Company
Document Fiscal Period Focus	Q2
Entity File Number	001-38115
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-1038121
Entity Address, Address Line One	1225 17th Street, Suite 1000
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80202
City Area Code	303
Local Phone Number	633-2840
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	SMPL
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Current Fiscal Year End Date	--08-28
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		95,762,832
Document Transition Report	false
Amendment Flag	true
Document Fiscal Year Focus	2021

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Feb. 27, 2021	Aug. 29, 2020
Current assets:
Cash and cash equivalents	$ 91,307	$ 95,847
Accounts receivable, net	97,329	89,740
Inventories	82,771	59,085
Prepaid expenses	4,894	3,644
Other current assets	12,833	11,947
Total current assets	289,134	260,263
Long-term assets:
Property and equipment, net	11,092	11,850
Intangible assets, net	1,146,039	1,158,768
Goodwill	543,134	544,774
Other long-term assets	32,119	32,790
Total assets	2,021,518	2,008,445
Current liabilities:
Accounts payable	43,585	32,240
Accrued interest	384	960
Accrued expenses and other current liabilities	36,313	38,007
Current maturities of long-term debt	278	271
Total current liabilities	80,560	71,478
Long-term liabilities:
Long-term debt, less current maturities	548,884	596,879
Deferred income taxes	92,536	84,352
Other long-term liabilities	20,880	22,765
Total liabilities	861,379	869,112
See commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $0.01 par value, 100,000,000 shares authorized, none issued	0	0
Common stock, $0.01 par value, 600,000,000 shares authorized, 95,856,715 and 95,751,845 shares issued at February 27, 2021 and August 29, 2020, respectively	959	958
Treasury stock, 98,234 and 98,234 shares at cost at February 27, 2021 and August 29, 2020, respectively	(2,145)	(2,145)
Additional paid-in-capital	1,080,340	1,076,472
Retained earnings	81,666	64,927
Accumulated other comprehensive loss	(681)	(879)
Total stockholders’ equity	1,160,139	1,139,333
Total liabilities and stockholders’ equity	2,021,518	2,008,445
Warrant liability	$ 118,519	$ 93,638

XML

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Feb. 27, 2021	Aug. 29, 2020
Statement of Financial Position [Abstract]
Preferred stock par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock shares authorized (in shares)	100,000,000	100,000,000
Preferred stock shares issued (in shares)	0	0
Common stock par value (in dollars per share)	$ 0.01	$ 0.01
Common stock shares authorized (in shares)	600,000,000	600,000,000
Common stock shares issued (in shares)	95,856,715	95,751,845
Treasury stock (in shares)	98,234	98,234

XML

Condensed Consolidated Statements of Operations and Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 27, 2021	Feb. 29, 2020	Feb. 27, 2021	Feb. 29, 2020
Income Statement [Abstract]
Net sales	$ 230,607	$ 227,101	$ 461,759	$ 379,254
Cost of goods sold	140,342	141,707	277,453	231,654
Gross profit	90,265	85,394	184,306	147,600
Operating expenses:
Selling and marketing	26,150	27,041	51,345	45,475
General and administrative	26,562	28,103	51,977	46,248
Depreciation and amortization	4,212	4,287	8,456	6,740
Business transaction costs	0	694	0	26,853
Total operating expenses	56,924	60,125	111,778	125,316
Income from operations	33,341	25,269	72,528	22,284
Other income (expense):
Interest income	0	85	3	1,464
Interest expense	(7,995)	(10,589)	(16,367)	(15,558)
Gain (loss) on foreign currency transactions	975	(194)	984	(178)
Other income	112	8	159	45
Total other (expense) income	(52,242)	26,954	(40,102)	36,725
(Loss) income before income taxes	(18,901)	52,223	32,426	59,009
Income tax expense	7,313	3,922	15,687	2,193
Net (loss) income	(26,214)	48,301	16,739	56,816
Other comprehensive income:
Foreign currency translation adjustments	243	(141)	198	(141)
Comprehensive (loss) income	$ (25,971)	$ 48,160	$ 16,937	$ 56,675
(Loss) earnings per share from net (loss) income:
Basic (in dollars per share)	$ (0.27)	$ 0.51	$ 0.17	$ 0.61
Diluted (in dollars per share)	$ (0.27)	$ 0.11	$ 0.17	$ 0.06
Weighted average shares outstanding:
Basic (in shares)	95,734,591	95,339,489	95,712,057	92,524,061
Diluted (in shares)	95,734,591	100,336,571	96,997,012	97,597,614
Loss in fair value change of warrant liability	$ (45,334)	$ 37,644	$ (24,881)	$ 50,952

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Feb. 27, 2021	Feb. 29, 2020
Operating activities
Net income	$ 16,739	$ 56,816
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	9,021	7,119
Amortization of deferred financing costs and debt discount	2,108	1,569
Stock compensation expense	3,594	3,795
Unrealized loss (gain) on foreign currency transactions	(985)	178
Deferred income taxes	8,119	2,485
Amortization of operating lease right-of-use asset	2,253	1,652
Loss on operating lease right-of-use asset impairment	681	0
(Gain) loss on Termination of Lease	(154)	0
Other operating activities	216	789
Changes in operating assets and liabilities, net of acquisition:
Accounts receivable, net	(7,015)	(19,062)
Inventories	(24,502)	768
Prepaid expenses	(1,191)	(873)
Other current assets	(674)	(5,808)
Accounts payable	10,275	(2,953)
Accrued interest	(577)	175
Accrued expenses and other current liabilities	(1,881)	(8,760)
Other assets and liabilities	(1,144)	(1,824)
Net cash provided by (used in) operating activities	39,764	(14,886)
Investing activities
Purchases of property and equipment	(449)	(481)
Issuance of notes receivable	0	(1,250)
Acquisition of business, net of cash acquired	0	(984,201)
Proceeds from sale of business	5,800	0
Investments in intangible assets	(114)	0
Net cash provided by (used in) investing activities	5,237	(985,932)
Financing activities
Proceeds from option exercises	527	931
Issuance of common stock	(252)	(80)
Payments of finance lease obligations	(168)	(157)
Deferred financing costs	0	(8,208)
Principal payments of long-term debt	(50,000)	(21,000)
Proceeds from Issuance of Common Stock	0	352,542
Equity issuance costs	0	(3,323)
Proceeds from Issuance of Long-term Debt	0	460,000
Net cash (used in) provided by financing activities	(49,893)	780,705
Net decrease in cash	(4,892)	(220,113)
Cash and cash equivalents
Effect of exchange rate on cash	352	(113)
Cash at beginning of period	95,847	266,341
Cash and cash equivalents at end of period	91,307	46,115
Supplemental disclosures of cash flow information
Cash paid for interest	14,835	13,814
Cash paid for taxes	10,023	4,345
Non-cash proceeds from sale of business	3,000	0
Operating lease right-of-use assets recognized at ASU 2016-02 transition	0	5,102
Finance lease right-of-use assets recognized at ASU 2016-02 transition	0	1,185
Operating lease right-of-use assets recognized after ASU 2016-02 transition	316	2,733
Fair Value Adjustment of Warrants	$ 24,881	$ (50,952)

XML

Condensed Consolidated Statements of Stockholders Equity Statement - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning balance at Aug. 31, 2019	$ 712,868	$ 820	$ (2,145)	$ 715,740	$ (711)	$ (836)
Beginning balance (in shares) at Aug. 31, 2019		81,973,284
Beginning balance, Treasury (in shares) at Aug. 31, 2019			98,234
Net income	8,515				8,515
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	1,673			1,673
Public equity offering (in shares)		13,379,205
Public equity offering	349,219	$ 134		349,085
Shares issued upon vesting of Restricted Stock Units	(70)	$ 0		(70)
Shares issued upon vesting of Restricted Stock Units (in shares)		46,911
Exercise of options to purchase common stock	208	$ 0		208
Exercise of options to purchase common stock (in shares)		17,372
Ending balance (in shares) at Nov. 30, 2019		95,416,772
Ending balance, Treasury (in shares) at Nov. 30, 2019			98,234
Ending balance at Nov. 30, 2019	1,072,413	$ 954	$ (2,145)	1,066,636	7,804	(836)
Beginning balance at Aug. 31, 2019	712,868	$ 820	$ (2,145)	715,740	(711)	(836)
Beginning balance (in shares) at Aug. 31, 2019		81,973,284
Beginning balance, Treasury (in shares) at Aug. 31, 2019			98,234
Net income	56,816
Foreign currency translation adjustments	(141)
Ending balance (in shares) at Feb. 29, 2020		95,476,537
Ending balance, Treasury (in shares) at Feb. 29, 2020			98,234
Ending balance at Feb. 29, 2020	1,123,409	$ 955	$ (2,145)	1,069,471	56,105	(977)
Beginning balance at Nov. 30, 2019	1,072,413	$ 954	$ (2,145)	1,066,636	7,804	(836)
Beginning balance (in shares) at Nov. 30, 2019		95,416,772
Beginning balance, Treasury (in shares) at Nov. 30, 2019			98,234
Net income	48,301				48,301
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	2,122			2,122
Foreign currency translation adjustments	(141)					(141)
Shares issued upon vesting of Restricted Stock Units	(10)	$ 0		(10)
Shares issued upon vesting of Restricted Stock Units (in shares)		771
Exercise of options to purchase common stock	724	$ 1		723
Exercise of options to purchase common stock (in shares)		58,994
Ending balance (in shares) at Feb. 29, 2020		95,476,537
Ending balance, Treasury (in shares) at Feb. 29, 2020			98,234
Ending balance at Feb. 29, 2020	1,123,409	$ 955	$ (2,145)	1,069,471	56,105	(977)
Beginning balance at Aug. 29, 2020	$ 1,139,333	$ 958	$ (2,145)	1,076,472	64,927	(879)
Beginning balance (in shares) at Aug. 29, 2020		95,751,845
Beginning balance, Treasury (in shares) at Aug. 29, 2020	98,234		98,234
Net income	$ 42,953				42,953
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	1,110			1,110
Foreign currency translation adjustments	(45)					(45)
Shares issued upon vesting of Restricted Stock Units	(201)	$ 0		(201)
Shares issued upon vesting of Restricted Stock Units (in shares)		53,908
Exercise of options to purchase common stock	157	$ 0		157
Exercise of options to purchase common stock (in shares)		13,118
Ending balance (in shares) at Nov. 28, 2020		95,818,871
Ending balance, Treasury (in shares) at Nov. 28, 2020			98,234
Ending balance at Nov. 28, 2020	1,183,307	$ 958	$ (2,145)	1,077,538	107,880	(924)
Beginning balance at Aug. 29, 2020	$ 1,139,333	$ 958	$ (2,145)	1,076,472	64,927	(879)
Beginning balance (in shares) at Aug. 29, 2020		95,751,845
Beginning balance, Treasury (in shares) at Aug. 29, 2020	98,234		98,234
Net income	$ 16,739
Foreign currency translation adjustments	$ 198
Ending balance (in shares) at Feb. 27, 2021		95,856,715
Ending balance, Treasury (in shares) at Feb. 27, 2021	98,234		98,234
Ending balance at Feb. 27, 2021	$ 1,160,139	$ 959	$ (2,145)	1,080,340	81,666	(681)
Beginning balance at Nov. 28, 2020	1,183,307	$ 958	$ (2,145)	1,077,538	107,880	(924)
Beginning balance (in shares) at Nov. 28, 2020		95,818,871
Beginning balance, Treasury (in shares) at Nov. 28, 2020			98,234
Net income	(26,214)				(26,214)
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	2,484			2,484
Foreign currency translation adjustments	243					243
Shares issued upon vesting of Restricted Stock Units	(51)	$ 0		(51)
Shares issued upon vesting of Restricted Stock Units (in shares)		7,034
Exercise of options to purchase common stock	$ 370	$ 1		369
Exercise of options to purchase common stock (in shares)		30,810
Ending balance (in shares) at Feb. 27, 2021		95,856,715
Ending balance, Treasury (in shares) at Feb. 27, 2021	98,234		98,234
Ending balance at Feb. 27, 2021	$ 1,160,139	$ 959	$ (2,145)	$ 1,080,340	$ 81,666	$ (681)

XML

Nature of Operations and Principles of Consolidation

6 Months Ended

Feb. 27, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Operations and Principles of Consolidation

Description of Business

    The Simply Good Foods Company (“Simply Good Foods” or the “Company”) is a consumer-packaged food and beverage company that aims to lead the nutritious snacking movement with trusted brands that offer a variety of convenient, innovative, great-tasting, better-for-you snacks and meal replacements. The Company’s nutritious snacking platform consists of the following core brands that specialize in providing products for consumers that follow certain nutritional philosophies, dietary approaches and/or health-and-wellness trends: Atkins® for those following a low-carb lifestyle; and Quest® for consumers seeking to partner with a brand that makes the foods they crave work for them, not against them, through a variety of protein-rich foods and beverages that also limit sugars and simple carbs. The Company distributes its products in major retail channels, primarily in North America, including grocery, club and mass merchandise, as well as through e-commerce, convenience, specialty and other channels. The Company’s portfolio of nutritious snacking brands gives it a strong platform with which to introduce new products, expand distribution, and attract new consumers to its products. The Company’s platform also positions it to continue to selectively pursue acquisition opportunities of brands in the nutritious snacking category.

    The common stock of Simply Good Foods is listed on the Nasdaq Capital Market under the symbol “SMPL.”

Unaudited Interim Condensed Consolidated Financial Statements

    The unaudited interim condensed consolidated financial statements include the accounts of Simply Good Foods and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated. Unless the context otherwise requires, “we,” “us,” “our” and the “Company” refer to Simply Good Foods and its subsidiaries.

    The Company maintains its accounting records on a 52/53-week fiscal year, ending on the last Saturday in August of each year.

    The interim condensed consolidated financial statements and related notes of the Company and its subsidiaries are unaudited. The unaudited interim condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”). The unaudited interim condensed consolidated financial statements reflect all adjustments and disclosures which are, in the Company's opinion, necessary for a fair presentation of the results of operations, financial position and cash flows for the indicated periods. All such adjustments were of a normal and recurring nature unless otherwise disclosed. The year-end balance sheet data was derived from the audited financial statements and, in accordance with the instructions to Form 10-Q, certain information and footnote disclosures required by GAAP have been condensed or omitted. The results reported in these unaudited interim condensed consolidated financial statements are not necessarily indicative of the results that may be reported for the entire fiscal year and should be read in conjunction with the Company’s consolidated financial statements for the fiscal year ended August 29, 2020, included in Amendment No. 1 to Form 10-K (“Form 10-K/A”) filed with the SEC on June 30, 2021. As discussed in Note 2, Restatement of Previously Issued Financial Statements, the consolidated financial statements have been restated to reflect certain warrants as liabilities rather than equity.

    The Company remains uncertain of the ultimate effect COVID-19 could have on its business notwithstanding the distribution of several U.S. government approved vaccines and various federal, state and local governments having begun to ease the movement restrictions and public health initiatives while continuing to adhere to enhanced safety measures, such as physical distancing and face mask protocols. This uncertainty as to the duration and severity of economic effects from the COVID-19 pandemic stems from the potential for, among other things, (i) continued rates of reported cases of COVID-19 and the potential for mutations of COVID-19 to result in increased rates of reported cases for which currently approved vaccines are not effective, (ii) unexpected supply chain disruptions, (iii) changes to customer operations, (iv) continued or additional changes in consumer purchasing and consumption behavior beyond those evidenced to date, and (v) the closure of customer establishments.

XML

Restatement of Previously Issued Financial Statements

6 Months Ended

Feb. 27, 2021

Accounting Changes and Error Corrections [Abstract]

Accounting Changes and Error Corrections

2. Restatement of Previously Issued Financial Statements

    On April 12, 2021, the SEC issued a statement (the “SEC Statement”) on the accounting and reporting considerations for warrants issued by special purpose acquisition companies (“SPAC”). The SEC Statement discussed certain features of warrants issued in SPAC transactions that may be common across many entities. Specifically, the SEC Statement focused in part on provisions in warrant agreements that provide for potential changes to the settlement amounts dependent upon the characteristics of the warrant holder. The SEC Statement indicated that, because the holder of a warrant is not an input into the pricing of a fixed-for-fixed option on equity shares, such provisions would preclude the warrant from being classified in equity and thus the warrant should be classified as a liability. Following consideration of the guidance in the SEC Statement, the Company concluded that its private warrants should be classified as a liability and measured at fair value at each reporting period, rather than as equity awards. Management concluded the effect of this error on the

Company’s previously reported condensed consolidated financial statements is material and, as such, the accompanying condensed consolidated financial statements as of February 27, 2021, and the thirteen and twenty-six weeks ended February 27, 2021, and accompanying notes thereto have been restated from the amounts previously reported to give effect to the correction of this error (the “Restatement”). Effects of the Restatement on the Consolidated Balance Sheets as of August 29, 2020, and the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the thirteen and twenty-six weeks ended February 29, 2020, are presented in the Company’s Amendment No. 1 to Form 10-K (“Form 10-K/A”) for the fiscal year ended August 29, 2020 filed with the SEC on June 30, 2021. Additionally, see Note 13, Earnings (Loss) Per Share, for restated earnings (loss) per share amounts.

    As a result of the Restatement, the Company’s private warrants (the “Private Warrants”) are now reflected as a liability measured at fair value on the Company’s Condensed Consolidated Balance Sheets, and the change in the fair value of this liability in each period is recognized as a gain or loss in the Company’s Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). The effect of the Restatement on the Condensed Consolidated Balance Sheets as of February 27, 2021, and Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) and Condensed Consolidated Statements of Cash Flows for the thirteen and twenty-six weeks ended February 27, 2021, are presented below. Regarding the Condensed Consolidated Statements of Cash Flows, the adjustments below to net income were offset by adjustments to non-cash operating activities within cash flow provided by operations. The Restatement had no effect on total net cash flows from operating, investing or financing activities. The effect of the Restatement on the February 27, 2021 stockholders’ equity balances is presented in the Condensed Consolidated Statements of Stockholders’ Equity below.

Condensed Consolidated Balance Sheet	February 27, 2021
(In thousands)	As Previously Reported		Restatement Adjustment	As Restated
Warrant liability	$	—	118,519	$	118,519
Total liabilities	742,860		118,519	861,379
Additional paid-in-capital	1,098,375		(18,035)	1,080,340
Retained earnings	182,150		(100,484)	81,666
Total stockholders’ equity	1,278,658		(118,519)	1,160,139

Condensed Consolidated Statement of Operations and Comprehensive Income (Loss)	Thirteen Weeks Ended
	February 27, 2021
(In thousands)	As Previously Reported		Restatement Adjustment		As Restated
Loss in fair value change of warrant liability	—		(45,334)		(45,334)
Total other expense	(6,908)		(45,334)		(52,242)
Income (loss) before income taxes	26,433		(45,334)		(18,901)
Net income (loss)	19,120		(45,334)		(26,214)
Comprehensive income (loss)	$	19,363	$	(45,334)	$	(25,971)

As a result of the Restatement adjustments, basic earnings per share decreased $0.47, from earnings of $0.20 per share to a loss of $0.27 per share, and diluted earnings per share decreased $0.46, from earnings of $0.19 per share to a loss of $0.27 per share.

Condensed Consolidated Statement of Operations and Comprehensive Income (Loss)	Twenty-Six Weeks Ended
	February 27, 2021
(In thousands)	As Previously Reported		Restatement Adjustment		As Restated
Loss in fair value change of warrant liability	—		(24,881)		(24,881)
Total other expense	(15,221)		(24,881)		(40,102)
Income before income taxes	57,307		(24,881)		32,426
Net income	41,620		(24,881)		16,739
Comprehensive income	$	41,818	$	(24,881)	$	16,937

As a result of the Restatement adjustments, basic earnings per share decreased $0.26, from earnings of $0.43 per share to $0.17 per share, and diluted earnings per share decreased $0.24, from earnings of $0.41 per share to $0.17 per share.

	Twenty-Six Weeks Ended
Condensed Consolidated Statement of Cash Flows	February 27, 2021
(In thousands)	As Previously Reported		Restatement Adjustment		As Restated
Operating activities
Net income	$	41,620	$	(24,881)	$	16,739
Adjustments to reconcile net income to net cash provided by operating activities:
Loss in fair value change of warrant liability	—		24,881		24,881
Net cash provided by operating activities	$	39,764	$	—	$	39,764

Condensed Consolidated Statement of Stockholders’ Equity	February 27, 2021
(In thousands)	As Previously Reported		Restatement Adjustment		As Restated
Additional paid-in-capital	$	1,098,375	$	(18,035)	$	1,080,340
Net income	41,620		(24,881)		16,739
Retained earnings	182,150		(100,484)		81,666
Total stockholders’ equity	$	1,278,658	$	(118,519)	$	1,160,139

XML

Summary of Significant Accounting Policies

6 Months Ended

Feb. 27, 2021

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Recently Issued and Adopted Accounting Pronouncements

Recently Issued Accounting Pronouncements Not Yet Adopted

    In December 2019, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which amends the existing guidance relating to the accounting for income taxes. This ASU is intended to simplify the accounting for income taxes by removing certain exceptions to the general principles of accounting for income taxes and to improve the consistent application of U.S. GAAP for other areas of accounting for income taxes by clarifying and amending existing guidance. This ASU is effective for fiscal years beginning after December 15, 2021, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements and does not expect that the adoption of this ASU will be material to its consolidated financial statements.

    In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance for a limited period of time to ease the potential burden in accounting for reference rate reform on financial reporting. The amendments in this ASU are effective for all entities and can be applied to contract modifications due to rate reform and eligible existing and new hedging relationships entered into between March 12, 2020 through December 31, 2022. The amendments of this ASU should be applied on a prospective basis. The Company will continue to monitor the effects of rate reform, if any, on its contracts and the effects of adoption of this ASU through December 31, 2022. The Company does not anticipate the amendments in this ASU to be material to its consolidated financial statements.

    In October 2020, the FASB issued ASU No. 2020-10, Codification Improvements, which provides updates for technical corrections, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements across various areas of accounting within U.S. GAAP. This ASU is effective for all entities for fiscal years beginning after December 15, 2020, with early adoption permitted. The amendments of this ASU should be applied retrospectively. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements and does not anticipate the adoption of this ASU will be material to its consolidated financial statements.

Recently Adopted Accounting Pronouncements

    In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326), which modified the measurement of expected credit losses of certain financial instruments. The Company adopted this ASU as of the first day of fiscal 2021. As a result of adopting this ASU, the Company changed its method of estimating its allowance for doubtful accounts for trade receivables to be based upon the Company’s historical credit loss experience adjusted for asset-specific risk characteristics, current economic conditions, and reasonable forecasts. The change in estimating the allowance for doubtful accounts did not have a material effect on the Company’s consolidated financial statements.

    In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820), which modified disclosure requirements on fair value measurements of Accounting Standards Codification (“ASC”) 820. The Company adopted this ASU as of the first day of fiscal 2021. The adoption of this ASU did not have a material effect on the consolidated financial statements or the related disclosures.

XML

Business Combination (Notes)

3 Months Ended

Feb. 27, 2021

Business Combinations [Abstract]

Business Combination Disclosure [Text Block]

On August 21, 2019, the Company’s wholly-owned subsidiary Simply Good Foods USA, Inc., formerly known as Atkins Nutritionals, Inc., (“Simply Good USA”) entered into a Stock and Unit Purchase Agreement (the “Purchase Agreement”) to acquire Quest Nutrition, LLC (“Quest”), a healthy lifestyle food company (the “Acquisition of Quest”). On November 7, 2019, Simply Good USA completed the Acquisition of Quest, via Simply Good USA’s direct or indirect acquisition of 100% of the equity interests of Voyage Holdings, LLC and VMG Quest Blocker, Inc. (the “Target Companies”) for a cash purchase price at closing of $988.9 million subject to customary post-closing adjustments for the Target Companies’ levels of cash, indebtedness, net working capital and transaction expenses as of the closing date.

    Simply Good USA acquired Quest as a part of the Company’s vision to lead the nutritious snacking movement with trusted brands that offer a variety of convenient, innovative, great-tasting, better-for-you snacks and meal replacements. Quest is a healthy lifestyle food company offering a variety of bars, cookies, chips, ready-to-drink shakes and pizzas that compete in many of the attractive, fast growing sub-segments within the nutritional snacking category.

    The Acquisition of Quest was funded by the Company through a combination of cash, equity and debt financing. Total consideration paid on the closing date was $988.9 million. Cash sources of funding included $195.3 million of cash on hand, net proceeds of approximately $350.0 million from an underwritten public offering of common stock, and $443.6 million in new term loan debt. In the third fiscal quarter of 2020, the Company received a post-closing release from escrow of approximately $2.1 million related to net working capital adjustments, resulting in a total net consideration paid of $986.8 million as of February 27, 2021.

    For the twenty-six weeks ended February 29, 2020, Business transaction costs within the Consolidated Statements of Operations and Comprehensive Income were $26.9 million, which included $14.5 million of transaction advisory fees related to the Acquisition of Quest, $3.2 million of banker commitment fees, $6.1 million of non-deferrable debt issuance costs related to the incremental term loan, and $3.1 million of other costs, including legal, due diligence, and accounting fees. Included in the transaction advisory fees was $12.0 million paid to Centerview Partners LLC, an investment banking firm that served as the lead financial advisor to the Company for this transaction. Three members of the Company’s Board of Directors, Messrs. Kilts, West, and Ratzan, have business relationships with certain partners of Centerview Partners LLC (including relating to Centerview Capital Consumer, a private equity firm and affiliate of Conyers Park Sponsor LLC), but they are not themselves partners, executives or employees of Centerview Partners LLC, and Centerview Partners LLC is not a related party of the Company pursuant to applicable rules and policies. The advisory fee paid to Centerview Partners LLC represented approximately 1.2% of the total cash purchase price paid by the Company on the closing date of the Acquisition of Quest. All transaction advisory fees relating to the Acquisition of Quest were approved by the Company’s Audit Committee.

    The following table sets forth the final purchase price allocation of the Acquisition of Quest to the estimated fair value of the net assets acquired at the date of acquisition, in thousands:

Assets acquired:
Cash and cash equivalents	$	4,745
Accounts receivable, net	25,359
Inventories	44,032
Prepaid assets	1,214
Other current assets	3,812
Property and equipment, net(1)	9,843
Intangible assets, net(2)	868,375
Other long-term assets	20,997
Liabilities assumed:
Accounts payable	25,200
Other current liabilities	11,237
Deferred income taxes(3)	10,754
Other long-term liabilities	18,891
Total identifiable net assets	912,295
Goodwill(4)	74,525
Total assets acquired and liabilities assumed	$	986,820

(1)    Property and equipment, net primarily consisted of leasehold improvements for the Quest headquarters of $6.9 million, furniture and fixtures of $2.2 million, and equipment of $0.7 million. The Quest headquarters lease ends in April 2029. The useful lives of the leasehold improvements, furniture and fixtures, and equipment are consistent with the Company’s accounting policies.

(2)    Intangible assets were recorded at fair value consistent with ASC 820 as a result of the Acquisition of Quest. Intangible assets consisted of $750.0 million of indefinite brands and trademarks, $115.0 million of amortizable customer relationships, and $3.4 million of internally developed software. The useful lives of the intangible assets are disclosed in Note 6 of the consolidated financial statements. The fair value measurement of the assets and liabilities was based on significant inputs not observable in the market and thus represent Level 3 measurements within the fair value measurement hierarchy. Level 3 fair market values were determined using a variety of information, including estimated future cash flows and market comparable data and companies. The fair values of the intangible assets were estimated using inputs primarily from the income approach and the with/without method, which estimates the value using the cash flow impact in a hypothetical scenario where the customer relationships are not in place. The significant assumptions used in estimating the fair value of the intangible assets include the estimated life the asset will contribute to cash flows, profitability, and the estimated discount rate.

(3)    Primarily as a result of the fair value attributable to the identifiable intangible assets, the deferred income tax liability was $10.8 million.

(4)    Goodwill was recorded at fair value consistent with ASC 820 as a result of the Acquisition of Quest. Amounts recorded for goodwill created in an acquisition structured as a stock purchase for tax are generally not expected to be deductible for tax purposes. Amounts recorded for goodwill resulting in a tax basis step-up are generally expected to be deductible for tax purposes. Tax deductible Goodwill was estimated to be $67.7 million. Goodwill represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized.

    The Company completed its final assessment of purchase price allocation for the Acquisition of Quest to the estimated fair value of the net assets acquired at the date of acquisition during the first quarter of fiscal 2021. Since the initial preliminary estimates reported in the first fiscal quarter of 2020, the Company updated certain amounts reflected in the final purchase price allocation, as summarized in the fair values of assets acquired and liabilities assumed as set forth above. Specifically, the carrying amount of the intangible assets, net were increased by $20.0 million as a result of valuation adjustments related to the Company’s finalization of tax attributes, which also resulted in a decrease to deferred income taxes of $3.2 million. Additionally, accounts receivable, net decreased $4.3 million and inventories increased $0.9 million due to fair value measurement period adjustments, and the carrying amount of property and equipment, net decreased by $0.5 million to reflect its estimated fair value. As a result of these adjustments and the change in total net consideration paid of approximately $2.1 million related to net working capital adjustments discussed above, goodwill decreased $21.5 million. Measurement period adjustments were recognized in the reporting period in which the adjustments were determined and calculated as if the accounting had been completed at the acquisition date.

    The results of Quest’s operations have been included in the Company’s Consolidated Financial Statements since November 7, 2019, the date of acquisition. The following table provides net sales from the acquired Quest business included in the Company’s results:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(in thousands)	February 27, 2021		February 29, 2020		February 27, 2021		February 29, 2020
Net sales(1)	$	105,025	$	88,305	$	200,794	$	105,387

(1)    Net sales for the thirteen and twenty-six weeks ended February 27, 2021 excludes immaterial international net sales.

Unaudited Pro Forma Financial Information

    Pro forma financial information is not intended to represent or be indicative of the actual results of operations of the combined business that would have been reported had the Acquisition of Quest been completed at the beginning of the fiscal year 2019, nor is it representative of future operating results of the Company. The pro forma combined financial information includes the fair value adjustments of the liability-classified Private Warrants.

The following unaudited pro forma financial information presents the combined results of the Company and Quest as if the Acquisition of Quest has occurred at the beginning of fiscal 2019:

	Thirteen Weeks Ended		Twenty-Six Weeks Ended
(in thousands)	February 29, 2020		February 29, 2020
Revenue	$	227,101	$	447,657
Gross profit	$	90,479	$	178,667
Net income	$	52,693	$	81,649

XML

Revenue Recognition

3 Months Ended

Feb. 27, 2021

Revenue from Contract with Customer [Abstract]

Revenue from Contract with Customer [Text Block]

Revenues from transactions with external customers for each of the Company’s products would be impracticable to disclose and management does not view its business by product line. The following is a summary of revenue disaggregated by geographic area and core brands:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(In thousands)	February 27, 2021		February 29, 2020		February 27, 2021		February 29, 2020
North America
Atkins	$	114,155	$	131,435	$	236,916	$	259,247
Quest (2)	105,025		88,305		200,794		105,387
Total North America (1)	219,180		219,740		437,710		364,634
International	11,427		7,361		24,049		14,620
Total net sales	$	230,607	$	227,101	$	461,759	$	379,254

(1)    The North America geographic area consists of net sales substantially related to the United States and there is no individual foreign country to which more than 10% of Company’s net sales are attributed or that is otherwise deemed individually material. The North America geographic area includes the divested SimplyProtein brand.

(2)    Quest net sales are primarily in North America.

    Charges related to credit loss on accounts receivables from transactions with external customers were nominal for each of the thirteen and twenty-six weeks ended February 27, 2021 and were approximately $0.1 million for each of the thirteen and twenty-six weeks ended February 29, 2020. As of February 27, 2021 and August 29, 2020, the allowance for doubtful accounts related to these accounts receivable was $0.6 million and $0.5 million, respectively.

XML

Goodwill and Intangibles

6 Months Ended

Feb. 27, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangibles

Changes to Goodwill during the thirteen week period ended February 27, 2021 were as follows:

(in thousands)	Goodwill
Balance as of August 29, 2020	$	544,774
Acquisition of business, measurement period adjustment	1,178
Sale of business	(2,818)
Balance as of February 27, 2021	$	543,134

    The change in Goodwill attributed to the acquisition of a business during the twenty-six weeks ended February 27, 2021 was the result of measurement period adjustments made to finalize the acquisition method of accounting for the Acquisition of Quest as described in Note 4. Additionally, effective September 24, 2020, the Company sold the assets exclusively related to its SimplyProtein® brand of products for approximately $8.8 million of consideration, including cash of $5.8 million and a note receivable for $3.0 million, to a newly formed entity led by the Company’s former Canadian-based management team who had been responsible for this brand prior to the sale transaction (the “SimplyProtein Sale”). In addition to purchasing these assets, the buyer assumed certain liabilities related to the SimplyProtein brand’s business. There was no gain or loss recognized as a result of the SimplyProtein Sale. In conjunction with the SimplyProtein Sale, the Company disposed of $2.8 million of goodwill associated with the SimplyProtein business.

    There were no impairment charges related to goodwill during the thirteen and twenty-six weeks ended February 27, 2021 or since the inception of the Company.

    Intangible assets, net in the Consolidated Balance Sheets consist of the following:

				February 27, 2021
(In thousands)	Useful life			Gross carrying amount		Accumulated amortization		Net carrying amount
Intangible assets with indefinite life:
Brands and trademarks	Indefinite life			$	974,000	$	—	$	974,000
Intangible assets with finite lives:
Customer relationships	15 years			174,000		24,303		149,697
Proprietary recipes and formulas	7 years			7,000		3,631		3,369
Licensing agreements	14 years			22,000		5,706		16,294
Software and website development costs	3	-	5 years	5,302		2,678		2,624
Intangible assets in progress	3	-	5 years	55		—		55
				$	1,182,357	$	36,318	$	1,146,039

				August 29, 2020
(In thousands)	Useful life			Gross carrying amount		Accumulated amortization		Net carrying amount
Intangible assets with indefinite life:
Brands and trademarks	Indefinite life			$	979,000	$	—	$	979,000
Intangible assets with finite lives:
Customer relationships	15 years			174,000		18,503		155,497
Proprietary recipes and formulas	7 years			7,000		3,131		3,869
Licensing agreements	14 years			22,000		4,920		17,080
Software and website development costs	3	-	5 years	5,967		2,645		3,322
				$	1,187,967	$	29,199	$	1,158,768

    Changes in Intangible assets, net during the twenty-six weeks ended February 27, 2021 were primarily related to the SimplyProtein Sale and recurring amortization expense. In conjunction with the SimplyProtein Sale, the Company sold its SimplyProtein brand intangible asset, which had a carrying value of approximately $5.0 million as of the date of the sale. Amortization expense related to intangible assets during each of the thirteen weeks ended February 27, 2021 and February 29, 2020 was $3.9 million, respectively. Amortization expense related to intangible assets during the twenty-six weeks ended February 27, 2021 and February 29, 2020 was $7.7 million and $6.2 million, respectively. There were no impairment charges related to intangible assets during the thirteen and twenty-six weeks ended February 27, 2021 and February 29, 2020.

    Estimated future amortization for each of the next five fiscal years and thereafter is as follows:

(In thousands)	Amortization
Remainder of 2021	$	7,674
2022	15,224
2023	14,938
2024	14,257
2025	13,171
2026 and thereafter	106,720
Total	$	171,984

XML

Long-Term Debt and Line of Credit

6 Months Ended

Feb. 27, 2021

Debt Disclosure [Abstract]

Debt Disclosure

On July 7, 2017, the Company entered into a credit agreement with Barclays Bank PLC and other parties (as amended to date, the “Credit Agreement”). The Credit Agreement provides for (i) a term facility of $200.0 million (“Term Facility”) with a seven year maturity and (ii) a revolving credit facility of up to $75.0 million (the “Revolving Credit Facility”) with a five year maturity. Substantially concurrent with the consummation of the Acquisition of Atkins, the full $200.0 million of the Term Facility (the “Term Loan”) was drawn. The interest rate per annum is based on either (i) a base rate equaling the higher of (a) the “prime rate”, (b) the federal funds effective rate plus 0.50% and (c) the Euro-currency rate applicable for an interest period of one month plus 1.00% plus (x) 3.00% margin for the Term Loan or (y) 2.00% margin for the Revolving Credit Facility, or (ii) London Interbank Offered Rate (“LIBOR”) adjusted for statutory reserve requirements, plus (x) 4.00% margin for the Term Loan subject to a floor of 1.00% or (y) 3.00% margin for the Revolving Credit Facility. As security for the payment or performance of its debt, the Company has pledged certain equity interests in its subsidiaries.

    On March 16, 2018 (the “Amendment Date”), the Company entered into an amendment (the “Repricing Amendment”) to the Credit Agreement. As a result of the Repricing Amendment, the interest rate on the Term Loan was reduced and, as of the Amendment Date, such loans had an interest rate equal to, at the Company’s option, either LIBOR plus an applicable margin of 3.50% or a base rate plus an applicable margin of 2.50%. The Repricing Amendment did not change the interest rate on the Revolving Credit Facility. The Revolving Credit Facility continued to bear interest based upon the Company’s consolidated net leverage ratio as of the last financial statements delivered to the administrative agent. No additional debt was incurred, or any proceeds received, by the Company in connection with the Repricing Amendment. The incremental fees paid to the administrative agent are reflected as additional debt discount and are amortized over the terms of the long-term financing agreements using the effective-interest method.

    On November 7, 2019, the Company entered into an amendment (the “Incremental Facility Amendment”) to the Credit Agreement to increase the principal borrowed on the Term Facility by $460.0 million. The Term Facility together with the incremental borrowing make up the Initial Term Loans (as defined in the Incremental Facility Amendment) and as of the Amendment No. 2 Effective Date (as defined in the Incremental Facility Amendment), the Initial Term Loans bear interest at a rate equal to, at the Company’s option, either LIBOR plus an applicable margin of 3.75% or a base rate plus an applicable margin of 2.75%. The Incremental Facility Amendment was executed to partially finance the Acquisition of Quest. No amounts under the Term Facility were repaid as a result of the execution of the Incremental Facility Amendment.

    The Credit Agreement contains certain financial and other covenants that limit the Company’s ability to, among other things, incur and/or undertake asset sales and other dispositions, liens, indebtedness, certain acquisitions and investments, consolidations, mergers, reorganizations and other fundamental changes, payment of dividends and other distributions to equity and warrant holders, and prepayments of material subordinated debt, in each case, subject to customary exceptions materially consistent with credit facilities of such type and size. The Revolving Credit Facility has a maximum total net leverage ratio equal to or less than 6.25:1.00 (with a reduction to 6.00:1.00 on and after the third anniversary of the closing date of the Credit Agreement) contingent on credit extensions in excess of 30% of the total amount of commitments available under the Revolving Credit Facility. Any failure to comply with the restrictions of the credit facilities may result in an event of default. The Company was in compliance with all financial covenants as of February 27, 2021 and August 29, 2020, respectively.

    Long-term debt consists of the following:

(In thousands)	February 27, 2021		August 29, 2020
Term Facility (effective rate of 4.8% at February 27, 2021)	$	556,500	$	606,500
Finance lease liabilities (effective rate of 5.6% at February 27, 2021)	826		922
Less: Deferred financing fees	8,164		10,272
Total debt	549,162		597,150
Less: Current finance lease liabilities	278		271
Long-term debt, net of deferred financing fees	$	548,884	$	596,879

    The Company is not required to make principal payments on the Term Facility over the twelve months following the period ended February 27, 2021. The outstanding balance of the Term Facility is due upon its maturity in July 2024. Additionally, as of February 27, 2021 and August 29, 2020, there were no amounts drawn against the Revolving Credit Facility.

    As of February 27, 2021, the Company had letters of credit in the amount of $4.2 million outstanding. These letters of credit offset against the availability of the Revolving Credit Facility and exist to support three of the Company’s leased buildings and insurance programs relating to workers’ compensation. No amounts were drawn against these letters of credit at February 27, 2021.

    The Company utilizes market approaches to estimate the fair value of certain outstanding borrowings by discounting anticipated future cash flows derived from the contractual terms of the obligations and observable market interest and foreign exchange rates. The Company carries debt at historical cost and discloses fair value. As of February 27, 2021 and August 29, 2020, the book value of the Company’s debt approximated fair value. The estimated fair value of the Term Loan is valued based on observable inputs and classified as Level 2 in the fair value hierarchy.

XML

Fair Value of Financial Instruments

6 Months Ended

Feb. 27, 2021

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measurements, a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies, is as follows:

Level 1 – Valuations based on quoted prices for identical assets and liabilities in active markets.

Level 2 – Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.

Level 3 – Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.

    The carrying amounts of cash and cash equivalents, accounts receivable and accounts payable approximated fair value as of February 27, 2021 and August 29, 2020 due to the relatively short maturity of these instruments.

Level 3 Measurements

    The Company has outstanding liability-classified Private Warrants that allow holders to purchase 6,700,000 shares of the Company’s common stock. Such Private Warrants are held by Conyers Park Sponsor, LLC, a related party. The Company utilizes the Black-Scholes valuation model to estimate the fair value of the Private Warrants at each reporting date. The application of the Black-Scholes model utilizes significant assumptions, including volatility. Significant judgment is required in determining the expected volatility (the key assumption) of the Private Warrants. In order to determine the most accurate measure of this volatility, the Company measured expected volatility based on several inputs, including considering a peer group of publicly traded companies, the Company’s implied volatility based on traded options, the implied volatility of comparable SPAC warrants, and the implied volatility of any outstanding Public Warrants during the periods they were outstanding. As a result of the unobservable inputs that were used to determine the expected volatility of the Private Warrants, the fair value measurement of these warrants reflects a Level 3 measurement within the fair value measurement hierarchy.

There were 6,700,000 Private Warrants outstanding as of November 28, 2020 and November 30, 2019. The table below summarizes the inputs used to calculate the fair value of the warrant liability at each of the dates indicated below:

	February 27, 2021			February 29, 2020
Exercise Price	$	11.50		$	11.50
Stock Price	$	29.17		$	22.06
Dividend Yield	—		%	—		%
Expected Term (in Years)	1.35			2.35
Risk-Free Interest Rate	0.10		%	0.85		%
Expected Volatility	28.00		%	29.10		%
Per Share Value of Warrants	$	17.69		$	10.99

    The periodic remeasurement of the warrant liability is reflected in (Loss) gain in fair value change of warrant liability within the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). The adjustments for the thirteen and twenty-six weeks ended February 27, 2021 were a loss of $45.3 million and $24.9 million, respectively. The adjustments for the thirteen and twenty-six weeks ended February 29, 2020 were a gain of $37.6 million and $51.0 million, respectively. The adjustments resulted in a total warrant liability at February 27, 2021 and February 29, 2020 of $118.5 million and $73.6 million, respectively.

XML

Income Taxes

6 Months Ended

Feb. 27, 2021

Income Tax Disclosure [Abstract]

Income Taxes

The tax expense and the effective tax rate resulting from operations were as follows:

	Twenty-Six Weeks Ended
(In thousands)	February 27, 2021			February 29, 2020
(Loss) income before income taxes	$	32,426		$	59,009
Income tax expense	$	15,687		$	2,193
Effective tax rate	48.4		%	3.7		%

    The effective tax rate for the twenty-six weeks ended February 27, 2021 was 44.7% greater than the effective tax rate for the twenty-six weeks ended February 29, 2020, which was primarily driven by the non-cash change in the fair value of the warrant liability and other permanent differences.

XML

Leases

6 Months Ended

Feb. 27, 2021

Leases [Abstract]

Leases of Lessee Disclosure [Text Block]

The components of lease expense were as follows:

		Thirteen Weeks Ended				Twenty-Six Weeks Ended
(In thousands)	Statement of Operations Caption	February 27, 2021		February 29, 2020		February 27, 2021		February 29, 2020
Operating lease cost:
Lease cost	Cost of goods sold and General and administrative	$	1,496	$	1,441	$	2,994	$	2,247
Variable lease cost (1)	Cost of goods sold and General and administrative	378		426		776		736
Operating lease cost		1,874		1,867		3,770		2,983
Short term lease cost	General and administrative	—		18		—		24
Finance lease cost:
Amortization of right-of-use assets	Cost of goods sold	68		66		136		136
Interest on lease liabilities	Interest expense	12		16		25		32
Total finance lease cost		80		82		161		168
Total lease cost		$	1,954	$	1,967	$	3,931	$	3,175

(1)    Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs.

    In conjunction with the Company’s restructuring activities as discussed in Note 14, the Company incurred impairment charges of $0.3 million and $0.7 million in the thirteen and twenty-six weeks ended February 27, 2021, respectively, related to its operating lease right-of-use assets for leases in Toronto, Ontario and the Netherlands. Additionally, the Company terminated the lease in Toronto, Ontario, which resulted in a gain on lease termination of $0.2 million in the thirteen and twenty-six weeks ended February 27, 2021. The effect of these restructuring activities has been included within General and administrative on the Consolidated Statements of Operations and Comprehensive Income. Refer to Note 14, Restructuring and Related Charges, for additional information regarding restructuring activities.

    The gross amounts of assets and liabilities related to both operating and finance leases are as follows:

(In thousands)	Balance Sheet Caption	February 27, 2021		August 29, 2020
Assets
Operating lease right-of-use assets	Other long-term assets	$	23,089	$	25,703
Finance lease right-of-use assets	Property and equipment, net	776		912
Total lease assets		$	23,865	$	26,615
Liabilities
Current:
Operating lease liabilities	Accrued expenses and other current liabilities	$	4,235	$	4,329
Finance lease liabilities	Current maturities of long-term debt	278		271
Long-term:
Operating lease liabilities	Other long-term liabilities	20,880		22,764
Finance lease liabilities	Long-term debt, less current maturities	548		651
Total lease liabilities		$	25,941	$	28,015

    Future maturities of lease liabilities as of February 27, 2021 were as follows:

(In thousands)	Operating Leases		Finance Leases
Fiscal year ending:
Remainder of 2021	$	2,935	$	157
2022	4,607		313
2023	4,071		278
2024	4,232		145
2025	3,838		—
Thereafter	11,050		—
Total lease payments	30,733		893
Less: Interest	(5,618)		(67)
Present value of lease liabilities	$	25,115	$	826

    As of February 27, 2021, the Company had entered into a lease with estimated total minimum future lease payments of $32.2 million over a 10.0-year minimum lease term that had not yet commenced, and as a result it is not recorded on the Consolidated Balance Sheets. The Company expects the lease to commence in fiscal year 2021, and the Company has the option to renew the lease for an additional 5.0 years or 10.0 years after the minimum lease term.

    The weighted-average remaining lease term and weighted-average discount rate for operating and finance leases were as follows:

	February 27, 2021		August 29, 2020
Weighted-average remaining lease term (in years)
Operating leases	6.76		6.97
Finance leases	2.92		3.41
Weighted-average discount rate
Operating leases	5.8	%	5.7	%
Finance leases	5.6	%	5.6	%

    Supplemental and other information related to leases was as follows:

	Twenty-Six Weeks Ended
(In thousands)	February 27, 2021		February 29, 2020
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	3,689	$	2,817
Operating cash flows from finance leases	12		9
Financing cash flows from finance leases	$	157	$	157

XML

Commitments and Contingencies

6 Months Ended

Feb. 27, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Litigation

    The Company is a party to certain litigation and claims that are considered normal to the operations of the business. From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of business. The Company is not presently a party to any litigation that it believes to be material, and the Company is not aware of any pending or threatened litigation against it that its management believes could have a material adverse effect on its business, operating result, financial condition or cash flows.

    During the fiscal year ended August 31, 2019, the Company reserved $3.5 million for the potential settlement of class action litigation concerning certain product label claims. During the twenty-six weeks ended February 29, 2020, the Company reserved an additional $0.3 million. The reserve was included within General and administrative in the Consolidated Statements of Operations and Comprehensive Income, and the reserve was fully paid into escrow and settled during the fiscal year ended August 29, 2020.

    As of February 27, 2021 and August 29, 2020, the Company had $0.7 million and $1.3 million reserved for potential settlements, respectively.

Other

    The Company has entered into endorsement contracts with certain celebrity figures and social media influencers to promote and endorse the Atkins and Quest brands and product lines. These contracts contain endorsement fees, which are expensed ratably over the life of the contract, and performance fees, that are recognized at the time of achievement. Based on the terms of the contracts in place and achievement of performance conditions as of February 27, 2021, the Company will be required to make payments of $2.8 million over the next year.

XML

Stockholders' Equity

6 Months Ended

Feb. 27, 2021

Equity [Abstract]

Stockholders' Equity

12. Stockholders’ Equity

Public Equity Offering

    On October 9, 2019, the Company completed an underwritten public offering of 13,379,205 shares of common stock at a price to the public of $26.35 per share. The Company paid underwriting discounts and commissions of $0.19 per share resulting in net proceeds to the Company of $26.16 per share, or approximately $350.0 million (the “Offering”). The Company paid $0.8 million for legal, accounting and registrations fees related to the Offering. The net proceeds were used to pay a portion of the purchase price and related fees and expenses for the Acquisition of Quest.

Warrants to Purchase Common Stock

Prior to the Acquisition of Atkins, Conyers Park issued 13,416,667 public warrants and 6,700,000 Private Warrants. The Company assumed the Conyers Park warrants to purchase common stock in connection with the Acquisition of Atkins. As a result of the Acquisition of Atkins, the warrants issued by Conyers Park were no longer exercisable for shares of Conyers Park common stock, but were instead exercisable for common stock of the Company. All other features of the warrants were unchanged.

Each whole warrant entitles the holder to purchase one share of the Company’s common stock at a price of $11.50 per share. The warrants became exercisable 30 days after the completion of the Acquisition of Atkins in 2017 and expire five years after that date, or earlier upon redemption or liquidation, as applicable.

    From August 26, 2018 through October 5, 2018, public warrants to purchase an aggregate of 9,866,451 shares of the Company’s common stock were exercised for cash at an exercise price of $11.50 per share, resulting in aggregate gross proceeds to the Company of $113.5 million.

    On October 4, 2018, the Company delivered a notice for the redemption (the “Redemption Notice”) of all of its public warrants that remained unexercised immediately after November 5, 2018. Exercises of public warrants following the Redemption Notice were required to be done on a cashless basis. Accordingly, holders were no longer permitted to exercise public warrants in exchange for payment in cash of $11.50 per share. Instead, a holder exercising a public warrant was deemed to have paid the $11.50 per share exercise price by the surrender of 0.61885 of a share of common stock that the holder would have been entitled to receive upon a cash exercise of each public warrant. Exercising holders received 0.38115 of a share of the Company’s common stock for each public warrant surrendered for exercise. Following the Redemption Notice, 3,499,639 public warrants were exercised on a cashless basis. An aggregate of 1,333,848 shares of the Company’s common stock were issued in connection with these exercises of the public warrants. All remaining public warrants were redeemed as of November 5, 2018 for an immaterial amount.

    As of February 27, 2021, the Private Warrants to purchase 6,700,000 shares of the Company’s common stock remain outstanding, have not been transferred by Conyers Park Sponsor, LLC, a related party, and remain liability-classified. As discussed in Note 8, the liability-classified warrants are remeasured on a recurring basis, primarily based on observable market data while the related theoretical private warrant volatility assumption within the Black-Scholes model represents a Level 3 measurement within the fair value measurement hierarchy. The periodic remeasurement of the warrant liability is reflected in (Loss) gain in fair value change of warrant liability within the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

XML

Earnings Per Share

6 Months Ended

Feb. 27, 2021

Earnings Per Share [Abstract]

Earnings Per Share

Basic earnings or loss per share is based on the weighted average number of common shares issued and outstanding. In computing diluted earnings per share, basic earnings per share is adjusted for the assumed issuance of all potentially dilutive securities. In periods in which the Company has a net loss, diluted earnings per share is based on the weighted average number of common shares issued and outstanding as the effect of including common stock equivalents outstanding would be antidilutive.    The Company has outstanding liability-classified Private Warrants to purchase 6,700,000 shares of the Company’s common stock. During periods when the effect is dilutive, the Company assumes share settlement of the instruments as of the beginning of the reporting period and adjusts the numerator to remove the change in fair value of the warrant liability and adjusts the denominator to include the dilutive shares, calculated using the treasury stock method. During periods when the impact is antidilutive, the share settlement is excluded.

    The following table reconciles the numerators and denominators used in the computations of both basic and diluted earnings per share:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(In thousands, except per share data)	February 27, 2021		February 29, 2020		February 27, 2021		February 29, 2020
Basic earnings per share computation:
Numerator:
Net (loss) income available to common stock stockholders	$	(26,214)	$	48,301	$	16,739	$	56,816
Denominator:
Weighted average common shares - basic	95,734,591		95,339,489		95,712,057		92,524,061
Basic (loss) earnings per share from net (loss) income	$	(0.27)	$	0.51	$	0.17	$	0.61
Diluted earnings per share computation:
Numerator:
Net (loss) income available to common stock stockholders	$	(26,214)	$	48,301	$	16,739	$	56,816
Gain in fair value change of warrant liability	—		(37,644)		—		(50,952)
Numerator for diluted earnings per share	$	(26,214)	$	10,657	$	16,739	$	5,864
Denominator:
Weighted average common shares outstanding - basic	95,734,591		95,339,489		95,712,057		92,524,061
Private Warrants	—		3,706,986		—		3,766,141
Employee stock options	—		1,173,631		1,056,707		1,194,968
Non-vested shares	—		116,465		228,248		112,444
Weighted average common shares - diluted	95,734,591		100,336,571		96,997,012		97,597,614
Diluted (loss) earnings per share from net income	$	(0.27)	$	0.11	$	0.17	$	0.06

    Diluted earnings per share calculations for the thirteen weeks ended February 27, 2021 and February 29, 2020 excluded 1.4 million and 0.4 million shares underlying stock options issuable upon exercise, respectively, that would have been anti-dilutive. Diluted earnings per share calculations for the thirteen weeks ended February 27, 2021 excluded 0.3 million number of non-vested shares and 3.9 million of Private Warrants that would have been anti-dilutive

    Diluted earnings per share calculations for the twenty-six weeks ended February 27, 2021 and February 29, 2020 excluded 0.6 million and 0.3 million shares underlying stock options issuable upon exercise, respectively, that would have been anti-dilutive. Diluted earnings per share for the twenty-six weeks ended February 27, 2021 excluded an immaterial number of non-vested shares and 3.6 million of Private Warrants that would have been anti-dilutive.

XML

Omnibus Incentive Plan

6 Months Ended

Feb. 27, 2021

Share-based Payment Arrangement [Abstract]

Stock Option Plan

Stock-based compensation includes stock options, restricted stock units, performance stock unit awards and stock appreciation rights, which are awarded to employees, directors, and consultants of the Company. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period of the award based on their grant date fair value. Stock-based compensation expense is included within General and administrative expense, which is the same financial statement caption where the recipient’s other compensation is reported.    The Company recorded stock-based compensation expense of $2.5 million and $2.1 million in the thirteen weeks ended February 27, 2021 and February 29, 2020, respectively, and $3.6 million and $3.8 million in the twenty-six weeks ended February 27, 2021 and February 29, 2020, respectively.

Stock Options

    The following table summarizes stock option activity for the twenty-six weeks ended February 27, 2021:

	Shares Underlying Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)
Outstanding as of August 29, 2020	2,615,899	$	14.33
Granted	289,555	20.47
Exercised	(43,928)	12.00
Forfeited	(39,575)	23.08
Outstanding as of February 27, 2021	2,821,951	$	14.88	7.11
Vested and expected to vest as of February 27, 2021	2,821,951	$	14.88	7.11
Exercisable as of February 27, 2021	2,197,655	$	13.24	6.61

    As of February 27, 2021, the Company had $3.5 million of total unrecognized compensation cost related to stock option plans that will be recognized over a weighted average period of 1.9 years. During the twenty-six weeks ended February 27, 2021 and February 29, 2020, the Company received $0.5 million and $0.9 million in cash from stock option exercises, respectively.

Restricted Stock Units

    The following table summarizes restricted stock unit activity for the twenty-six weeks ended February 27, 2021:

	Restricted Stock Units	Weighted average grant-date fair value
Non-vested as of August 29, 2020	208,023	$	22.82
Granted	311,873	21.57
Vested	(72,568)	25.89
Forfeited	(15,706)	22.99
Non-vested as of February 27, 2021	431,622	$	21.39

    As of February 27, 2021, the Company had $7.6 million of total unrecognized compensation cost related to restricted stock units that will be recognized over a weighted average period of 2.2 years.

Performance Stock Units

    During the twenty-six weeks ended February 27, 2021, the Board of Directors granted performance stock units under the Company’s equity compensation plan. Performance stock units vest in a range between 0% and 200% based upon certain performance criteria in a three-year period. Performance stock units were valued using a Monte-Carlo simulation.

    The following table summarizes performance stock unit activity for the twenty-six weeks ended February 27, 2021:

	Performance Stock Units	Weighted average grant-date fair value
Non-vested as of August 29, 2020	295,256	$	17.93
Granted	116,309	23.59
Vested	—	—
Forfeited	(26,400)	22.06
Non-vested as of February 27, 2021	385,165	$	19.35

    As of February 27, 2021, the Company had $4.4 million of total unrecognized compensation cost related to performance stock units that will be recognized over a weighted average period of 1.6 years.

Stock Appreciation Rights

    Stock appreciation rights (“SARs”) permit the holder to participate in the appreciation of the Company’s common stock price. The Company’s SARs settle in shares of its common stock once the applicable vesting criteria has been met. SARs cliff vest 3 years from the date of grant and must be exercised within 10 years.

    The following table summarizes SARs activity for the twenty-six weeks ended February 27, 2021:

	Shares Underlying SARs	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)
Outstanding as of August 29, 2020	150,000	$	24.20
Granted	—	—
Exercised	—	—
Forfeited	—	—
Outstanding as of February 27, 2021	150,000	$	24.20	8.68
Vested and expected to vest as of February 27, 2021	150,000	$	24.20	8.68
Exercisable as of February 27, 2021	—	$	—	0.00

    As of February 27, 2021, the Company had $0.2 million of total unrecognized compensation cost related to its SARs that will be recognized over a weighted average period of 1.7 years.

XML

Restructuring and Related Charges

6 Months Ended

Feb. 27, 2021

Restructuring and Related Activities [Abstract]

Restructuring and Related Activities Disclosure [Text Block]

In May 2020, the Company announced certain restructuring activities in conjunction with the implementation of the Company’s future-state organization design, which created a fully integrated organization with its completed Acquisition of Quest. The new organization design became effective on August 31, 2020. These restructuring plans primarily include workforce reductions, changes in management structure, and the relocation of business activities from one location to another.

    The one-time termination benefits and employee severance costs to be incurred in relation to these restructuring activities are accounted for in accordance with ASC Topic 420, Exit or Disposal Cost Obligations, and ASC Topic 712, Compensation-Nonretirement Postemployment Benefits, respectively. The Company recognizes a liability and the related expense for these restructuring costs when the liability is incurred and can be measured. Restructuring accruals are based upon management estimates at the time and can change depending upon changes in facts and circumstances subsequent to the date the original liability was recorded.

    Changes to the restructuring liability during the twenty-six weeks ended February 27, 2021 were as follows:

(in thousands)	Termination benefits and severance		Other		Restructuring Liability
Balance as of August 29, 2020	$	4,139	$	—	$	4,139
Charges	3,118		144		3,262
Cash payments	(6,146)		(144)		(6,290)
Non-cash settlements or adjustments	—		—		—
Balance as of February 27, 2021	$	1,111	$	—	$	1,111

    In addition to the restructuring costs shown above, the Company incurred impairment charges of $0.3 million and $0.7 million in the thirteen and twenty-six weeks ended February 27, 2021, respectively, related to its operating lease right-of-use assets for leases in Toronto, Ontario and the Netherlands. Additionally, the Company terminated the lease in Toronto, Ontario, which resulted in a gain on lease termination of $0.2 million in the thirteen and twenty-six weeks ended February 27, 2021. As a result, for the thirteen and twenty-six weeks ended February 27, 2021, the Company incurred a total of $1.3 million and $3.8 million in restructuring and restructuring related costs, respectively, which have been included within General and administrative on the Consolidated Statements of Operations and Comprehensive Income.

    As of February 27, 2021, the Company has incurred aggregate restructuring and restructuring-related costs of $9.3 million since May 2020. Overall, the Company expects to incur a total of approximately $10.0 million in restructuring and restructuring related costs, which are to be paid throughout fiscal 2021 and the first quarter of fiscal 2022.

XML

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Feb. 27, 2021

Accounting Policies [Abstract]

New Accounting Pronouncements, Policy [Policy Text Block]

Recently Issued and Adopted Accounting Pronouncements

Recently Issued Accounting Pronouncements Not Yet Adopted

    In December 2019, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which amends the existing guidance relating to the accounting for income taxes. This ASU is intended to simplify the accounting for income taxes by removing certain exceptions to the general principles of accounting for income taxes and to improve the consistent application of U.S. GAAP for other areas of accounting for income taxes by clarifying and amending existing guidance. This ASU is effective for fiscal years beginning after December 15, 2021, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements and does not expect that the adoption of this ASU will be material to its consolidated financial statements.

    In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance for a limited period of time to ease the potential burden in accounting for reference rate reform on financial reporting. The amendments in this ASU are effective for all entities and can be applied to contract modifications due to rate reform and eligible existing and new hedging relationships entered into between March 12, 2020 through December 31, 2022. The amendments of this ASU should be applied on a prospective basis. The Company will continue to monitor the effects of rate reform, if any, on its contracts and the effects of adoption of this ASU through December 31, 2022. The Company does not anticipate the amendments in this ASU to be material to its consolidated financial statements.

    In October 2020, the FASB issued ASU No. 2020-10, Codification Improvements, which provides updates for technical corrections, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements across various areas of accounting within U.S. GAAP. This ASU is effective for all entities for fiscal years beginning after December 15, 2020, with early adoption permitted. The amendments of this ASU should be applied retrospectively. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements and does not anticipate the adoption of this ASU will be material to its consolidated financial statements.

Recently Adopted Accounting Pronouncements

    In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326), which modified the measurement of expected credit losses of certain financial instruments. The Company adopted this ASU as of the first day of fiscal 2021. As a result of adopting this ASU, the Company changed its method of estimating its allowance for doubtful accounts for trade receivables to be based upon the Company’s historical credit loss experience adjusted for asset-specific risk characteristics, current economic conditions, and reasonable forecasts. The change in estimating the allowance for doubtful accounts did not have a material effect on the Company’s consolidated financial statements.

    In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820), which modified disclosure requirements on fair value measurements of Accounting Standards Codification (“ASC”) 820. The Company adopted this ASU as of the first day of fiscal 2021. The adoption of this ASU did not have a material effect on the consolidated financial statements or the related disclosures.

Basis of Accounting, Policy [Policy Text Block]

Unaudited Interim Condensed Consolidated Financial Statements

    The unaudited interim condensed consolidated financial statements include the accounts of Simply Good Foods and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated. Unless the context otherwise requires, “we,” “us,” “our” and the “Company” refer to Simply Good Foods and its subsidiaries.

    The Company maintains its accounting records on a 52/53-week fiscal year, ending on the last Saturday in August of each year.

    The interim condensed consolidated financial statements and related notes of the Company and its subsidiaries are unaudited. The unaudited interim condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”). The unaudited interim condensed consolidated financial statements reflect all adjustments and disclosures which are, in the Company's opinion, necessary for a fair presentation of the results of operations, financial position and cash flows for the indicated periods. All such adjustments were of a normal and recurring nature unless otherwise disclosed. The year-end balance sheet data was derived from the audited financial statements and, in accordance with the instructions to Form 10-Q, certain information and footnote disclosures required by GAAP have been condensed or omitted. The results reported in these unaudited interim condensed consolidated financial statements are not necessarily indicative of the results that may be reported for the entire fiscal year and should be read in conjunction with the Company’s consolidated financial statements for the fiscal year ended August 29, 2020, included in Amendment No. 1 to Form 10-K (“Form 10-K/A”) filed with the SEC on June 30, 2021. As discussed in Note 2, Restatement of Previously Issued Financial Statements, the consolidated financial statements have been restated to reflect certain warrants as liabilities rather than equity.

    The Company remains uncertain of the ultimate effect COVID-19 could have on its business notwithstanding the distribution of several U.S. government approved vaccines and various federal, state and local governments having begun to ease the movement restrictions and public health initiatives while continuing to adhere to enhanced safety measures, such as physical distancing and face mask protocols. This uncertainty as to the duration and severity of economic effects from the COVID-19 pandemic stems from the potential for, among other things, (i) continued rates of reported cases of COVID-19 and the potential for mutations of COVID-19 to result in increased rates of reported cases for which currently approved vaccines are not effective, (ii) unexpected supply chain disruptions, (iii) changes to customer operations, (iv) continued or additional changes in consumer purchasing and consumption behavior beyond those evidenced to date, and (v) the closure of customer establishments.

XML

Restatement of Previously Issued Financial Statements (Tables)

6 Months Ended

Feb. 27, 2021

Accounting Changes and Error Corrections [Abstract]

Schedule of Error Corrections and Prior Period Adjustments

Condensed Consolidated Balance Sheet	February 27, 2021
(In thousands)	As Previously Reported		Restatement Adjustment	As Restated
Warrant liability	$	—	118,519	$	118,519
Total liabilities	742,860		118,519	861,379
Additional paid-in-capital	1,098,375		(18,035)	1,080,340
Retained earnings	182,150		(100,484)	81,666
Total stockholders’ equity	1,278,658		(118,519)	1,160,139

Condensed Consolidated Statement of Operations and Comprehensive Income (Loss)	Thirteen Weeks Ended
	February 27, 2021
(In thousands)	As Previously Reported		Restatement Adjustment		As Restated
Loss in fair value change of warrant liability	—		(45,334)		(45,334)
Total other expense	(6,908)		(45,334)		(52,242)
Income (loss) before income taxes	26,433		(45,334)		(18,901)
Net income (loss)	19,120		(45,334)		(26,214)
Comprehensive income (loss)	$	19,363	$	(45,334)	$	(25,971)

As a result of the Restatement adjustments, basic earnings per share decreased $0.47, from earnings of $0.20 per share to a loss of $0.27 per share, and diluted earnings per share decreased $0.46, from earnings of $0.19 per share to a loss of $0.27 per share.

Condensed Consolidated Statement of Operations and Comprehensive Income (Loss)	Twenty-Six Weeks Ended
	February 27, 2021
(In thousands)	As Previously Reported		Restatement Adjustment		As Restated
Loss in fair value change of warrant liability	—		(24,881)		(24,881)
Total other expense	(15,221)		(24,881)		(40,102)
Income before income taxes	57,307		(24,881)		32,426
Net income	41,620		(24,881)		16,739
Comprehensive income	$	41,818	$	(24,881)	$	16,937

As a result of the Restatement adjustments, basic earnings per share decreased $0.26, from earnings of $0.43 per share to $0.17 per share, and diluted earnings per share decreased $0.24, from earnings of $0.41 per share to $0.17 per share.

	Twenty-Six Weeks Ended
Condensed Consolidated Statement of Cash Flows	February 27, 2021
(In thousands)	As Previously Reported		Restatement Adjustment		As Restated
Operating activities
Net income	$	41,620	$	(24,881)	$	16,739
Adjustments to reconcile net income to net cash provided by operating activities:
Loss in fair value change of warrant liability	—		24,881		24,881
Net cash provided by operating activities	$	39,764	$	—	$	39,764

Condensed Consolidated Statement of Stockholders’ Equity	February 27, 2021
(In thousands)	As Previously Reported		Restatement Adjustment		As Restated
Additional paid-in-capital	$	1,098,375	$	(18,035)	$	1,080,340
Net income	41,620		(24,881)		16,739
Retained earnings	182,150		(100,484)		81,666
Total stockholders’ equity	$	1,278,658	$	(118,519)	$	1,160,139

XML

Business Combination (Tables)

6 Months Ended

Feb. 27, 2021

Business Combinations [Abstract]

Schedule of Business Acquisitions, by Acquisition

The following table sets forth the final purchase price allocation of the Acquisition of Quest to the estimated fair value of the net assets acquired at the date of acquisition, in thousands:

Assets acquired:
Cash and cash equivalents	$	4,745
Accounts receivable, net	25,359
Inventories	44,032
Prepaid assets	1,214
Other current assets	3,812
Property and equipment, net(1)	9,843
Intangible assets, net(2)	868,375
Other long-term assets	20,997
Liabilities assumed:
Accounts payable	25,200
Other current liabilities	11,237
Deferred income taxes(3)	10,754
Other long-term liabilities	18,891
Total identifiable net assets	912,295
Goodwill(4)	74,525
Total assets acquired and liabilities assumed	$	986,820

Business Combination, Revenues of Acquired Entity

The results of Quest’s operations have been included in the Company’s Consolidated Financial Statements since November 7, 2019, the date of acquisition. The following table provides net sales from the acquired Quest business included in the Company’s results:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(in thousands)	February 27, 2021		February 29, 2020		February 27, 2021		February 29, 2020
Net sales(1)	$	105,025	$	88,305	$	200,794	$	105,387

Business Acquisition, Pro Forma Information

The following unaudited pro forma financial information presents the combined results of the Company and Quest as if the Acquisition of Quest has occurred at the beginning of fiscal 2019:

	Thirteen Weeks Ended		Twenty-Six Weeks Ended
(in thousands)	February 29, 2020		February 29, 2020
Revenue	$	227,101	$	447,657
Gross profit	$	90,479	$	178,667
Net income	$	52,693	$	81,649

XML

Revenue Recognition (Tables)

6 Months Ended

Feb. 27, 2021

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

Revenues from transactions with external customers for each of the Company’s products would be impracticable to disclose and management does not view its business by product line. The following is a summary of revenue disaggregated by geographic area and core brands:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(In thousands)	February 27, 2021		February 29, 2020		February 27, 2021		February 29, 2020
North America
Atkins	$	114,155	$	131,435	$	236,916	$	259,247
Quest (2)	105,025		88,305		200,794		105,387
Total North America (1)	219,180		219,740		437,710		364,634
International	11,427		7,361		24,049		14,620
Total net sales	$	230,607	$	227,101	$	461,759	$	379,254

(1)    The North America geographic area consists of net sales substantially related to the United States and there is no individual foreign country to which more than 10% of Company’s net sales are attributed or that is otherwise deemed individually material. The North America geographic area includes the divested SimplyProtein brand.

(2)    Quest net sales are primarily in North America.

XML

Goodwill and Intangibles (Tables)

6 Months Ended

Feb. 27, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

Changes to Goodwill during the thirteen week period ended February 27, 2021 were as follows:

(in thousands)	Goodwill
Balance as of August 29, 2020	$	544,774
Acquisition of business, measurement period adjustment	1,178
Sale of business	(2,818)
Balance as of February 27, 2021	$	543,134

Schedule of Finite-Lived Intangible Assets

Intangible assets, net in the Consolidated Balance Sheets consist of the following:

				February 27, 2021
(In thousands)	Useful life			Gross carrying amount		Accumulated amortization		Net carrying amount
Intangible assets with indefinite life:
Brands and trademarks	Indefinite life			$	974,000	$	—	$	974,000
Intangible assets with finite lives:
Customer relationships	15 years			174,000		24,303		149,697
Proprietary recipes and formulas	7 years			7,000		3,631		3,369
Licensing agreements	14 years			22,000		5,706		16,294
Software and website development costs	3	-	5 years	5,302		2,678		2,624
Intangible assets in progress	3	-	5 years	55		—		55
				$	1,182,357	$	36,318	$	1,146,039

				August 29, 2020
(In thousands)	Useful life			Gross carrying amount		Accumulated amortization		Net carrying amount
Intangible assets with indefinite life:
Brands and trademarks	Indefinite life			$	979,000	$	—	$	979,000
Intangible assets with finite lives:
Customer relationships	15 years			174,000		18,503		155,497
Proprietary recipes and formulas	7 years			7,000		3,131		3,869
Licensing agreements	14 years			22,000		4,920		17,080
Software and website development costs	3	-	5 years	5,967		2,645		3,322
				$	1,187,967	$	29,199	$	1,158,768

Schedule of Indefinite-Lived Intangible Assets

Intangible assets, net in the Consolidated Balance Sheets consist of the following:

				February 27, 2021
(In thousands)	Useful life			Gross carrying amount		Accumulated amortization		Net carrying amount
Intangible assets with indefinite life:
Brands and trademarks	Indefinite life			$	974,000	$	—	$	974,000
Intangible assets with finite lives:
Customer relationships	15 years			174,000		24,303		149,697
Proprietary recipes and formulas	7 years			7,000		3,631		3,369
Licensing agreements	14 years			22,000		5,706		16,294
Software and website development costs	3	-	5 years	5,302		2,678		2,624
Intangible assets in progress	3	-	5 years	55		—		55
				$	1,182,357	$	36,318	$	1,146,039

				August 29, 2020
(In thousands)	Useful life			Gross carrying amount		Accumulated amortization		Net carrying amount
Intangible assets with indefinite life:
Brands and trademarks	Indefinite life			$	979,000	$	—	$	979,000
Intangible assets with finite lives:
Customer relationships	15 years			174,000		18,503		155,497
Proprietary recipes and formulas	7 years			7,000		3,131		3,869
Licensing agreements	14 years			22,000		4,920		17,080
Software and website development costs	3	-	5 years	5,967		2,645		3,322
				$	1,187,967	$	29,199	$	1,158,768

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

Estimated future amortization for each of the next five fiscal years and thereafter is as follows:

(In thousands)	Amortization
Remainder of 2021	$	7,674
2022	15,224
2023	14,938
2024	14,257
2025	13,171
2026 and thereafter	106,720
Total	$	171,984

XML

Long-Term Debt and Line of Credit (Tables)

6 Months Ended

Feb. 27, 2021

Debt Disclosure [Abstract]

Schedule of Debt

Long-term debt consists of the following:

(In thousands)	February 27, 2021		August 29, 2020
Term Facility (effective rate of 4.8% at February 27, 2021)	$	556,500	$	606,500
Finance lease liabilities (effective rate of 5.6% at February 27, 2021)	826		922
Less: Deferred financing fees	8,164		10,272
Total debt	549,162		597,150
Less: Current finance lease liabilities	278		271
Long-term debt, net of deferred financing fees	$	548,884	$	596,879

XML

Fair Value of Financial Instruments (Tables)

6 Months Ended

Feb. 27, 2021

Fair Value Disclosures [Abstract]

Fair Value Measurement Inputs and Valuation Techniques

The table below summarizes the inputs used to calculate the fair value of the warrant liability at each of the dates indicated below:

	February 27, 2021			February 29, 2020
Exercise Price	$	11.50		$	11.50
Stock Price	$	29.17		$	22.06
Dividend Yield	—		%	—		%
Expected Term (in Years)	1.35			2.35
Risk-Free Interest Rate	0.10		%	0.85		%
Expected Volatility	28.00		%	29.10		%
Per Share Value of Warrants	$	17.69		$	10.99

XML

Income Taxes (Tables)

6 Months Ended

Feb. 27, 2021

Income Tax Disclosure [Abstract]

Schedule of Effective Income Tax Rate Reconciliation

The tax expense and the effective tax rate resulting from operations were as follows:

	Twenty-Six Weeks Ended
(In thousands)	February 27, 2021			February 29, 2020
(Loss) income before income taxes	$	32,426		$	59,009
Income tax expense	$	15,687		$	2,193
Effective tax rate	48.4		%	3.7		%

XML

Leases (Tables)

6 Months Ended

Feb. 27, 2021

Leases [Abstract]

Lease, Cost

The components of lease expense were as follows:

		Thirteen Weeks Ended				Twenty-Six Weeks Ended
(In thousands)	Statement of Operations Caption	February 27, 2021		February 29, 2020		February 27, 2021		February 29, 2020
Operating lease cost:
Lease cost	Cost of goods sold and General and administrative	$	1,496	$	1,441	$	2,994	$	2,247
Variable lease cost (1)	Cost of goods sold and General and administrative	378		426		776		736
Operating lease cost		1,874		1,867		3,770		2,983
Short term lease cost	General and administrative	—		18		—		24
Finance lease cost:
Amortization of right-of-use assets	Cost of goods sold	68		66		136		136
Interest on lease liabilities	Interest expense	12		16		25		32
Total finance lease cost		80		82		161		168
Total lease cost		$	1,954	$	1,967	$	3,931	$	3,175

(1)    Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs.

Lease assets and liabilities

The gross amounts of assets and liabilities related to both operating and finance leases are as follows:

(In thousands)	Balance Sheet Caption	February 27, 2021		August 29, 2020
Assets
Operating lease right-of-use assets	Other long-term assets	$	23,089	$	25,703
Finance lease right-of-use assets	Property and equipment, net	776		912
Total lease assets		$	23,865	$	26,615
Liabilities
Current:
Operating lease liabilities	Accrued expenses and other current liabilities	$	4,235	$	4,329
Finance lease liabilities	Current maturities of long-term debt	278		271
Long-term:
Operating lease liabilities	Other long-term liabilities	20,880		22,764
Finance lease liabilities	Long-term debt, less current maturities	548		651
Total lease liabilities		$	25,941	$	28,015

Finance Lease, Liability, Maturity

Future maturities of lease liabilities as of February 27, 2021 were as follows:

(In thousands)	Operating Leases		Finance Leases
Fiscal year ending:
Remainder of 2021	$	2,935	$	157
2022	4,607		313
2023	4,071		278
2024	4,232		145
2025	3,838		—
Thereafter	11,050		—
Total lease payments	30,733		893
Less: Interest	(5,618)		(67)
Present value of lease liabilities	$	25,115	$	826

Lessee, Operating Lease, Liability, Maturity

Future maturities of lease liabilities as of February 27, 2021 were as follows:

(In thousands)	Operating Leases		Finance Leases
Fiscal year ending:
Remainder of 2021	$	2,935	$	157
2022	4,607		313
2023	4,071		278
2024	4,232		145
2025	3,838		—
Thereafter	11,050		—
Total lease payments	30,733		893
Less: Interest	(5,618)		(67)
Present value of lease liabilities	$	25,115	$	826

Schedule of Weighted Average Remaining Lease Terms

The weighted-average remaining lease term and weighted-average discount rate for operating and finance leases were as follows:

	February 27, 2021		August 29, 2020
Weighted-average remaining lease term (in years)
Operating leases	6.76		6.97
Finance leases	2.92		3.41
Weighted-average discount rate
Operating leases	5.8	%	5.7	%
Finance leases	5.6	%	5.6	%

Schedule of Supplemental Cash Flow Information Related to Leases

Supplemental and other information related to leases was as follows:

	Twenty-Six Weeks Ended
(In thousands)	February 27, 2021		February 29, 2020
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	3,689	$	2,817
Operating cash flows from finance leases	12		9
Financing cash flows from finance leases	$	157	$	157

XML

Earnings Per Share (Tables)

6 Months Ended

Feb. 27, 2021

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table reconciles the numerators and denominators used in the computations of both basic and diluted earnings per share:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(In thousands, except per share data)	February 27, 2021		February 29, 2020		February 27, 2021		February 29, 2020
Basic earnings per share computation:
Numerator:
Net (loss) income available to common stock stockholders	$	(26,214)	$	48,301	$	16,739	$	56,816
Denominator:
Weighted average common shares - basic	95,734,591		95,339,489		95,712,057		92,524,061
Basic (loss) earnings per share from net (loss) income	$	(0.27)	$	0.51	$	0.17	$	0.61
Diluted earnings per share computation:
Numerator:
Net (loss) income available to common stock stockholders	$	(26,214)	$	48,301	$	16,739	$	56,816
Gain in fair value change of warrant liability	—		(37,644)		—		(50,952)
Numerator for diluted earnings per share	$	(26,214)	$	10,657	$	16,739	$	5,864
Denominator:
Weighted average common shares outstanding - basic	95,734,591		95,339,489		95,712,057		92,524,061
Private Warrants	—		3,706,986		—		3,766,141
Employee stock options	—		1,173,631		1,056,707		1,194,968
Non-vested shares	—		116,465		228,248		112,444
Weighted average common shares - diluted	95,734,591		100,336,571		96,997,012		97,597,614
Diluted (loss) earnings per share from net income	$	(0.27)	$	0.11	$	0.17	$	0.06

XML

Omnibus Incentive Plan (Tables)

6 Months Ended

Feb. 27, 2021

Share-based Payment Arrangement [Abstract]

Stock option activity

The following table summarizes stock option activity for the twenty-six weeks ended February 27, 2021:

	Shares Underlying Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)
Outstanding as of August 29, 2020	2,615,899	$	14.33
Granted	289,555	20.47
Exercised	(43,928)	12.00
Forfeited	(39,575)	23.08
Outstanding as of February 27, 2021	2,821,951	$	14.88	7.11
Vested and expected to vest as of February 27, 2021	2,821,951	$	14.88	7.11
Exercisable as of February 27, 2021	2,197,655	$	13.24	6.61

Restricted stock activity

The following table summarizes restricted stock unit activity for the twenty-six weeks ended February 27, 2021:

	Restricted Stock Units	Weighted average grant-date fair value
Non-vested as of August 29, 2020	208,023	$	22.82
Granted	311,873	21.57
Vested	(72,568)	25.89
Forfeited	(15,706)	22.99
Non-vested as of February 27, 2021	431,622	$	21.39

Performance stock unit activity

The following table summarizes performance stock unit activity for the twenty-six weeks ended February 27, 2021:

	Performance Stock Units	Weighted average grant-date fair value
Non-vested as of August 29, 2020	295,256	$	17.93
Granted	116,309	23.59
Vested	—	—
Forfeited	(26,400)	22.06
Non-vested as of February 27, 2021	385,165	$	19.35

Stock appreciation right activity

The following table summarizes SARs activity for the twenty-six weeks ended February 27, 2021:

	Shares Underlying SARs	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)
Outstanding as of August 29, 2020	150,000	$	24.20
Granted	—	—
Exercised	—	—
Forfeited	—	—
Outstanding as of February 27, 2021	150,000	$	24.20	8.68
Vested and expected to vest as of February 27, 2021	150,000	$	24.20	8.68
Exercisable as of February 27, 2021	—	$	—	0.00

XML

Restructuring and related charges (Tables)

6 Months Ended

Feb. 27, 2021

Restructuring and Related Activities [Abstract]

Restructuring and Related Costs

Changes to the restructuring liability during the twenty-six weeks ended February 27, 2021 were as follows:

(in thousands)	Termination benefits and severance		Other		Restructuring Liability
Balance as of August 29, 2020	$	4,139	$	—	$	4,139
Charges	3,118		144		3,262
Cash payments	(6,146)		(144)		(6,290)
Non-cash settlements or adjustments	—		—		—
Balance as of February 27, 2021	$	1,111	$	—	$	1,111

XML

Restatement of Previously Issued Financial Statements (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Feb. 27, 2021	Nov. 28, 2020	Feb. 29, 2020	Nov. 30, 2019	Feb. 27, 2021	Feb. 29, 2020	Aug. 29, 2020	Aug. 31, 2019
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Warrant liability	$ 118,519				$ 118,519		$ 93,638
Total liabilities	861,379				861,379		869,112
Additional paid-in-capital	1,080,340				1,080,340		1,076,472
Retained earnings	81,666				81,666		64,927
Stockholders' Equity Attributable to Parent	1,160,139	$ 1,183,307	$ 1,123,409	$ 1,072,413	1,160,139	$ 1,123,409	$ 1,139,333	$ 712,868
Loss in fair value change of warrant liability	(45,334)		37,644		(24,881)	50,952
Total other expense	(52,242)		26,954		(40,102)	36,725
Income (loss) before income taxes	(18,901)		52,223		32,426	59,009
Net income	(26,214)	$ 42,953	48,301	$ 8,515	16,739	56,816
Comprehensive income (loss)	$ (25,971)		$ 48,160		$ 16,937	$ 56,675
Basic earnings per share from net income (in dollars per share)	$ (0.27)		$ 0.51		$ 0.17	$ 0.61
Diluted earnings per share from net income (in dollars per share)	$ (0.27)		$ 0.11		$ 0.17	$ 0.06
Net Cash Provided by (Used in) Operating Activities					$ 39,764	$ (14,886)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Warrant liability	$ 0				0
Total liabilities	742,860				742,860
Additional paid-in-capital	1,098,375				1,098,375
Retained earnings	182,150				182,150
Stockholders' Equity Attributable to Parent	1,278,658				1,278,658
Loss in fair value change of warrant liability	0				0
Total other expense	(6,908)				(15,221)
Income (loss) before income taxes	26,433				57,307
Net income	19,120				41,620
Comprehensive income (loss)	$ 19,363				$ 41,818
Basic earnings per share from net income (in dollars per share)	$ 0.2				$ 0.43
Diluted earnings per share from net income (in dollars per share)	$ 0.19				$ 0.41
Net Cash Provided by (Used in) Operating Activities					$ 39,764
Change in Accounting Principle and Presentation
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Warrant liability	$ 118,519				118,519
Total liabilities	118,519				118,519
Additional paid-in-capital	(18,035)				(18,035)
Retained earnings	(100,484)				(100,484)
Stockholders' Equity Attributable to Parent	(118,519)				(118,519)
Loss in fair value change of warrant liability	45,334				24,881
Total other expense	(45,334)				(24,881)
Income (loss) before income taxes	(45,334)				(24,881)
Net income	(45,334)				(24,881)
Comprehensive income (loss)	$ (45,334)				$ (24,881)
Basic earnings per share from net income (in dollars per share)	$ 0.47				$ 0.26
Diluted earnings per share from net income (in dollars per share)	$ 0.46				$ 0.24
Net Cash Provided by (Used in) Operating Activities					$ 0

XML

Business Combination (Details) - USD ($) $ in Thousands			3 Months Ended				6 Months Ended
	Nov. 07, 2019	Oct. 09, 2019	Feb. 27, 2021	Nov. 28, 2020	Aug. 29, 2020	Feb. 29, 2020	Feb. 27, 2021	Feb. 29, 2020
Business Acquisition [Line Items]
Payments to acquire business, equity issuance		$ 350,000
Business transaction costs			$ 0			$ 694	$ 0	$ 26,853
Acquisition of Quest
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 988,900
Total purchase price	986,820		$ 986,800				$ 986,800
Payments to acquire business, cash on hand	195,300
Payments to acquire business, equity issuance		$ 350,000
Proceeds from long-term line of credit	443,600
Business transaction costs								$ 26,900
Transaction advisory fees	14,500
Banker commitment fees	3,200
Non-deferrable debt issuance costs	6,100
Legal, due diligence and accounting fees	3,100
Intangible assets, net	868,375
Deferred income taxes	10,754
Property and equipment, net	9,843
Goodwill, Purchase Accounting Adjustments				$ 21,500
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred					$ 2,100
Acquisition of Quest | Deferred income taxes
Business Acquisition [Line Items]
Fair value measurement period adjustment				3,200
Acquisition of Quest | Intangible assets, net
Business Acquisition [Line Items]
Fair value measurement period adjustment				20,000
Acquisition of Quest | Accounts receivable, net
Business Acquisition [Line Items]
Fair value measurement period adjustment				(4,300)
Acquisition of Quest | Inventories
Business Acquisition [Line Items]
Fair value measurement period adjustment				900
Acquisition of Quest | Property and equipment, net
Business Acquisition [Line Items]
Fair value measurement period adjustment				$ (500)
Centerview Partners | Acquisition of Quest
Business Acquisition [Line Items]
Transaction advisory fees	12,000
Brands and trademarks | Acquisition of Quest
Business Acquisition [Line Items]
Intangible assets, net	750,000
Customer relationships | Acquisition of Quest
Business Acquisition [Line Items]
Intangible assets, net	115,000
Tax deductible goodwill	67,700
Software and website development costs | Acquisition of Quest
Business Acquisition [Line Items]
Intangible assets, net	3,400
Leasehold improvements | Acquisition of Quest
Business Acquisition [Line Items]
Property and equipment, net	6,900
Furniture and fixtures | Acquisition of Quest
Business Acquisition [Line Items]
Property and equipment, net	2,200
Equipment | Acquisition of Quest
Business Acquisition [Line Items]
Property and equipment, net	$ 700

XML

Business Combination (Details 2) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 27, 2021	Feb. 29, 2020	Feb. 27, 2021	Feb. 29, 2020	Aug. 29, 2020	Nov. 07, 2019
Business Combination, Description [Abstract]
Net sales	$ 230,607	$ 227,101	$ 461,759	$ 379,254
Business Combination, Consideration Transferred [Abstract]
Goodwill	543,134		543,134		$ 544,774
Acquisition of Quest
Business Combination, Consideration Transferred [Abstract]
Cash and equivalents						$ 4,745
Accounts receivable, net						25,359
Inventories						44,032
Prepaid assets						1,214
Other current assets						3,812
Property and equipment, net						9,843
Intangible assets, net						868,375
Other long-term assets						20,997
Accounts payable						25,200
Other current liabilities						11,237
Deferred income taxes						10,754
Other long-term liabilities						18,891
Total identifiable net assets						912,295
Goodwill						74,525
Total assets acquired and liabilities assumed	986,800		986,800			$ 986,820
Quest | Acquisition of Quest
Business Combination, Description [Abstract]
Net sales	$ 105,025	$ 88,305	$ 200,794	$ 105,387

XML

Business Combination (Details 3) - Acquisition of Quest - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Feb. 29, 2020	Feb. 29, 2020
Business Acquisition [Line Items]
Pro forma revenue	$ 447,657	$ 227,101
Pro forma gross profit	178,667	90,479
Pro forma net income (loss)	$ 81,649	$ 52,693

XML

Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 27, 2021	Feb. 29, 2020	Feb. 27, 2021	Feb. 29, 2020
Disaggregation of revenue
Net sales	$ 230,607	$ 227,101	$ 461,759	$ 379,254
North America
Disaggregation of revenue
Net sales	219,180	219,740	437,710	364,634
International
Disaggregation of revenue
Net sales	11,427	7,361	24,049	14,620
Atkins
Disaggregation of revenue
Net sales	114,155	131,435	236,916	259,247
Acquisition of Quest | Quest
Disaggregation of revenue
Net sales	$ 105,025	$ 88,305	$ 200,794	$ 105,387

XML

Revenue Recognition (Details 2) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Feb. 29, 2020	Feb. 29, 2020	Feb. 27, 2021	Aug. 29, 2020
Revenue from Contract with Customer [Abstract]
Allowance for doubtful accounts			$ 0.6	$ 0.5
Credit loss expense (reversal), accounts receivable	$ 0.1	$ 0.1

XML

Goodwill and Intangibles Goodwill Rollforward (Details) - USD ($) $ in Thousands	6 Months Ended
	Feb. 27, 2021	Aug. 29, 2020
Goodwill [Line Items]
Goodwill	$ 543,134	$ 544,774
Change in goodwill due to acquisition of a business	1,178
Goodwill disposed of with sale of business	$ (2,818)

XML

Goodwill and Intangibles - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
	Sep. 24, 2020	Feb. 27, 2021	Feb. 29, 2020	Feb. 27, 2021	Feb. 29, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Proceeds from SimplyProtein Sale	$ 8,800
Cash proceeds from SimplyProtein Sale	5,800
Note Receivable from SimplyProtein Sale	3,000
Gain (loss) on sale of business	0
Goodwill, Impaired, Accumulated Impairment Loss		$ 0		$ 0
Indefinite-lived intangible assets disposed of in sale of business	$ 5,000
Intangible asset amortization expense		$ 3,900	$ 3,900	$ 7,700	$ 6,200
Impairment of intangible assets, excluding goodwill			$ 0		$ 0

XML

Goodwill and Intangibles - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Feb. 27, 2021	Aug. 29, 2020
Intangible assets with finite lives:
Intangible assets, Gross carrying amount	$ 1,182,357	$ 1,187,967
Accumulated amortization	36,318	29,199
Intangible assets, Net carrying amount	1,146,039	$ 1,158,768
Finite-lived intangible assets, Net carrying amount	$ 171,984
Customer relationships
Intangible assets with finite lives:
Useful life	15 years	15 years
Finite-lived intangible assets, Gross carrying amount	$ 174,000	$ 174,000
Accumulated amortization	24,303	18,503
Finite-lived intangible assets, Net carrying amount	149,697	155,497
Software and website development costs
Intangible assets with finite lives:
Finite-lived intangible assets, Gross carrying amount	5,302	5,967
Accumulated amortization	2,678	2,645
Finite-lived intangible assets, Net carrying amount	$ 2,624	$ 3,322
Proprietary recipes and formulas
Intangible assets with finite lives:
Useful life	7 years	7 years
Finite-lived intangible assets, Gross carrying amount	$ 7,000	$ 7,000
Accumulated amortization	3,631	3,131
Finite-lived intangible assets, Net carrying amount	$ 3,369	$ 3,869
Licensing agreements
Intangible assets with finite lives:
Useful life	14 years	14 years
Finite-lived intangible assets, Gross carrying amount	$ 22,000	$ 22,000
Accumulated amortization	5,706	4,920
Finite-lived intangible assets, Net carrying amount	16,294	$ 17,080
Intangible assets in progress
Intangible assets with finite lives:
Finite-lived intangible assets, Gross carrying amount	55
Accumulated amortization	0
Finite-lived intangible assets, Net carrying amount	$ 55
Minimum | Software and website development costs
Intangible assets with finite lives:
Useful life	3 years	3 years
Minimum | Intangible assets in progress
Intangible assets with finite lives:
Useful life	3 years
Maximum | Software and website development costs
Intangible assets with finite lives:
Useful life	5 years	5 years
Maximum | Intangible assets in progress
Intangible assets with finite lives:
Useful life	5 years
Brands and trademarks
Intangible assets with indefinite lives:
Indefinite-lived intangible assets	$ 974,000	$ 979,000

XML

Goodwill and Intangibles - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) $ in Thousands	Feb. 27, 2021 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2021	$ 7,674
2020	15,224
2021	14,938
2022	14,257
2023	13,171
2026 and thereafter	106,720
Finite-lived intangible assets, Net carrying amount	$ 171,984

XML

Long-Term Debt and Line of Credit - Narrative (Details) - USD ($) $ in Millions	Nov. 07, 2019	Mar. 16, 2018	Jul. 07, 2017	Feb. 27, 2021	Aug. 29, 2020
Debt Instrument [Line Items]
Revolving Credit Facility, Amount Outstanding				$ 0.0	$ 0.0
Letters of Credit Outstanding, Amount				$ 4.2
Term Loan
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage				4.80%
Proceeds from long-term line of credit	$ 460.0
Repayments of principal in next twelve months				$ 0.0
Term Loan | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate	3.75%
Finance leases
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage				5.60%
Barclays Bank PLC and Other Parties | Term Loan
Debt Instrument [Line Items]
Borrowing capacity			$ 200.0
Maturity period			7 years
Barclays Bank PLC and Other Parties | Revolving Credit Facility
Debt Instrument [Line Items]
Borrowing capacity			$ 75.0
Maturity period			5 years
Net leverage ratio (equal to or less than)			6.25
Net leverage ratio post reduction (equal to or less than)			6.00
Percent of commitments (in excess of)			30.00%
Line of Credit | Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate	2.75%
Line of Credit | Barclays Bank PLC and Other Parties | Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate		2.50%	0.50%
Line of Credit | Barclays Bank PLC and Other Parties | Eurocurrency
Debt Instrument [Line Items]
Basis spread on variable rate			1.00%
Line of Credit | Barclays Bank PLC and Other Parties | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate		3.50%
Line of Credit | Barclays Bank PLC and Other Parties | Term Loan | Eurocurrency
Debt Instrument [Line Items]
Basis spread on variable rate			3.00%
Line of Credit | Barclays Bank PLC and Other Parties | Term Loan | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate			4.00%
Interest rate floor			1.00%
Line of Credit | Barclays Bank PLC and Other Parties | Revolving Credit Facility | Eurocurrency
Debt Instrument [Line Items]
Basis spread on variable rate			2.00%
Line of Credit | Barclays Bank PLC and Other Parties | Revolving Credit Facility | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate			3.00%

XML

Long-Term Debt and Line of Credit - Schedule of Debt (Details) - USD ($) $ in Thousands	Feb. 27, 2021	Aug. 29, 2020
Debt Disclosure [Abstract]
Term Facility (effective rate of 4.8% at February 27, 2021)	$ 556,500	$ 606,500
Finance lease liabilities (effective rate of 5.6% at February 27, 2021)	826	922
Less: Deferred financing fees	8,164	10,272
Total debt	549,162	597,150
Less: Current finance lease liabilities	(278)	(271)
Long-term debt, net of deferred financing fees	$ 548,884	$ 596,879

XML

Fair Value of Financial Instruments (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 27, 2021	Feb. 29, 2020	Feb. 27, 2021	Feb. 29, 2020	Aug. 29, 2020	Jul. 06, 2017
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Stock price	$ 29.17	$ 22.06	$ 29.17	$ 22.06
Expected term (in years)	1 year 4 months 6 days	2 years 4 months 6 days	1 year 4 months 6 days	2 years 4 months 6 days
Risk Free Interest Rate			0.10%	0.85%
Expected volatility			28.00%	29.10%
Per Share Value of Warrants			$ 17.69	$ 10.99
Fair Value Adjustment of Warrants	$ 45,334	$ (37,644)	$ 24,881	$ (50,952)
Warrant liability	$ 118,519		$ 118,519		$ 93,638
Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise price	$ 11.50	$ 11.50	$ 11.50	$ 11.50
Fair Value Adjustment of Warrants	$ (45,300)	$ (24,900)	$ (37,600)	$ 51,000
Warrant liability	$ 118,500	$ 73,600	$ 118,500	$ 73,600
Private Placement Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Class of Warrant or Right, Outstanding	6,700,000		6,700,000			6,700,000

XML

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 27, 2021	Feb. 29, 2020	Feb. 27, 2021	Feb. 29, 2020
Income Tax Disclosure [Abstract]
Income (loss) before income taxes	$ (18,901)	$ 52,223	$ 32,426	$ 59,009
Income tax expense	$ 7,313	$ 3,922	$ 15,687	$ 2,193
Effective tax rate			48.40%	3.70%

XML

Income Taxes - Narrative (Details)	6 Months Ended
	Feb. 27, 2021
Income Tax Disclosure [Abstract]
Effective tax rate difference	44.70%

XML

Leases (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 27, 2021	Feb. 29, 2020	Feb. 27, 2021	Feb. 29, 2020	Aug. 29, 2020
Components of lease expense
Lease cost	$ 1,496	$ 1,441	$ 2,994	$ 2,247
Variable lease cost (1)	378	426	776	736
Operating lease cost	1,874	1,867	3,770	2,983
Short term lease cost	0	18	0	24
Amortization of right-of-use assets	68	66	136	136
Interest on lease liabilities	12	16	25	32
Total finance lease cost	80	82	161	168
Total lease cost	1,954	$ 1,967	3,931	3,175
Assets and liabilities, lessee
Operating lease, right-of-use asset	23,089		23,089		$ 25,703
Finance lease, right-of-use asset	776		776		912
Total lease assets	23,865		23,865		26,615
Operating lease, liability, current	4,235		4,235		4,329
Finance lease, liability, current	278		278		271
Operating lease, liability, noncurrent	20,880		20,880		22,764
Finance lease, liability, noncurrent	548		548		651
Total lease liabilities	25,941		25,941		28,015
Future maturities of lease liabilities, operating leases
Remainder of 2021	2,935		2,935
2021	4,607		4,607
2022	4,071		4,071
2023	4,232		4,232
2024	3,838		3,838
Thereafter	11,050		11,050
Total lease payments	30,733		30,733
Less: Interest	(5,618)		(5,618)
Present value of lease liabilities	25,115		25,115
Future maturities of lease liabilities, finance leases
Remainder of 2021	157		157
2021	313		313
2022	278		278
2023	145		145
2024	0		0
Thereafter	0		0
Total lease payments	893		893
Less: Interest	(67)		(67)
Present value of lease liabilities	826		826		$ 922
Loss on operating lease right-of-use asset impairment	300		681	0
Lessee, Operating Lease, Lease Not Yet Commences, Expected Payments	$ 32,200		$ 32,200
Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract	10 years		10 years
Lessee, Lease, Description [Line Items]
Loss on operating lease right-of-use asset impairment	$ 300		$ 681	0
(Gain) loss on Termination of Lease	$ (200)		$ (154)	0
Finance Lease, Weighted Average Discount Rate, Percent	5.60%		5.60%		5.60%
Finance Lease, Weighted Average Remaining Lease Term	2 years 11 months 1 day		2 years 11 months 1 day		3 years 4 months 28 days
Operating Lease, Weighted Average Discount Rate, Percent	5.80%		5.80%		5.70%
Operating Lease, Weighted Average Remaining Lease Term	6 years 9 months 3 days		6 years 9 months 3 days		6 years 11 months 19 days
Supplemental and other information related to leases
Operating cash flows from operating leases			$ 3,689	2,817
Operating cash flows from finance leases			12	9
Financing cash flows from finance leases			$ 157	$ 157
Maximum
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Lease Not yet Commenced, Renewal Term	10 years		10 years
Minimum
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Lease Not yet Commenced, Renewal Term	5 years		5 years

XML

Commitments and Contingencies (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Feb. 29, 2020	Aug. 31, 2019	Feb. 27, 2021	Aug. 29, 2020
Commitments and Contingencies Disclosure [Abstract]
Litigation Settlement, Expense	$ 0.3	$ 3.5
Other commitment payment obligation			$ 2.8
Loss Contingency Accrual			$ 0.7	$ 1.3

XML

Stockholders' Equity (Details) - USD ($) $ / shares in Units, $ in Millions		1 Months Ended	6 Months Ended
	Oct. 09, 2019	Oct. 05, 2018	Feb. 27, 2021	Feb. 29, 2020	Oct. 04, 2018	Jul. 06, 2017
Class of Stock [Line Items]
Shares, Issued	13,379,205
Shares issued price per share to public	$ 26.35
Underwriting discounts and commissions, Price per share	0.19
Shares issued proceeds per shares	$ 26.16
Proceeds from issuance of equity	$ 350.0
Equity Issuance costs, Legal	$ 0.8
Repurchase of common stock (in shares)			0	0
Stock Repurchase Program, Remaining Authorized Repurchase Amount			$ 47.9
Number of Warrants Exercised in Exchange for Common Stock		9,866,451
Cash received from warrant exercises		$ 113.5
Common Shares Surrendered For Each Public Warrant Surrendered					0.61885
Common Shares Received for each Public Warrant Surrendered					0.38115
Public Warrants Exercised		3,499,639
Common Shares Issued for Public Warrant Exercises		1,333,848
Private Placement Warrants
Class of Stock [Line Items]
Class of Warrant or Right, Outstanding			6,700,000			6,700,000
Public Warrants
Class of Stock [Line Items]
Class of Warrant or Right, Outstanding						13,416,667
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 11.50
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 11.50
Treasury Stock
Class of Stock [Line Items]
Stock repurchase program, authorized amount			$ 50.0

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Feb. 27, 2021	Nov. 28, 2020	Feb. 29, 2020	Nov. 30, 2019	Feb. 27, 2021	Feb. 29, 2020
Earnings per share, diluted
Fair Value Adjustment of Warrants	$ 45,334		$ (37,644)		$ 24,881	$ (50,952)
Numerator:
Net income	$ (26,214)	$ 42,953	$ 48,301	$ 8,515	$ 16,739	$ 56,816
Denominator:
Weighted average common shares - basic (in shares)	95,734,591		95,339,489		95,712,057	92,524,061
Basic earnings per share from net income (in dollars per share)	$ (0.27)		$ 0.51		$ 0.17	$ 0.61
Numerator:
Net income	$ (26,214)	$ 42,953	$ 48,301	$ 8,515	$ 16,739	$ 56,816
Denominator:
Weighted average common shares - basic (in shares)	95,734,591		95,339,489		95,712,057	92,524,061
Public and Private Warrants	0		3,706,986		0	3,766,141
Employee stock options	0		1,173,631		1,056,707	1,194,968
Non-vested shares	0		116,465		228,248	112,444
Weighted average common shares - diluted (in shares)	95,734,591		100,336,571		96,997,012	97,597,614
Diluted earnings per share from net income (in dollars per share)	$ (0.27)		$ 0.11		$ 0.17	$ 0.06
Fair Value Adjustment of Warrants	$ 45,334		$ (37,644)		$ 24,881	$ (50,952)
Numerator for Diluted Earnings	(26,214)		10,657		16,739	5,864
Private Warrants
Earnings per share, diluted
Fair Value Adjustment of Warrants	0		(37,644)		0	(50,952)
Denominator:
Fair Value Adjustment of Warrants	$ 0		$ (37,644)		$ 0	$ (50,952)
Stock Options
Earnings per share, diluted
Antidilutive securities excluded from computation of earnings per share	1,400,000		400,000		600,000	300,000
Restricted Stock Units
Earnings per share, diluted
Antidilutive securities excluded from computation of earnings per share	300,000				0.0
Private Warrants
Earnings per share, diluted
Antidilutive securities excluded from computation of earnings per share	3,900,000				3,600,000

XML

Omnibus Incentive Plan (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Feb. 27, 2021	Nov. 28, 2020	Feb. 29, 2020	Nov. 30, 2019	Feb. 27, 2021	Feb. 29, 2020
Share-based Compensation Arrangement by Share-based Payment Award
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	$ 2,484	$ 1,110	$ 2,122	$ 1,673
Stock compensation expense	$ 2,500		$ 2,100		$ 3,594	$ 3,795

XML

Omnibus Incentive Plan - Stock Options Activity (Details) $ / shares in Units, $ in Thousands	6 Months Ended
	Feb. 27, 2021 USD ($) $ / shares shares	Feb. 29, 2020 USD ($)
Additional disclosures
Proceeds from option exercises | $	$ 527	$ 931
Stock Options
Shares
Outstanding at beginning of period (in shares) | shares	2,615,899
Granted (in shares) | shares	289,555
Exercised (in shares) | shares	(43,928)
Forfeited (in shares) | shares	(39,575)
Outstanding at end of period (in shares) | shares	2,821,951
Options vested or expected to vest (in shares) | shares	2,821,951
Exercisable (in shares) | shares	2,197,655
Weighted average exercise price
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 14.33
Granted (in dollars per share) | $ / shares	20.47
Exercised (in dollars per share) | $ / shares	12.00
Forfeited (in dollars per share) | $ / shares	23.08
Outstanding at end of period (in dollars per share) | $ / shares	14.88
Options vested or expected to vest (in dollars per share) | $ / shares	14.88
Exercisable (in dollars per share) | $ / shares	$ 13.24
Weighted average remaining contractual term
Outstanding at end of period, weighted average remaining contractual life	7 years 1 month 9 days
Vested and expected to vest at end of period, weighted average remaining contractual life	7 years 1 month 9 days
Exercisable at end of period, weighted average remaining contractual life	6 years 7 months 9 days
Additional disclosures
Unrecognized compensation costs | $	$ 3,500
Period for recognition of unrecognized compensation cost	1 year 10 months 24 days
Proceeds from option exercises | $	$ 500	$ 900

XML

Omnibus Incentive Plan - Restricted Stock Units Activity (Details) - Restricted Stock Units $ / shares in Units, $ in Millions	6 Months Ended
	Feb. 27, 2021 USD ($) $ / shares shares
Units
Non-vested at beginning of period (in shares) | shares	208,023
Granted (in shares) | shares	311,873
Vested (in shares) | shares	(72,568)
Forfeited (in shares) | shares	(15,706)
Non-vested at end of period (in shares) | shares	431,622
Weighted average grant-date fair value
Non-vested at beginning of period (in dollars per share) | $ / shares	$ 22.82
Granted (in dollars per share) | $ / shares	21.57
Vested (in dollars per share) | $ / shares	25.89
Forfeited (in dollars per share) | $ / shares	22.99
Non-vested at end of period (in dollars per share) | $ / shares	$ 21.39
Additional disclosures
Unrecognized compensation costs | $	$ 7.6
Period for recognition of unrecognized compensation cost	2 years 2 months 12 days

XML

Omnibus Incentive Plan - Performance Stock Units Activity (Details) - Performance Stock Units $ / shares in Units, $ in Millions	6 Months Ended
	Feb. 27, 2021 USD ($) $ / shares shares
Units
Non-vested at beginning of period (in shares) | shares	295,256
Granted (in shares) | shares	116,309
Vested (in shares) | shares	0
Forfeited (in shares) | shares	(26,400)
Non-vested at end of period (in shares) | shares	385,165
Weighted average grant-date fair value
Non-vested at beginning of period (in dollars per share) | $ / shares	$ 17.93
Granted (in dollars per share) | $ / shares	23.59
Vested (in dollars per share) | $ / shares	0
Forfeited (in dollars per share) | $ / shares	22.06
Non-vested at end of period (in dollars per share) | $ / shares	$ 19.35
Additional disclosures
Period for recognition of unrecognized compensation cost	1 year 7 months 6 days
Unrecognized compensation costs | $	$ 4.4
Requisite service period	3 years
Minimum
Additional disclosures
Performance stock vesting range	0.00%
Maximum
Additional disclosures
Performance stock vesting range	200.00%

XML

Omnibus Incentive Plan - Stock Appreciation Rights (Activity) (Details) - USD ($) $ / shares in Units, $ in Millions	6 Months Ended
	Feb. 27, 2021
Additional disclosures
Award vesting period	3 years
Award expiration period	10 years
Stock Appreciation Rights (SARs)
Shares
Outstanding at beginning of period (in shares)	150,000
Granted (in shares)	0
Exercised (in shares)	0
Forfeited (in shares)	0
Outstanding at end of period (in shares)	150,000
Options vested or expected to vest (in shares)	150,000
Exercisable (in shares)	0
Weighted average exercise price
Outstanding at beginning of period (in dollars per share)	$ 24.20
Granted (in dollars per share)	0
Exercised (in dollars per share)	0
Forfeited (in dollars per share)	0
Outstanding at end of period (in dollars per share)	24.20
Options vested or expected to vest (in dollars per share)	24.20
Exercisable (in dollars per share)	$ 0
Weighted average remaining contractual term
Vested and expected to vest at end of period, weighted average remaining contractual life	8 years 8 months 4 days
Outstanding at end of period, weighted average remaining contractual life	8 years 8 months 4 days
Exercisable at end of period, weighted average remaining contractual life	0 years
Additional disclosures
Unrecognized compensation costs	$ 0.2
Period for recognition of unrecognized compensation cost	1 year 8 months 12 days

XML

Restructuring and related charges (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Feb. 27, 2021	Feb. 27, 2021	Feb. 29, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring, Incurred cost	$ 1,300	$ 3,800
Restructuring and Related Cost, Cost Incurred to Date	9,300	9,300
Changes to the restructuring liability
Balance as of August 29, 2020		4,139
Charges		3,262
Cash payments		(6,290)
Non-cash settlements or adjustments		0
Balance as of February 27, 2021	1,111	1,111
Loss on operating lease right-of-use asset impairment	300	681	$ 0
(Gain) loss on Termination of Lease	(200)	(154)	$ 0
Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring, Expected cost	10,000	10,000
Changes to the restructuring liability
Balance as of August 29, 2020		4,139
Charges		3,118
Cash payments		(6,146)
Non-cash settlements or adjustments		0
Balance as of February 27, 2021	1,111	1,111
Other Restructuring
Changes to the restructuring liability
Balance as of August 29, 2020		0
Charges		144
Cash payments		(144)
Non-cash settlements or adjustments		0
Balance as of February 27, 2021	$ 0	$ 0